data_2n71_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n71 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.621 ' HB2' ' OE1' ' A' ' 34' ' ' GLN . 19.5 tptm . . . . . 0 N--CA 1.445 -0.68 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.59 120.59 20.36 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.732 0.777 . . . . 0.0 112.218 -166.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 51.0 t -136.57 145.68 45.24 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 169.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.9 m -147.77 63.13 1.13 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.499 0.666 . . . . 0.0 110.769 -172.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.416 ' HG3' ' HB3' ' A' ' 13' ' ' GLU . 7.6 ptt180 -88.73 -18.72 27.24 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.147 176.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.416 ' HB3' ' HG3' ' A' ' 12' ' ' ARG . 37.8 tt0 -179.76 161.45 0.99 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.739 -1.119 . . . . 0.0 107.994 -163.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -121.11 92.03 3.66 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.896 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.577 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 16.5 m-85 -121.06 99.22 46.76 Favored Pre-proline 0 CA--C 1.501 -0.925 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 164.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -83.23 138.71 8.98 Favored 'Trans proline' 0 N--CA 1.437 -1.83 0 C-N-CA 121.17 1.247 . . . . 0.0 112.614 -171.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -140.23 164.52 22.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.126 177.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.5 t -116.35 131.3 56.98 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.516 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -85.74 156.04 29.76 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.416 -0.897 . . . . 0.0 111.113 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.808 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 68.5 m -57.71 -11.68 2.36 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -175.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -77.23 -6.8 54.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.664 0.745 . . . . 0.0 109.914 173.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.03 28.29 37.95 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 -174.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.456 HG13 ' CE2' ' A' ' 25' ' ' TYR . 3.1 p -105.61 140.94 22.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 120.945 0.402 . . . . 0.0 111.975 -172.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.7 m -84.29 120.98 26.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.327 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.516 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 59.2 m-85 -107.51 128.47 54.54 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.845 175.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.6 m -66.77 -25.66 66.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.315 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.581 ' OD1' ' HB3' ' A' ' 29' ' ' CYS . 7.4 p30 -171.54 170.36 2.7 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -177.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 79.3 Cg_exo -50.19 -42.13 47.77 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.46 2.107 . . . . 0.0 112.454 176.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.581 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 35.7 t -57.77 -40.75 80.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.883 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.51 -45.03 94.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.049 177.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -64.32 -48.42 75.66 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.013 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.4 t -63.99 -52.21 60.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.39 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.43 -45.33 84.25 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 120.961 0.41 . . . . 0.0 111.508 -173.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.621 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 7.7 tp60 -64.12 -41.23 97.31 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.283 -177.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.66 ' NE2' HD12 ' A' ' 42' ' ' ILE . 59.7 mt-30 -77.76 -36.6 50.42 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -176.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -64.52 -26.13 68.29 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.276 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.579 HE22 ' HG2' ' A' ' 8' ' ' LYS . 8.2 mt-30 -86.84 -36.86 18.24 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.75 0.31 . . . . 0.0 111.661 173.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.6 m -112.26 -79.15 0.58 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -169.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.453 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 8.8 t70 -126.43 91.44 47.61 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.515 -172.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -68.96 -12.12 33.58 Favored 'Trans proline' 0 C--N 1.332 -0.301 0 C-N-CA 122.858 2.372 . . . . 0.0 112.142 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -88.67 -12.94 40.99 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -166.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.808 ' HB ' ' HB2' ' A' ' 20' ' ' SER . 10.5 pt -80.35 162.29 3.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.581 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.7 p -121.54 169.2 10.9 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.148 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.1 mt -69.98 117.83 13.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.7 -48.37 26.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.287 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -160.75 154.69 22.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.839 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -73.56 140.34 46.22 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.82 141.21 10.42 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.391 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -56.92 144.19 34.66 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 122.447 0.299 . . . . 0.0 111.143 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.915 -0.564 . . . . 0.0 111.203 -176.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.553 ' HZ3' ' HB3' ' A' ' 8' ' ' LYS . 2.0 mmmp? . . . . . 0 N--CA 1.449 -0.475 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.08 117.95 17.49 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.795 0.807 . . . . 0.0 112.706 -165.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 36.5 t -138.55 145.58 40.84 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 168.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.8 m -157.83 66.29 0.48 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.814 0.816 . . . . 0.0 110.602 -177.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -101.26 8.89 42.29 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 173.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 178.03 154.58 0.34 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 113.984 -1.462 . . . . 0.0 107.896 -171.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -128.32 92.52 3.45 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.494 174.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.672 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 30.9 m-85 -122.54 101.29 40.43 Favored Pre-proline 0 N--CA 1.441 -0.917 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 164.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -81.78 138.68 10.67 Favored 'Trans proline' 0 N--CA 1.439 -1.703 0 C-N-CA 120.92 1.08 . . . . 0.0 111.586 -172.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.7 m -140.32 169.69 15.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.131 0.491 . . . . 0.0 109.997 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.6 t -117.03 129.61 56.13 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.318 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.06 144.69 26.35 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 174.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.45 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 50.8 p -61.29 -11.42 9.63 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -171.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -73.88 -10.18 59.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.501 0.667 . . . . 0.0 109.662 171.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.85 25.64 14.53 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.744 -178.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.527 HG11 ' CE2' ' A' ' 25' ' ' TYR . 3.1 p -106.73 142.0 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.438 -175.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.522 HG21 ' HA ' ' A' ' 49' ' ' GLU . 85.8 m -84.21 119.47 25.06 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 120.959 0.409 . . . . 0.0 110.643 -178.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.527 ' CE2' HG11 ' A' ' 23' ' ' VAL . 37.0 m-85 -106.87 132.91 52.29 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.525 0.678 . . . . 0.0 111.08 177.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.3 t -64.88 -31.37 72.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.186 -172.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.672 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 26.8 p30 -175.5 170.7 1.3 Allowed Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.55 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 82.0 Cg_exo -50.2 -40.92 51.36 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.316 2.011 . . . . 0.0 112.508 176.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 35.2 t -54.46 -48.64 71.51 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.094 0.473 . . . . 0.0 110.569 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -66.62 -46.37 76.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.486 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.52 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 38.3 t80 -63.73 -48.09 78.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.521 0.201 . . . . 0.0 110.947 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.5 p -64.1 -50.65 67.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.013 -175.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.479 ' HA ' ' HG2' ' A' ' 36' ' ' GLU . . . -65.3 -44.44 87.92 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.071 0.462 . . . . 0.0 110.937 -176.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -63.52 -37.38 87.07 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.446 0.641 . . . . 0.0 110.395 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.576 ' HG3' ' O ' ' A' ' 39' ' ' ASP . 2.1 mp0 -77.61 -37.59 49.95 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.873 -177.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.479 ' HG2' ' HA ' ' A' ' 33' ' ' ALA . 12.8 pt-20 -73.62 -27.76 61.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.842 0.353 . . . . 0.0 110.762 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.438 HE21 ' HB2' ' A' ' 37' ' ' GLN . 11.0 mt-30 -91.36 -34.09 15.02 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.774 -178.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 64.2 m -119.96 -74.88 0.59 Allowed 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.068 -0.653 . . . . 0.0 112.761 -169.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.576 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 4.8 t0 -115.33 97.96 49.51 Favored Pre-proline 0 C--N 1.326 -0.444 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.113 -175.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.14 -13.23 31.06 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 123.2 2.6 . . . . 0.0 113.698 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -85.57 -21.85 28.34 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -163.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.571 HD13 ' NE2' ' A' ' 35' ' ' GLN . 6.5 pt -87.99 154.1 3.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 119.294 -0.963 . . . . 0.0 111.126 -175.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.5 p -127.88 169.68 13.66 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.515 -1.221 . . . . 0.0 109.036 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mp -68.87 119.41 14.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.53 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 20' ' ' SER . . . -81.18 -46.15 15.3 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.428 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -168.02 157.13 9.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.561 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 87.7 mtp -79.99 130.56 35.37 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.63 162.2 11.56 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 -173.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.522 ' HA ' HG21 ' A' ' 24' ' ' THR . 0.5 OUTLIER -73.35 147.93 43.92 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.067 0.46 . . . . 0.0 111.095 -178.8 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.832 -0.604 . . . . 0.0 111.033 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.544 ' HB2' ' OE1' ' A' ' 34' ' ' GLN . 6.6 tmtm? . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.44 117.63 16.48 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.896 0.855 . . . . 0.0 112.184 -166.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.538 ' SG ' ' HG3' ' A' ' 12' ' ' ARG . 44.5 t -138.51 146.38 41.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.103 -1.408 . . . . 0.0 107.494 172.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.2 m -152.54 64.22 0.81 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.79 0.805 . . . . 0.0 110.144 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.538 ' HG3' ' SG ' ' A' ' 10' ' ' CYS . 21.2 mtm180 -104.27 0.78 29.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.291 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 177.02 153.16 0.21 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 113.837 -1.529 . . . . 0.0 107.129 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 65.2 t-105 -117.45 92.21 3.78 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.847 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.661 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 37.3 m-85 -122.87 101.9 38.71 Favored Pre-proline 0 N--CA 1.434 -1.237 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 164.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.16 137.95 12.43 Favored 'Trans proline' 0 N--CA 1.441 -1.606 0 C-N-CA 120.546 0.83 . . . . 0.0 111.566 -172.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.0 m -138.01 173.86 11.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.044 0.45 . . . . 0.0 110.101 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.1 t -122.73 132.5 54.27 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.634 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.11 146.5 25.26 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 173.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.606 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 10.0 t -57.95 -13.92 5.4 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -172.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.45 ' HB2' HG22 ' A' ' 42' ' ' ILE . 31.4 t70 -74.94 -8.41 56.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.51 0.671 . . . . 0.0 109.924 174.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.47 25.38 21.24 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.287 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.5 p -105.73 140.88 22.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.921 0.391 . . . . 0.0 111.285 -173.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.405 HG21 ' HA ' ' A' ' 49' ' ' GLU . 36.8 m -85.15 123.77 31.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.19 0.519 . . . . 0.0 111.239 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -111.51 137.47 49.3 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.933 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 65.5 m -68.4 -26.09 65.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.229 -175.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.661 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 30.8 p30 -172.67 171.96 1.8 Allowed Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.554 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 75.5 Cg_exo -52.34 -39.87 71.92 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.379 2.053 . . . . 0.0 112.597 176.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.42 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 21.5 t -55.14 -44.91 75.52 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.959 0.409 . . . . 0.0 110.558 176.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.428 ' C ' HD21 ' A' ' 30' ' ' ASN . 0.2 OUTLIER -61.68 -46.45 89.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.367 179.207 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -65.96 -47.9 73.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.928 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.7 t -63.58 -49.26 74.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.571 -174.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.456 ' HA ' ' HG2' ' A' ' 36' ' ' GLU . . . -64.78 -44.92 88.44 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.706 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.544 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 7.5 tp60 -62.65 -40.79 98.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.543 0.687 . . . . 0.0 110.398 -177.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.556 ' HG3' ' O ' ' A' ' 39' ' ' ASP . 2.2 mp0 -76.08 -36.29 59.01 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.98 -177.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.456 ' HG2' ' HA ' ' A' ' 33' ' ' ALA . 11.1 pt-20 -67.08 -42.92 83.83 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.364 -178.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -111.74 5.85 19.42 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -175.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 34' ' ' GLN . 66.5 m -135.0 -63.25 0.7 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.158 0.89 . . . . 0.0 113.0 175.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.556 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 8.6 t0 -116.94 92.57 39.31 Favored Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 118.808 0.731 . . . . 0.0 110.7 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -72.08 -12.95 28.53 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.43 2.753 . . . . 0.0 113.374 -177.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -92.62 -21.86 19.8 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -163.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.606 ' HB ' ' HB3' ' A' ' 20' ' ' SER . 19.0 pt -90.72 160.04 2.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.835 0.826 . . . . 0.0 112.363 -174.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.5 p -123.22 169.37 11.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.323 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.5 mt -65.17 119.29 9.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 175.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.53 -50.69 10.35 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.523 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -164.76 161.43 20.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 44.7 tpp -75.92 139.25 41.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.025 173.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 107.33 159.73 21.17 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.53 -176.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.405 ' HA ' HG21 ' A' ' 24' ' ' THR . 0.8 OUTLIER -73.69 149.12 42.11 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.916 0.389 . . . . 0.0 111.04 -178.64 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.331 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.13 118.67 30.62 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.961 -174.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 30' ' ' ASN . 21.2 p -137.34 148.68 46.48 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 168.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.7 m -148.89 89.0 1.64 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.408 0.623 . . . . 0.0 111.381 -175.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -109.67 -19.8 13.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.527 173.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -177.61 163.92 1.97 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -169.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -118.28 92.99 3.97 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.156 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.659 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 15.3 m-85 -122.67 101.09 40.27 Favored Pre-proline 0 N--CA 1.441 -0.911 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 164.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.59 140.04 11.62 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 121.345 1.363 . . . . 0.0 112.487 -172.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' A' ' 25' ' ' TYR . 27.2 m -143.29 170.91 9.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.98 0.419 . . . . 0.0 109.944 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 18.5 t -123.63 139.41 54.03 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.495 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -94.5 156.96 22.27 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.285 177.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.871 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 64.1 m -57.22 -12.67 2.45 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -174.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -76.71 -7.92 56.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.841 0.829 . . . . 0.0 109.712 173.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.04 28.68 36.55 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -173.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.514 HG11 ' CE2' ' A' ' 25' ' ' TYR . 2.7 p -101.48 140.8 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 121.066 0.46 . . . . 0.0 111.427 -172.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.515 HG21 ' N ' ' A' ' 50' ' ' CYS . 1.3 m -82.49 117.27 22.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.252 -177.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.514 ' CE2' HG11 ' A' ' 23' ' ' VAL . 52.3 m-85 -106.56 130.42 54.33 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-O 121.269 0.556 . . . . 0.0 110.744 176.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.4 t -70.29 -26.86 64.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.746 -174.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.675 ' HB2' ' HD2' ' A' ' 28' ' ' PRO . 26.1 p-10 178.25 173.9 0.38 Allowed Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -173.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.675 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 79.6 Cg_exo -47.8 -49.48 13.56 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 123.219 2.613 . . . . 0.0 114.901 -176.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.455 ' SG ' ' ND2' ' A' ' 27' ' ' ASN . 7.8 p -59.27 -35.77 74.34 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.044 0.45 . . . . 0.0 111.058 -177.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.402 ' N ' ' SG ' ' A' ' 10' ' ' CYS . 2.1 t-20 -64.84 -46.02 83.66 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.946 -178.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.422 ' HD2' ' CD2' ' A' ' 25' ' ' TYR . 65.0 t80 -65.4 -47.92 74.62 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.129 0.49 . . . . 0.0 109.726 178.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.8 t -64.03 -51.71 62.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.905 -175.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.47 ' O ' ' HG2' ' A' ' 37' ' ' GLN . . . -69.01 -44.09 73.46 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.088 0.47 . . . . 0.0 111.452 -175.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -62.47 -41.66 98.93 Favored 'General case' 0 C--O 1.215 -0.715 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.949 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.637 ' NE2' HD12 ' A' ' 42' ' ' ILE . 61.9 mt-30 -78.69 -35.91 44.33 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 33' ' ' ALA . 12.8 pt-20 -61.94 -27.94 69.18 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.797 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.616 ' HG3' ' SG ' ' A' ' 38' ' ' CYS . 20.6 pt20 -100.85 -38.06 8.41 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 119.488 -0.885 . . . . 0.0 112.793 174.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.616 ' SG ' ' HG3' ' A' ' 37' ' ' GLN . 17.7 m -96.12 -77.98 0.47 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.897 -169.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 5.8 t0 -124.13 89.76 51.46 Favored Pre-proline 0 C--N 1.331 -0.207 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.06 -175.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.32 -11.8 32.27 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 123.315 2.677 . . . . 0.0 112.836 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -79.66 -21.81 44.28 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -167.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.871 ' HB ' ' HB2' ' A' ' 20' ' ' SER . 9.0 pt -85.62 161.91 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.406 -175.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.96 169.5 12.04 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.258 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.4 mt -65.4 117.89 6.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.242 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.84 -44.24 50.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.005 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -166.96 151.58 7.23 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.38 176.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -73.54 139.4 45.61 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 108.67 145.14 11.24 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -171.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.46 ' HB2' ' CG2' ' A' ' 24' ' ' THR . 0.9 OUTLIER -73.97 145.64 44.48 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.996 0.398 . . . . 0.0 110.692 -175.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.515 ' N ' HG21 ' A' ' 24' ' ' THR . 1.3 m . . . . . 0 C--O 1.242 0.697 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.32 173.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.8 mmtt . . . . . 0 CA--C 1.512 -0.481 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.55 115.42 16.29 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.49 -173.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 48.8 t -139.98 146.1 38.68 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 167.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -168.0 56.17 0.06 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.642 0.734 . . . . 0.0 110.641 -172.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -80.72 -23.81 39.23 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.265 175.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -163.31 157.66 20.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.612 -1.176 . . . . 0.0 107.923 -177.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 71.2 t-105 -112.42 94.43 4.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.403 0.62 . . . . 0.0 111.038 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.555 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 30.4 m-85 -120.33 100.02 47.78 Favored Pre-proline 0 N--CA 1.442 -0.852 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 165.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -81.36 138.37 10.99 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 120.996 1.131 . . . . 0.0 113.266 -168.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.23 174.15 6.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.504 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.0 t -126.7 138.61 53.42 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.447 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.83 153.14 21.79 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 175.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.565 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 16.2 m -56.81 -15.17 4.22 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -174.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -74.01 -7.82 53.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.691 0.758 . . . . 0.0 109.968 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.09 27.89 29.84 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -175.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.418 HG11 ' CE2' ' A' ' 25' ' ' TYR . 3.6 p -105.73 140.73 22.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.269 -0.466 . . . . 0.0 111.18 -172.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.404 HG21 ' HA ' ' A' ' 49' ' ' GLU . 42.0 m -85.05 122.19 28.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.98 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.418 ' CE2' HG11 ' A' ' 23' ' ' VAL . 29.7 m-85 -109.91 133.07 53.57 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.225 177.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.8 m -65.97 -34.6 78.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.586 -173.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 8.2 p30 -178.07 177.23 0.43 Allowed Pre-proline 0 C--O 1.237 0.403 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.532 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 95.7 Cg_exo -46.03 -43.21 20.48 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 122.821 2.347 . . . . 0.0 114.765 -177.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 29.1 p -60.96 -37.33 82.0 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.222 0.465 . . . . 0.0 110.695 -177.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -67.89 -46.27 72.09 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.541 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.526 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 62.7 t80 -65.95 -46.7 77.19 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 176.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 39.3 t -63.39 -50.88 68.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.515 -176.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.56 ' O ' ' HG2' ' A' ' 37' ' ' GLN . . . -68.07 -44.79 75.5 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 120.78 0.324 . . . . 0.0 111.018 -175.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.8 tp60 -65.85 -35.4 80.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.223 0.535 . . . . 0.0 110.246 -177.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.782 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -77.43 -36.7 52.85 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.365 -177.665 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.487 ' HG2' ' HA ' ' A' ' 33' ' ' ALA . 9.5 pt-20 -70.92 -28.05 64.23 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.105 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.61 ' HG3' ' SG ' ' A' ' 38' ' ' CYS . 9.7 pt20 -99.79 -35.16 9.88 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.069 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.61 ' SG ' ' HG3' ' A' ' 37' ' ' GLN . 25.0 m -104.49 -77.57 0.58 Allowed 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.805 -172.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 9.2 t70 -118.08 99.3 51.89 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.885 0.374 . . . . 0.0 111.136 -175.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.23 -13.95 25.68 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 123.111 2.541 . . . . 0.0 112.92 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -86.43 -21.75 26.93 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -164.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.782 HD11 ' NE2' ' A' ' 35' ' ' GLN . 23.5 pt -85.67 166.21 2.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.608 -177.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.8 p -132.12 170.56 14.8 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.317 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.3 mt -65.77 118.16 7.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 175.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.26 -43.55 27.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.52 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -164.38 157.69 17.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.545 177.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.77 138.48 36.28 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 175.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 110.69 151.89 12.77 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -173.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.404 ' HA ' HG21 ' A' ' 24' ' ' THR . 14.2 pt-20 -65.54 149.4 50.12 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.75 0.31 . . . . 0.0 111.269 -178.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.134 0 CA-C-O 119.225 -0.417 . . . . 0.0 110.464 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp . . . . . 0 N--CA 1.455 -0.208 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.08 121.96 27.23 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.358 0.599 . . . . 0.0 112.286 -171.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 46.8 t -136.32 147.44 47.43 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 170.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.0 m -153.42 67.21 0.77 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.406 0.622 . . . . 0.0 111.805 -174.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.3 ptt85 -110.87 -3.05 15.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.236 0.541 . . . . 0.0 109.82 172.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 174.63 151.33 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.592 -1.186 . . . . 0.0 108.396 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -110.02 94.62 5.11 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.143 0.497 . . . . 0.0 110.366 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.751 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 31.2 m-85 -120.52 100.44 47.06 Favored Pre-proline 0 N--CA 1.441 -0.901 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 167.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.93 138.52 10.4 Favored 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 121.02 1.146 . . . . 0.0 111.744 -172.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.2 m -143.75 176.98 2.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.125 0.488 . . . . 0.0 110.292 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.2 t -124.7 130.25 52.06 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.319 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.67 147.71 29.81 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 174.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.89 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 32.7 t -57.85 -12.58 3.24 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -172.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -77.59 -7.95 57.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.702 0.763 . . . . 0.0 110.214 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.14 24.96 20.94 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -176.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.431 HG12 ' CE2' ' A' ' 25' ' ' TYR . 3.2 p -106.01 140.96 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 120.934 0.397 . . . . 0.0 111.269 -174.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.9 m -83.73 124.52 30.96 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.383 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.497 ' HE1' ' HG2' ' A' ' 34' ' ' GLN . 29.9 m-85 -113.05 135.85 53.34 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.421 177.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.1 m -69.24 -29.07 66.92 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.422 -173.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.751 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 28.6 p30 -170.17 168.8 4.13 Favored Pre-proline 0 C--O 1.236 0.353 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.518 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 72.3 Cg_exo -50.6 -38.19 54.51 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.515 2.143 . . . . 0.0 112.515 177.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.428 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 7.6 t -55.21 -50.9 68.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.551 176.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -62.14 -45.26 94.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.735 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.526 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 58.7 t80 -61.17 -49.13 78.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.305 0.098 . . . . 0.0 111.028 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.492 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 16.2 t -65.86 -51.0 62.55 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.485 0.18 . . . . 0.0 111.485 -177.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.66 -43.51 93.37 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.487 0.661 . . . . 0.0 110.995 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.497 ' HG2' ' HE1' ' A' ' 25' ' ' TYR . 9.5 tp60 -64.68 -36.92 85.85 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.166 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.71 ' HG3' ' O ' ' A' ' 39' ' ' ASP . 2.2 mp0 -72.81 -44.39 61.53 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.383 -176.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 32' ' ' SER . 9.3 pt-20 -63.68 -31.01 72.05 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.092 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.481 ' NE2' ' HG3' ' A' ' 36' ' ' GLU . 2.9 mp0 -87.32 -35.09 18.61 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 177.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 18.7 m -108.59 -80.7 0.57 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -171.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.71 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 55.8 t0 -126.14 83.91 62.61 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 120.871 0.367 . . . . 0.0 110.662 -172.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -67.99 -12.64 35.89 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 123.446 2.764 . . . . 0.0 114.13 -170.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -99.54 11.71 38.43 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -169.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.89 ' HB ' ' HB3' ' A' ' 20' ' ' SER . 12.5 pt -97.31 151.36 4.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.371 174.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -107.54 167.67 9.78 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.361 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.2 mt -70.33 118.94 15.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 173.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.24 -51.07 16.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.473 -176.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -160.75 158.43 28.61 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.271 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.4 tpt -71.3 145.03 49.76 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.003 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.35 154.45 30.75 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.609 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -62.53 149.28 43.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.821 0.344 . . . . 0.0 110.699 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.86 -0.59 . . . . 0.0 110.842 -173.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 8' ' ' LYS . 65.2 mmtt . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.69 120.44 21.08 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.872 0.844 . . . . 0.0 113.104 -162.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 43.4 t -128.55 147.2 50.68 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 168.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.9 m -150.21 61.98 0.97 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.554 0.693 . . . . 0.0 111.326 -175.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -91.52 -13.38 32.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.697 174.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -173.71 157.5 3.12 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -173.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 67.2 t-105 -119.07 92.99 3.93 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.038 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.723 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 14.6 m-85 -122.15 101.06 41.88 Favored Pre-proline 0 CA--C 1.501 -0.92 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 166.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -80.88 138.1 11.44 Favored 'Trans proline' 0 N--CA 1.443 -1.475 0 C-N-CA 120.697 0.931 . . . . 0.0 111.767 -172.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.4 m -142.77 -179.9 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.361 -177.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.4 t -127.98 134.57 49.28 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.583 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.47 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -82.69 147.58 25.36 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 174.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.639 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 10.6 t -57.88 -13.77 4.98 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -172.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.446 ' HB2' HG22 ' A' ' 42' ' ' ILE . 18.6 t70 -76.83 -8.53 57.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.531 0.681 . . . . 0.0 109.931 175.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.49 26.39 17.99 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.377 -177.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.593 HG11 ' CE2' ' A' ' 25' ' ' TYR . 2.5 p -106.57 141.93 20.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 120.698 0.285 . . . . 0.0 111.721 -174.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.7 m -83.63 126.86 33.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.23 -176.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.593 ' CE2' HG11 ' A' ' 23' ' ' VAL . 51.2 m-85 -117.07 137.99 51.9 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.408 0.623 . . . . 0.0 111.894 177.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.7 m -70.21 -28.37 65.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.121 -175.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.723 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 26.6 p30 -173.84 169.33 2.04 Favored Pre-proline 0 C--O 1.234 0.285 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.549 -177.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.543 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 78.3 Cg_exo -51.47 -42.13 56.76 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.473 2.115 . . . . 0.0 112.416 177.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 41.5 t -54.72 -45.36 74.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.093 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.462 ' C ' HD21 ' A' ' 30' ' ' ASN . 0.2 OUTLIER -62.43 -47.58 83.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.953 -179.521 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.58 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 55.3 t80 -66.57 -48.11 70.64 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.569 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.422 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 22.2 t -63.79 -50.63 68.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.052 -174.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.92 -45.43 74.37 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.169 0.509 . . . . 0.0 111.126 -175.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.417 ' OE1' ' HE1' ' A' ' 25' ' ' TYR . 22.0 tt0 -65.57 -31.9 73.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.172 0.511 . . . . 0.0 110.695 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.773 ' NE2' HD13 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -78.15 -46.97 19.18 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.367 -177.136 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.619 ' HG3' ' HG3' ' A' ' 37' ' ' GLN . 11.7 pt-20 -61.57 -30.59 70.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.875 0.369 . . . . 0.0 110.481 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.619 ' HG3' ' HG3' ' A' ' 36' ' ' GLU . 10.9 mt-30 -94.29 -34.81 12.7 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.57 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 59.8 m -120.13 -65.82 1.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -170.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.495 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 0.7 OUTLIER -116.19 74.66 5.7 Favored Pre-proline 0 N--CA 1.465 0.312 0 CA-C-O 120.729 0.299 . . . . 0.0 111.667 -173.005 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.57 ' HD3' ' O ' ' A' ' 38' ' ' CYS . 6.9 Cg_exo -72.62 -13.11 27.21 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 123.131 2.554 . . . . 0.0 112.698 -174.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -77.36 -20.99 53.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.346 -169.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.773 HD13 ' NE2' ' A' ' 35' ' ' GLN . 10.9 pt -95.32 153.13 3.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.597 -175.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.426 ' O ' ' HB2' ' A' ' 20' ' ' SER . 22.1 p -112.23 168.21 9.8 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.624 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.0 mt -65.93 118.71 9.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.97 -50.82 11.4 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.699 -176.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -166.0 163.27 18.35 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.2 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 86.5 mmm -74.89 146.59 41.74 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 173.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.52 146.37 18.41 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.658 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.41 149.19 50.78 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.718 0.294 . . . . 0.0 110.983 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.976 -0.535 . . . . 0.0 110.978 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.439 -1.025 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.24 128.86 35.77 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -162.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 36.7 t -119.01 147.72 43.78 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 170.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.7 m -153.35 79.59 1.17 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.19 0.519 . . . . 0.0 111.919 -175.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -115.33 -29.09 6.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.4 0.619 . . . . 0.0 109.783 170.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -148.11 158.88 44.32 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -118.17 93.79 4.26 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.15 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.737 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 67.3 m-85 -121.39 99.78 45.35 Favored Pre-proline 0 CA--C 1.504 -0.799 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 164.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -81.77 139.61 11.17 Favored 'Trans proline' 0 N--CA 1.442 -1.537 0 C-N-CA 121.132 1.221 . . . . 0.0 112.558 -171.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.5 m -138.71 172.28 13.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 176.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 29.6 t -116.38 130.61 56.86 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.859 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.647 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -83.65 142.09 20.75 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 172.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.528 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 4.5 t -60.04 -11.04 4.95 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -171.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.472 ' HB2' HG21 ' A' ' 42' ' ' ILE . 19.2 t70 -74.28 -8.21 55.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.487 0.66 . . . . 0.0 109.504 173.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.1 24.91 23.5 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.357 -177.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.542 HG12 ' CE2' ' A' ' 25' ' ' TYR . 2.3 p -105.35 138.52 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 121.061 0.458 . . . . 0.0 111.423 -175.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.516 HG22 ' N ' ' A' ' 50' ' ' CYS . 7.6 m -85.06 116.46 23.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.564 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.647 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 47.5 m-85 -101.37 133.0 46.65 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.337 0.589 . . . . 0.0 111.704 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.9 m -64.18 -30.25 71.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.299 -1.319 . . . . 0.0 112.384 -175.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.737 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 22.1 p30 -174.58 169.6 1.72 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.463 -175.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.658 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 9.2 Cg_endo -52.39 -38.76 74.14 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.599 2.2 . . . . 0.0 112.022 176.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 33.3 t -55.22 -45.01 75.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.451 176.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.482 ' O ' ' HB3' ' A' ' 34' ' ' GLN . 0.2 OUTLIER -66.31 -46.26 77.52 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.961 -178.622 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.451 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 61.3 t80 -65.87 -48.06 72.82 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.517 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.58 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 19.9 t -64.37 -52.09 60.06 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.415 -175.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.524 ' O ' ' HB2' ' A' ' 37' ' ' GLN . . . -68.02 -42.85 80.01 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.014 0.435 . . . . 0.0 111.27 -174.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.482 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 42.4 tp60 -63.92 -34.64 78.43 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.416 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.766 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -78.01 -50.22 12.54 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.316 -178.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' A' ' 32' ' ' SER . 12.2 pt-20 -65.27 -26.51 68.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.732 0.301 . . . . 0.0 111.055 -177.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.524 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 2.4 mp0 -92.38 -33.84 14.4 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 82.4 m -133.49 -58.2 0.88 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -169.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.537 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 16.2 m-20 -114.54 68.98 1.98 Allowed Pre-proline 0 N--CA 1.467 0.386 0 CA-C-N 117.996 0.362 . . . . 0.0 111.764 -173.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.25 -14.25 28.44 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.42 2.08 . . . . 0.0 112.614 -174.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -89.06 -6.85 56.83 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -167.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.766 HD11 ' NE2' ' A' ' 35' ' ' GLN . 10.2 pt -91.7 170.79 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 119.964 -0.695 . . . . 0.0 110.941 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.3 p -126.61 168.64 14.03 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.733 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mp -72.27 119.47 18.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.528 ' HB2' ' HA ' ' A' ' 20' ' ' SER . . . -81.79 -46.72 13.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.751 -176.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 34.8 p80 -167.08 156.69 10.78 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.219 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 96.9 mmm -74.22 156.47 37.22 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 175.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.9 156.76 28.04 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.088 -1.053 . . . . 0.0 110.551 -173.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.449 ' HB2' ' CG2' ' A' ' 24' ' ' THR . 11.6 pt-20 -65.52 135.26 54.91 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.013 0.435 . . . . 0.0 110.292 -177.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.516 ' N ' HG22 ' A' ' 24' ' ' THR . 1.6 t . . . . . 0 C--O 1.251 1.171 0 CA-C-O 118.4 -0.809 . . . . 0.0 110.746 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 8' ' ' LYS . 64.2 mmtt . . . . . 0 N--CA 1.455 -0.221 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.79 119.41 19.75 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -162.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 78.4 m -127.55 146.08 50.64 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 165.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.2 m -154.22 28.95 0.45 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.215 1.007 . . . . 0.0 110.29 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -82.82 -5.06 58.78 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.865 177.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -171.76 150.94 2.75 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -167.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -128.81 93.62 3.66 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.666 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.69 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 77.0 m-85 -121.73 100.48 43.72 Favored Pre-proline 0 CA--C 1.501 -0.915 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 164.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.47 138.11 10.72 Favored 'Trans proline' 0 N--CA 1.441 -1.605 0 C-N-CA 120.555 0.837 . . . . 0.0 111.59 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.4 m -141.42 176.12 4.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.7 t -123.09 128.99 50.87 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.617 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.437 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -81.09 146.46 26.56 Favored Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 174.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.628 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 8.6 t -58.91 -12.79 4.91 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -172.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -74.08 -8.63 56.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.641 0.734 . . . . 0.0 110.128 173.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.92 26.84 23.25 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.12 -176.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.433 HG11 ' CE2' ' A' ' 25' ' ' TYR . 3.3 p -106.54 141.08 22.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.808 0.337 . . . . 0.0 111.384 -174.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.457 HG21 ' HA ' ' A' ' 49' ' ' GLU . 90.1 m -84.43 123.23 30.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.057 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.437 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 35.8 m-85 -109.84 136.13 49.64 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.563 0.697 . . . . 0.0 111.525 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.3 m -70.17 -32.07 69.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.323 -1.308 . . . . 0.0 112.361 -173.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.726 ' HB2' ' HD2' ' A' ' 28' ' ' PRO . 27.5 p30 -175.61 171.92 1.12 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.216 -174.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.726 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 6.1 Cg_endo -49.47 -41.49 43.87 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.736 2.291 . . . . 0.0 112.616 176.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.409 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 48.2 t -54.8 -50.62 68.09 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.163 0.506 . . . . 0.0 110.296 177.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -63.32 -45.92 89.05 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.296 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -65.74 -47.26 75.86 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.61 0.243 . . . . 0.0 110.818 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.434 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 41.6 t -63.61 -51.43 65.31 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.291 -176.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.45 -43.71 84.82 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 120.814 0.34 . . . . 0.0 110.828 -174.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.54 ' OE1' ' HA ' ' A' ' 34' ' ' GLN . 6.6 tp60 -64.06 -37.78 88.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.317 0.58 . . . . 0.0 110.576 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.814 ' NE2' HD13 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -74.8 -50.32 17.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.967 -178.017 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 32' ' ' SER . 12.8 pt-20 -64.8 -26.15 68.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.559 0.218 . . . . 0.0 111.477 -176.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -93.33 -35.94 12.8 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 98.9 m -124.74 -54.67 1.64 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -167.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -133.58 85.68 41.98 Favored Pre-proline 0 N--CA 1.465 0.313 0 CA-C-N 119.094 0.861 . . . . 0.0 111.38 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.98 -12.97 23.93 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 123.314 2.676 . . . . 0.0 112.751 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -81.72 -14.22 56.8 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.354 -165.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.814 HD13 ' NE2' ' A' ' 35' ' ' GLN . 9.9 pt -86.53 157.05 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.605 0.717 . . . . 0.0 111.0 -178.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.4 p -110.99 167.39 10.29 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.783 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mp -70.1 119.27 15.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 173.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.31 -48.7 19.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.279 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -168.93 158.69 8.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.31 176.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 25.9 ttt -77.75 140.07 39.44 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 172.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 110.68 161.15 17.7 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -172.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.457 ' HA ' HG21 ' A' ' 24' ' ' THR . 9.6 pt-20 -75.4 149.24 38.65 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.041 0.448 . . . . 0.0 111.234 -176.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.749 -0.643 . . . . 0.0 111.051 -177.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.0 tptp . . . . . 0 N--CA 1.446 -0.643 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.71 122.63 24.29 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.687 0.756 . . . . 0.0 112.366 -168.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 34.8 t -134.37 147.85 50.58 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 172.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.73 44.75 0.68 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -172.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -84.45 -13.82 50.97 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.593 0.711 . . . . 0.0 109.51 173.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -170.7 151.84 3.62 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.529 ' CZ3' ' HB3' ' A' ' 26' ' ' SER . 57.7 t-105 -118.82 91.84 3.66 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.008 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.708 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 10.4 m-85 -123.73 100.77 37.2 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 164.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -80.59 143.36 15.06 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 121.236 1.291 . . . . 0.0 112.499 -170.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.0 m -137.04 -179.03 2.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.944 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 18.8 t -129.35 131.88 46.97 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.34 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.9 151.19 36.95 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 176.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.608 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 31.2 t -59.65 -12.69 7.33 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -171.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -80.24 -8.49 59.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.26 0.553 . . . . 0.0 110.101 174.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.22 28.77 10.28 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 -175.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.441 HG13 ' CE2' ' A' ' 25' ' ' TYR . 3.6 p -104.86 141.73 19.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.03 0.443 . . . . 0.0 111.592 -172.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.55 HG22 ' N ' ' A' ' 50' ' ' CYS . 0.9 OUTLIER -82.43 121.78 27.17 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.2 -175.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.441 ' CE2' HG13 ' A' ' 23' ' ' VAL . 23.9 m-85 -116.67 134.0 55.34 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.241 0.543 . . . . 0.0 111.137 176.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.529 ' HB3' ' CZ3' ' A' ' 14' ' ' TRP . 16.9 m -67.28 -26.27 66.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.005 -173.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.708 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 25.7 p30 -179.62 175.6 0.42 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.114 -172.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.65 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 71.6 Cg_exo -51.67 -49.23 17.89 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.487 2.125 . . . . 0.0 113.636 177.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.8 p -62.38 -32.04 72.79 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.662 0.267 . . . . 0.0 111.117 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.457 ' C ' HD21 ' A' ' 30' ' ' ASN . 0.2 OUTLIER -63.38 -46.32 87.01 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.865 175.152 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.496 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 42.5 t80 -66.19 -47.48 73.78 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.329 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.3 m -62.43 -49.8 74.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.768 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.39 -44.07 79.81 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.323 0.582 . . . . 0.0 111.114 -177.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.1 tp60 -67.71 -34.39 76.79 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.263 -177.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.785 ' NE2' HD12 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -77.41 -37.98 50.71 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.282 -178.217 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.588 ' HG3' ' HG3' ' A' ' 37' ' ' GLN . 10.2 pt-20 -70.09 -29.89 66.98 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.631 -0.427 . . . . 0.0 111.052 -177.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.588 ' HG3' ' HG3' ' A' ' 36' ' ' GLU . 9.7 mt-30 -103.05 -35.99 8.33 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -177.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 10.0 m -107.64 -66.96 0.99 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -169.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -126.29 85.59 59.67 Favored Pre-proline 0 C--N 1.328 -0.33 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.9 -175.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.56 -13.12 27.38 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 123.119 2.546 . . . . 0.0 112.696 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -97.95 19.53 13.74 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -168.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.785 HD12 ' NE2' ' A' ' 35' ' ' GLN . 10.9 pt -115.74 156.67 16.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.736 172.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.449 ' H ' ' CB ' ' A' ' 20' ' ' SER . 0.2 OUTLIER -109.05 168.49 9.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.147 178.775 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.9 mp -66.25 119.24 10.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.498 ' HB1' ' HA ' ' A' ' 20' ' ' SER . . . -82.47 -47.42 12.24 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.094 0.473 . . . . 0.0 110.333 -177.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -168.47 158.55 9.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.198 176.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 82.5 mtp -81.55 154.2 26.36 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.08 135.56 8.82 Favored Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -170.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.457 ' HB2' ' CG2' ' A' ' 24' ' ' THR . 9.6 pt-20 -68.84 141.09 55.21 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.078 0.466 . . . . 0.0 111.266 -175.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.55 ' N ' HG22 ' A' ' 24' ' ' THR . 3.9 m . . . . . 0 C--O 1.245 0.825 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.179 172.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.597 ' HG2' HE22 ' A' ' 37' ' ' GLN . 24.4 tptp . . . . . 0 N--CA 1.446 -0.667 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.91 117.29 16.6 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 122.025 0.917 . . . . 0.0 112.852 -160.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.5 t -138.96 144.09 38.85 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 166.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.5 m -162.26 71.96 0.34 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.398 0.618 . . . . 0.0 110.621 -174.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.9 ppt_? -115.17 6.95 15.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.423 0.63 . . . . 0.0 109.953 176.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 178.99 148.22 0.21 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -174.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 64.2 t-105 -118.41 95.28 4.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.42 0.629 . . . . 0.0 111.814 -177.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.65 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 48.1 m-85 -120.31 99.78 47.99 Favored Pre-proline 0 CA--C 1.505 -0.778 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 165.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -82.55 137.54 9.16 Favored 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 120.981 1.121 . . . . 0.0 112.616 -171.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.0 m -141.85 175.92 4.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.589 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 52.6 t -127.45 123.86 37.03 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.699 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -78.08 150.37 35.53 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 177.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.774 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 26.9 t -58.04 -12.25 3.21 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -171.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -74.96 -10.12 59.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.706 0.765 . . . . 0.0 109.612 173.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.04 21.07 34.15 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.382 -176.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.7 p -106.94 140.36 25.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.787 -176.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.524 ' OG1' ' HA ' ' A' ' 49' ' ' GLU . 1.6 t -87.72 131.28 34.53 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.58 0.705 . . . . 0.0 111.003 -176.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.699 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 69.7 m-85 -106.09 132.38 52.23 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.729 177.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.1 t -63.2 -26.73 68.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.998 -176.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.65 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 26.0 p30 -176.23 171.15 1.1 Allowed Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.154 -175.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.576 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 74.4 Cg_exo -50.76 -43.77 44.59 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.359 2.039 . . . . 0.0 112.247 177.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.3 t -54.62 -43.38 72.18 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.203 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -66.18 -46.08 78.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.006 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -66.41 -47.19 74.06 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.431 0.159 . . . . 0.0 111.431 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.6 p -63.34 -50.0 71.72 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.016 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.15 -43.92 85.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.944 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.579 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 9.5 tp60 -64.17 -41.15 97.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.805 -177.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.688 ' NE2' HD11 ' A' ' 42' ' ' ILE . 2.6 mp0 -72.93 -37.42 67.18 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.888 -176.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.48 -26.88 62.88 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.706 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.597 HE22 ' HG2' ' A' ' 8' ' ' LYS . 18.5 mt-30 -87.55 -31.6 19.82 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.6 m -117.14 -75.93 0.58 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -168.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.519 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 2.7 t70 -130.53 87.64 49.46 Favored Pre-proline 0 N--CA 1.463 0.206 0 CA-C-O 120.781 0.324 . . . . 0.0 111.073 -173.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -62.95 -13.32 34.27 Favored 'Trans proline' 0 N--CA 1.473 0.289 0 C-N-CA 123.578 2.852 . . . . 0.0 113.499 -176.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -84.56 -21.33 30.48 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -167.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.774 ' HB ' ' HB3' ' A' ' 20' ' ' SER . 3.0 pt -77.53 151.18 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.924 -177.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.3 p -110.75 168.2 9.65 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.114 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.4 mt -70.53 118.47 15.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 173.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.43 ' HB3' ' HA ' ' A' ' 20' ' ' SER . . . -75.38 -43.91 47.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.502 -176.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 26.8 p80 -167.79 155.94 9.0 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.668 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 22.7 ttt -77.04 145.14 38.14 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 174.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.33 167.45 16.67 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.26 -0.972 . . . . 0.0 112.042 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.524 ' HA ' ' OG1' ' A' ' 24' ' ' THR . 24.6 mt-10 -82.9 124.36 30.27 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.135 0.493 . . . . 0.0 111.524 -175.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.427 ' H ' ' CB ' ' A' ' 24' ' ' THR . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.124 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.844 173.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.438 ' HD3' ' HA ' ' A' ' 8' ' ' LYS . 55.4 mmtt . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.86 119.22 20.33 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.388 0.613 . . . . 0.0 112.485 -165.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.49 ' SG ' ' HG3' ' A' ' 12' ' ' ARG . 43.6 t -138.32 146.78 42.81 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 171.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.47 62.49 0.75 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.685 0.755 . . . . 0.0 111.568 -177.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.49 ' HG3' ' SG ' ' A' ' 10' ' ' CYS . 6.2 mtm180 -95.42 -3.47 46.9 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 174.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 179.05 156.26 0.49 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.599 -163.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -128.86 91.93 3.31 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.034 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.729 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 60.3 m-85 -122.73 101.2 39.95 Favored Pre-proline 0 CA--C 1.503 -0.864 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 165.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -80.37 140.0 13.36 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 120.933 1.089 . . . . 0.0 111.695 -172.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.1 m -143.82 -175.49 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.373 0.606 . . . . 0.0 110.596 -177.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.3 t -128.59 134.48 48.6 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.694 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.527 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -82.26 148.23 26.55 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 175.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.735 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 32.3 t -59.16 -13.74 8.26 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -170.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.412 ' HD2' ' CG1' ' A' ' 23' ' ' VAL . 9.2 p-10 -91.06 6.56 44.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.102 0.477 . . . . 0.0 110.599 175.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.22 28.74 16.56 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.507 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.5 HG13 ' CE2' ' A' ' 25' ' ' TYR . 7.1 p -105.37 144.08 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.088 0.47 . . . . 0.0 111.972 -173.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.504 ' CG2' ' HB2' ' A' ' 49' ' ' GLU . 1.3 m -82.39 122.39 27.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.012 -176.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.527 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 31.0 m-85 -114.59 132.81 56.22 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 121.497 0.665 . . . . 0.0 111.633 176.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.0 m -70.81 -28.73 64.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.862 -176.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.729 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 28.4 p30 -172.5 166.83 3.32 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.464 -175.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.489 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 75.0 Cg_exo -50.77 -44.11 42.82 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.336 2.024 . . . . 0.0 112.619 178.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 14.4 t -54.91 -45.91 74.79 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.159 0.504 . . . . 0.0 111.493 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.414 ' OD1' ' HD1' ' A' ' 25' ' ' TYR . 1.5 t-20 -59.26 -45.34 91.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.536 177.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.406 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 55.1 t80 -66.33 -48.92 68.72 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.802 178.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.2 p -64.65 -49.18 72.02 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -174.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.44 ' HA ' ' HG2' ' A' ' 36' ' ' GLU . . . -66.42 -44.74 82.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.728 0.299 . . . . 0.0 111.151 -177.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.453 ' OE1' ' HE1' ' A' ' 25' ' ' TYR . 36.0 tt0 -67.64 -33.36 74.81 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.54 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.804 ' NE2' HD12 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -72.96 -43.33 62.42 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.114 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.44 ' HG2' ' HA ' ' A' ' 33' ' ' ALA . 14.1 pt-20 -67.41 -29.46 68.96 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.394 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.449 HE21 ' HB2' ' A' ' 37' ' ' GLN . 16.5 mt-30 -84.31 -34.66 23.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.84 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 91.7 m -127.5 -66.46 0.88 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -164.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -120.56 90.17 45.42 Favored Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.271 -176.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -72.6 -11.77 26.43 Favored 'Trans proline' 0 CA--C 1.529 0.251 0 C-N-CA 123.287 2.658 . . . . 0.0 112.407 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -90.23 -22.53 21.6 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -167.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.804 HD12 ' NE2' ' A' ' 35' ' ' GLN . 17.5 pt -80.68 162.76 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.27 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.507 ' H ' ' HB2' ' A' ' 20' ' ' SER . 15.4 p -123.8 167.73 13.67 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.692 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.3 mt -67.93 118.77 12.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 173.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.42 -49.9 11.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.659 -176.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -160.36 161.94 33.28 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 79.0 mtp -84.57 150.24 25.35 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.76 150.32 26.7 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -170.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.504 ' HB2' ' CG2' ' A' ' 24' ' ' THR . 0.3 OUTLIER -61.93 138.52 58.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.211 0.529 . . . . 0.0 110.581 -176.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.417 ' N ' HG21 ' A' ' 24' ' ' THR . 0.7 OUTLIER . . . . . 0 C--O 1.244 0.803 0 CA-C-O 118.661 -0.685 . . . . 0.0 110.481 -178.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.687 ' HB2' ' OE1' ' A' ' 34' ' ' GLN . 2.3 tmtp? . . . . . 0 CA--C 1.515 -0.388 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.84 115.68 16.83 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.458 -172.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.401 ' C ' ' HG1' ' A' ' 11' ' ' THR . 44.2 t -139.02 147.12 41.69 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 171.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.401 ' HG1' ' C ' ' A' ' 10' ' ' CYS . 1.9 m -157.91 63.48 0.46 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.348 0.594 . . . . 0.0 110.396 -177.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -93.85 -18.9 21.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.249 174.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -173.03 156.9 3.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.034 -0.984 . . . . 0.0 108.357 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 28.2 t-105 -111.58 93.07 4.28 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.964 178.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.724 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 14.5 m-85 -121.56 100.08 44.58 Favored Pre-proline 0 CA--C 1.504 -0.802 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 163.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -82.61 143.27 11.98 Favored 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 121.125 1.216 . . . . 0.0 112.749 -169.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.6 m -133.47 169.06 22.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 33.6 t -121.52 122.61 40.09 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.134 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.89 144.19 28.53 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 176.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.506 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 59.1 m -57.26 -12.07 2.14 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -172.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -78.85 -2.42 39.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.615 0.721 . . . . 0.0 109.773 174.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.68 28.73 45.96 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -175.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.45 HG12 ' CE2' ' A' ' 25' ' ' TYR . 2.7 p -104.59 129.19 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 121.088 0.47 . . . . 0.0 110.922 -175.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.602 ' OG1' ' HB2' ' A' ' 50' ' ' CYS . 26.8 m -82.24 116.52 21.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.051 -169.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.544 ' HE1' ' HG2' ' A' ' 34' ' ' GLN . 33.9 m-85 -104.52 131.21 52.18 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.476 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.1 t -68.28 -27.08 66.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.975 -173.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.724 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 21.2 p30 -174.98 172.87 1.09 Allowed Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.211 -174.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.568 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 72.6 Cg_exo -52.24 -46.55 32.06 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.369 2.046 . . . . 0.0 113.465 178.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.2 p -61.95 -31.37 71.69 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.017 0.437 . . . . 0.0 111.327 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -65.82 -47.56 74.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.852 175.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -66.62 -47.51 72.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.816 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.0 m -63.18 -50.19 71.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.851 -175.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.445 ' HA ' ' HG2' ' A' ' 36' ' ' GLU . . . -68.32 -43.06 78.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.164 0.506 . . . . 0.0 111.239 -177.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.687 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 44.0 tp60 -64.24 -35.49 81.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.022 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.814 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -77.98 -43.96 28.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.638 -178.311 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.445 ' HG2' ' HA ' ' A' ' 33' ' ' ALA . 11.4 pt-20 -66.11 -30.85 71.43 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.281 -177.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.431 ' HG3' ' HG3' ' A' ' 36' ' ' GLU . 16.4 mt-30 -93.74 -35.47 12.77 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.997 -178.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.3 m -109.35 -75.34 0.63 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.825 -169.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 12.4 t0 -124.39 91.23 49.81 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.843 0.354 . . . . 0.0 110.654 -176.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.45 -13.25 27.68 Favored 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 123.123 2.549 . . . . 0.0 112.868 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -82.62 -21.74 34.99 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -166.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.814 HD11 ' NE2' ' A' ' 35' ' ' GLN . 10.9 pt -78.34 164.41 3.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.04 -177.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.09 169.45 9.09 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.985 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.5 mt -72.19 117.47 15.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 167.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.419 ' HB3' ' HA ' ' A' ' 20' ' ' SER . . . -77.05 -42.48 38.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 -175.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -168.5 158.71 9.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.422 176.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.0 tpt -72.66 139.77 47.52 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 175.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.26 153.67 26.19 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.458 -175.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.557 ' HB2' HG22 ' A' ' 24' ' ' THR . 6.9 pt-20 -67.44 149.34 50.36 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.665 0.269 . . . . 0.0 111.421 -177.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.602 ' HB2' ' OG1' ' A' ' 24' ' ' THR . 60.3 m . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.873 -0.584 . . . . 0.0 111.243 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.7 tptp . . . . . 0 N--CA 1.449 -0.503 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.75 120.22 21.61 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.439 0.638 . . . . 0.0 112.362 -167.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.47 ' SG ' ' N ' ' A' ' 30' ' ' ASN . 16.9 p -136.14 148.45 48.22 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 166.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.1 m -148.81 83.89 1.46 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.344 0.592 . . . . 0.0 111.385 -172.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.639 HH21 ' HB2' ' A' ' 28' ' ' PRO . 27.5 ptt180 -115.57 -10.25 11.9 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.262 176.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 177.51 159.04 0.41 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -174.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -114.0 93.69 4.48 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.802 176.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.668 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 50.2 m-85 -119.53 99.93 49.66 Favored Pre-proline 0 CA--C 1.502 -0.887 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 165.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.74 138.58 10.66 Favored 'Trans proline' 0 N--CA 1.438 -1.792 0 C-N-CA 120.69 0.927 . . . . 0.0 112.146 -171.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.3 m -140.99 168.87 15.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 45.1 t -119.68 126.95 52.35 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.696 -178.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.6 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -77.16 145.97 31.43 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 175.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.416 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 28.2 t -57.84 -11.8 2.6 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -172.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -78.75 -8.93 59.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.357 0.598 . . . . 0.0 110.31 174.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.73 28.26 11.48 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.666 -177.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.543 HG13 ' CE2' ' A' ' 25' ' ' TYR . 2.1 p -106.21 141.79 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -174.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.1 m -83.45 122.53 28.64 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.482 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.6 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 49.6 m-85 -111.27 136.82 49.82 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.429 0.633 . . . . 0.0 112.195 177.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.7 m -70.62 -38.68 73.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.31 -1.314 . . . . 0.0 112.401 -174.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.668 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 6.3 p30 -173.35 175.45 0.97 Allowed Pre-proline 0 C--N 1.329 -0.326 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.639 ' HB2' HH21 ' A' ' 12' ' ' ARG . 92.6 Cg_exo -46.01 -42.01 20.79 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 122.911 2.407 . . . . 0.0 114.944 -176.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.5 p -63.79 -33.39 75.57 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.626 0.648 . . . . 0.0 111.083 -177.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.47 ' N ' ' SG ' ' A' ' 10' ' ' CYS . 1.8 t-20 -67.56 -47.1 70.78 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.421 -176.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.532 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 62.4 t80 -66.49 -46.94 74.63 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.698 175.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.5 t -60.86 -50.89 71.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.424 -175.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.418 ' HA ' ' HG2' ' A' ' 36' ' ' GLU . . . -68.8 -47.39 66.22 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.484 -175.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.565 ' O ' ' HB2' ' A' ' 38' ' ' CYS . 31.9 tt0 -65.63 -31.35 72.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.367 0.603 . . . . 0.0 110.203 -176.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.827 ' NE2' HD12 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -78.15 -44.62 25.47 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.595 -178.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.418 ' HG2' ' HA ' ' A' ' 33' ' ' ALA . 10.7 pt-20 -65.25 -36.67 84.86 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.293 -176.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.617 ' HG3' ' SG ' ' A' ' 38' ' ' CYS . 12.8 pt20 -98.21 -34.14 10.84 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.994 -176.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.617 ' SG ' ' HG3' ' A' ' 37' ' ' GLN . 62.2 m -108.43 -67.58 0.96 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -170.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -123.66 86.59 52.76 Favored Pre-proline 0 N--CA 1.465 0.31 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.043 -176.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -73.61 -11.95 24.42 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 123.076 2.518 . . . . 0.0 113.115 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -86.02 -12.39 50.4 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -167.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.827 HD12 ' NE2' ' A' ' 35' ' ' GLN . 11.6 pt -93.97 159.17 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.05 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.5 p -121.35 168.0 12.14 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.381 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.9 mt -69.1 119.98 15.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.09 -50.94 7.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.859 -177.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 27.6 p80 -162.08 159.12 25.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.157 177.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 80.7 mtp -76.94 148.79 36.15 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 175.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.1 150.96 22.64 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -175.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -71.06 148.99 46.97 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.961 0.41 . . . . 0.0 111.023 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.73 -178.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.405 ' HG2' ' OE1' ' A' ' 34' ' ' GLN . 23.5 mmtt . . . . . 0 N--CA 1.451 -0.415 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.33 119.6 17.79 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.581 0.705 . . . . 0.0 112.009 -169.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 44.8 t -137.56 146.2 43.78 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 174.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 m -156.38 53.71 0.55 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.284 0.564 . . . . 0.0 111.414 -174.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 23.7 ptt85 -100.84 -0.04 37.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.461 0.648 . . . . 0.0 110.037 173.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -172.56 155.15 3.29 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -175.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -129.3 93.32 3.54 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.447 177.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.644 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 50.7 m-85 -122.72 102.35 38.65 Favored Pre-proline 0 CA--C 1.5 -0.973 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 165.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -81.26 137.84 10.83 Favored 'Trans proline' 0 N--CA 1.439 -1.719 0 C-N-CA 120.732 0.955 . . . . 0.0 112.283 -172.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.0 m -140.8 172.28 11.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.329 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 47.7 t -121.25 132.7 54.97 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.59 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.58 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -84.48 149.74 25.04 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 174.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.455 ' HA ' ' HB1' ' A' ' 45' ' ' ALA . 8.2 t -59.28 -12.46 5.59 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -171.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.421 ' HB2' HG22 ' A' ' 42' ' ' ILE . 23.3 t70 -77.08 -7.26 55.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.58 0.705 . . . . 0.0 109.599 174.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.39 25.13 24.53 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.279 -177.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.525 HG13 ' CE2' ' A' ' 25' ' ' TYR . 3.5 p -105.51 140.99 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 121.13 0.491 . . . . 0.0 111.557 -172.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.0 m -82.78 121.66 27.19 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.183 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.58 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 51.6 m-85 -105.65 132.93 51.19 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.995 177.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.4 m -70.46 -26.42 63.63 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.765 -1.107 . . . . 0.0 112.181 -174.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.689 ' HB2' ' HD2' ' A' ' 28' ' ' PRO . 30.3 p30 -173.93 170.4 1.78 Allowed Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.689 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 9.3 Cg_endo -52.63 -37.28 74.4 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.569 2.179 . . . . 0.0 111.866 175.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.476 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 12.8 t -54.42 -51.55 64.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.375 175.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.423 ' CG ' ' HD1' ' A' ' 25' ' ' TYR . 1.8 t-20 -63.93 -44.8 91.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.13 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.507 ' HD1' ' CD2' ' A' ' 25' ' ' TYR . 64.8 t80 -63.21 -50.06 71.77 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 120.895 0.378 . . . . 0.0 110.466 -178.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.466 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 34.8 t -64.88 -52.2 57.86 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.141 -176.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.54 -40.88 89.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.881 0.372 . . . . 0.0 111.502 -173.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.405 ' OE1' ' HG2' ' A' ' 8' ' ' LYS . 49.4 tp60 -62.69 -42.04 99.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.393 0.616 . . . . 0.0 110.485 -178.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.597 ' NE2' HD12 ' A' ' 42' ' ' ILE . 43.5 mt-30 -78.96 -41.3 29.58 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -176.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 32' ' ' SER . 12.6 pt-20 -69.14 -25.6 64.46 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.827 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -95.58 -27.76 15.18 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 78.8 m -137.77 -50.8 0.61 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -172.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.532 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 57.9 m-20 -119.92 68.81 12.8 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 118.229 0.468 . . . . 0.0 111.492 -170.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.55 -13.78 35.74 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.526 2.151 . . . . 0.0 113.73 -170.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -94.38 10.04 35.89 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -166.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.597 HD12 ' NE2' ' A' ' 35' ' ' GLN . 7.7 pt -109.59 156.6 10.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 118.981 -1.088 . . . . 0.0 111.47 175.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.0 p -118.53 168.58 10.54 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.562 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.7 mt -64.8 119.45 9.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.455 ' HB1' ' HA ' ' A' ' 20' ' ' SER . . . -84.31 -44.98 13.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.953 -177.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -168.37 156.89 8.67 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.736 175.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 95.8 mmm -74.62 144.72 43.77 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.18 148.44 24.07 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 110.614 -0.995 . . . . 0.0 110.614 -174.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.85 149.27 45.38 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.003 0.43 . . . . 0.0 111.037 -176.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.011 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.584 -171.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 120.379 0.133 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 70.57 -66.85 0.27 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.705 0.802 . . . . 0.0 111.7 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -119.48 113.19 20.37 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.448 0.642 . . . . 0.0 110.298 -177.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -153.64 145.04 23.12 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.636 -1.166 . . . . 0.0 108.765 174.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.4 t -128.24 132.04 68.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 120.984 0.421 . . . . 0.0 111.55 -173.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.14 -136.48 9.61 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 173.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.0 ptt180 -126.2 140.45 52.54 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 173.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.621 ' HB2' ' OE1' ' A' ' 34' ' ' GLN . 19.5 tptm -97.86 123.76 41.97 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 175.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.59 120.59 20.36 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.732 0.777 . . . . 0.0 112.218 -166.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 51.0 t -136.57 145.68 45.24 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 169.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.9 m -147.77 63.13 1.13 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.499 0.666 . . . . 0.0 110.769 -172.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.416 ' HG3' ' HB3' ' A' ' 13' ' ' GLU . 7.6 ptt180 -88.73 -18.72 27.24 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.147 176.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.416 ' HB3' ' HG3' ' A' ' 12' ' ' ARG . 37.8 tt0 -179.76 161.45 0.99 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.739 -1.119 . . . . 0.0 107.994 -163.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -121.11 92.03 3.66 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.896 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.577 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 16.5 m-85 -121.06 99.22 46.76 Favored Pre-proline 0 CA--C 1.501 -0.925 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 164.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -83.23 138.71 8.98 Favored 'Trans proline' 0 N--CA 1.437 -1.83 0 C-N-CA 121.17 1.247 . . . . 0.0 112.614 -171.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -140.23 164.52 22.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.126 177.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.5 t -116.35 131.3 56.98 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.516 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -85.74 156.04 29.76 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.416 -0.897 . . . . 0.0 111.113 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.808 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 68.5 m -57.71 -11.68 2.36 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -175.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -77.23 -6.8 54.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.664 0.745 . . . . 0.0 109.914 173.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.03 28.29 37.95 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 -174.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.456 HG13 ' CE2' ' A' ' 25' ' ' TYR . 3.1 p -105.61 140.94 22.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 120.945 0.402 . . . . 0.0 111.975 -172.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.7 m -84.29 120.98 26.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.327 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.516 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 59.2 m-85 -107.51 128.47 54.54 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.845 175.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.6 m -66.77 -25.66 66.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.315 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.581 ' OD1' ' HB3' ' A' ' 29' ' ' CYS . 7.4 p30 -171.54 170.36 2.7 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -177.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 79.3 Cg_exo -50.19 -42.13 47.77 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.46 2.107 . . . . 0.0 112.454 176.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.581 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 35.7 t -57.77 -40.75 80.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.883 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.51 -45.03 94.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.049 177.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -64.32 -48.42 75.66 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.013 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.4 t -63.99 -52.21 60.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.39 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.43 -45.33 84.25 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 120.961 0.41 . . . . 0.0 111.508 -173.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.621 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 7.7 tp60 -64.12 -41.23 97.31 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.283 -177.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.66 ' NE2' HD12 ' A' ' 42' ' ' ILE . 59.7 mt-30 -77.76 -36.6 50.42 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -176.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -64.52 -26.13 68.29 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.276 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.579 HE22 ' HG2' ' A' ' 8' ' ' LYS . 8.2 mt-30 -86.84 -36.86 18.24 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.75 0.31 . . . . 0.0 111.661 173.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.6 m -112.26 -79.15 0.58 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -169.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.453 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 8.8 t70 -126.43 91.44 47.61 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.515 -172.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -68.96 -12.12 33.58 Favored 'Trans proline' 0 C--N 1.332 -0.301 0 C-N-CA 122.858 2.372 . . . . 0.0 112.142 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -88.67 -12.94 40.99 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -166.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.808 ' HB ' ' HB2' ' A' ' 20' ' ' SER . 10.5 pt -80.35 162.29 3.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.581 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.7 p -121.54 169.2 10.9 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.148 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.1 mt -69.98 117.83 13.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.7 -48.37 26.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.287 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -160.75 154.69 22.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.839 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -73.56 140.34 46.22 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.82 141.21 10.42 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.391 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -56.92 144.19 34.66 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 122.447 0.299 . . . . 0.0 111.143 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.915 -0.564 . . . . 0.0 111.203 -176.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 111.386 0.143 . . . . 0.0 111.386 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 38' ' ' CYS . 2.2 mp0 66.63 -72.98 0.08 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.274 0.63 . . . . 0.0 111.211 -177.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -125.68 119.45 28.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.828 -178.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 31.7 p -150.97 116.01 5.29 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.164 0.507 . . . . 0.0 109.918 173.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -112.13 132.28 61.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.997 177.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 122.03 -123.0 5.3 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.068 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -130.51 130.9 44.76 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.359 0.599 . . . . 0.0 111.399 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.553 ' HZ3' ' HB3' ' A' ' 8' ' ' LYS . 2.0 mmmp? -100.48 123.48 44.75 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 168.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.08 117.95 17.49 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.795 0.807 . . . . 0.0 112.706 -165.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 36.5 t -138.55 145.58 40.84 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 168.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.8 m -157.83 66.29 0.48 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.814 0.816 . . . . 0.0 110.602 -177.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -101.26 8.89 42.29 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 173.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 178.03 154.58 0.34 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 113.984 -1.462 . . . . 0.0 107.896 -171.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -128.32 92.52 3.45 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.494 174.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.672 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 30.9 m-85 -122.54 101.29 40.43 Favored Pre-proline 0 N--CA 1.441 -0.917 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 164.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -81.78 138.68 10.67 Favored 'Trans proline' 0 N--CA 1.439 -1.703 0 C-N-CA 120.92 1.08 . . . . 0.0 111.586 -172.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.7 m -140.32 169.69 15.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.131 0.491 . . . . 0.0 109.997 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.6 t -117.03 129.61 56.13 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.318 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.06 144.69 26.35 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 174.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.45 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 50.8 p -61.29 -11.42 9.63 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -171.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -73.88 -10.18 59.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.501 0.667 . . . . 0.0 109.662 171.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.85 25.64 14.53 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.744 -178.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.527 HG11 ' CE2' ' A' ' 25' ' ' TYR . 3.1 p -106.73 142.0 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.438 -175.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.522 HG21 ' HA ' ' A' ' 49' ' ' GLU . 85.8 m -84.21 119.47 25.06 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 120.959 0.409 . . . . 0.0 110.643 -178.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.527 ' CE2' HG11 ' A' ' 23' ' ' VAL . 37.0 m-85 -106.87 132.91 52.29 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.525 0.678 . . . . 0.0 111.08 177.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.3 t -64.88 -31.37 72.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.186 -172.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.672 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 26.8 p30 -175.5 170.7 1.3 Allowed Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.55 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 82.0 Cg_exo -50.2 -40.92 51.36 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.316 2.011 . . . . 0.0 112.508 176.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 35.2 t -54.46 -48.64 71.51 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.094 0.473 . . . . 0.0 110.569 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -66.62 -46.37 76.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.486 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.52 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 38.3 t80 -63.73 -48.09 78.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.521 0.201 . . . . 0.0 110.947 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.5 p -64.1 -50.65 67.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.013 -175.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.479 ' HA ' ' HG2' ' A' ' 36' ' ' GLU . . . -65.3 -44.44 87.92 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.071 0.462 . . . . 0.0 110.937 -176.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -63.52 -37.38 87.07 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.446 0.641 . . . . 0.0 110.395 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.576 ' HG3' ' O ' ' A' ' 39' ' ' ASP . 2.1 mp0 -77.61 -37.59 49.95 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.873 -177.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.479 ' HG2' ' HA ' ' A' ' 33' ' ' ALA . 12.8 pt-20 -73.62 -27.76 61.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.842 0.353 . . . . 0.0 110.762 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.438 HE21 ' HB2' ' A' ' 37' ' ' GLN . 11.0 mt-30 -91.36 -34.09 15.02 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.774 -178.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 2' ' ' GLU . 64.2 m -119.96 -74.88 0.59 Allowed 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.068 -0.653 . . . . 0.0 112.761 -169.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.576 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 4.8 t0 -115.33 97.96 49.51 Favored Pre-proline 0 C--N 1.326 -0.444 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.113 -175.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.14 -13.23 31.06 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 123.2 2.6 . . . . 0.0 113.698 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -85.57 -21.85 28.34 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -163.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.571 HD13 ' NE2' ' A' ' 35' ' ' GLN . 6.5 pt -87.99 154.1 3.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 119.294 -0.963 . . . . 0.0 111.126 -175.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.5 p -127.88 169.68 13.66 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.515 -1.221 . . . . 0.0 109.036 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mp -68.87 119.41 14.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.53 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 20' ' ' SER . . . -81.18 -46.15 15.3 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.428 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -168.02 157.13 9.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.561 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 87.7 mtp -79.99 130.56 35.37 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.63 162.2 11.56 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 -173.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.522 ' HA ' HG21 ' A' ' 24' ' ' THR . 0.5 OUTLIER -73.35 147.93 43.92 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.067 0.46 . . . . 0.0 111.095 -178.8 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.832 -0.604 . . . . 0.0 111.033 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 120.941 0.4 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -117.14 -49.61 2.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.427 178.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -125.87 115.57 20.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.695 174.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.1 p -149.67 117.96 6.43 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.158 0.504 . . . . 0.0 110.512 177.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.8 p -103.85 119.82 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 121.34 0.591 . . . . 0.0 110.161 176.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 140.58 -125.31 2.83 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -131.1 139.64 49.89 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.128 0.49 . . . . 0.0 110.318 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.544 ' HB2' ' OE1' ' A' ' 34' ' ' GLN . 6.6 tmtm? -98.86 122.4 42.05 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 174.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.44 117.63 16.48 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.896 0.855 . . . . 0.0 112.184 -166.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.538 ' SG ' ' HG3' ' A' ' 12' ' ' ARG . 44.5 t -138.51 146.38 41.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.103 -1.408 . . . . 0.0 107.494 172.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.2 m -152.54 64.22 0.81 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.79 0.805 . . . . 0.0 110.144 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.538 ' HG3' ' SG ' ' A' ' 10' ' ' CYS . 21.2 mtm180 -104.27 0.78 29.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.291 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 177.02 153.16 0.21 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 113.837 -1.529 . . . . 0.0 107.129 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 65.2 t-105 -117.45 92.21 3.78 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.847 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.661 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 37.3 m-85 -122.87 101.9 38.71 Favored Pre-proline 0 N--CA 1.434 -1.237 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 164.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.16 137.95 12.43 Favored 'Trans proline' 0 N--CA 1.441 -1.606 0 C-N-CA 120.546 0.83 . . . . 0.0 111.566 -172.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.0 m -138.01 173.86 11.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.044 0.45 . . . . 0.0 110.101 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.1 t -122.73 132.5 54.27 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.634 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.11 146.5 25.26 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 173.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.606 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 10.0 t -57.95 -13.92 5.4 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -172.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.45 ' HB2' HG22 ' A' ' 42' ' ' ILE . 31.4 t70 -74.94 -8.41 56.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.51 0.671 . . . . 0.0 109.924 174.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.47 25.38 21.24 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.287 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.5 p -105.73 140.88 22.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.921 0.391 . . . . 0.0 111.285 -173.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.405 HG21 ' HA ' ' A' ' 49' ' ' GLU . 36.8 m -85.15 123.77 31.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.19 0.519 . . . . 0.0 111.239 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -111.51 137.47 49.3 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.933 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 65.5 m -68.4 -26.09 65.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.229 -175.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.661 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 30.8 p30 -172.67 171.96 1.8 Allowed Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.554 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 75.5 Cg_exo -52.34 -39.87 71.92 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.379 2.053 . . . . 0.0 112.597 176.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.42 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 21.5 t -55.14 -44.91 75.52 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.959 0.409 . . . . 0.0 110.558 176.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.428 ' C ' HD21 ' A' ' 30' ' ' ASN . 0.2 OUTLIER -61.68 -46.45 89.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.367 179.207 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -65.96 -47.9 73.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.928 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.7 t -63.58 -49.26 74.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.571 -174.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.456 ' HA ' ' HG2' ' A' ' 36' ' ' GLU . . . -64.78 -44.92 88.44 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.706 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.544 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 7.5 tp60 -62.65 -40.79 98.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.543 0.687 . . . . 0.0 110.398 -177.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.556 ' HG3' ' O ' ' A' ' 39' ' ' ASP . 2.2 mp0 -76.08 -36.29 59.01 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.98 -177.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.456 ' HG2' ' HA ' ' A' ' 33' ' ' ALA . 11.1 pt-20 -67.08 -42.92 83.83 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.364 -178.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -111.74 5.85 19.42 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -175.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 34' ' ' GLN . 66.5 m -135.0 -63.25 0.7 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.158 0.89 . . . . 0.0 113.0 175.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.556 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 8.6 t0 -116.94 92.57 39.31 Favored Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 118.808 0.731 . . . . 0.0 110.7 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -72.08 -12.95 28.53 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.43 2.753 . . . . 0.0 113.374 -177.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -92.62 -21.86 19.8 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -163.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.606 ' HB ' ' HB3' ' A' ' 20' ' ' SER . 19.0 pt -90.72 160.04 2.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.835 0.826 . . . . 0.0 112.363 -174.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.5 p -123.22 169.37 11.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.323 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.5 mt -65.17 119.29 9.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 175.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.53 -50.69 10.35 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.523 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -164.76 161.43 20.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 44.7 tpp -75.92 139.25 41.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.025 173.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 107.33 159.73 21.17 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.53 -176.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.405 ' HA ' HG21 ' A' ' 24' ' ' THR . 0.8 OUTLIER -73.69 149.12 42.11 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.916 0.389 . . . . 0.0 111.04 -178.64 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.331 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -55.29 -27.29 45.74 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.779 -176.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -125.86 111.39 14.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.345 0.593 . . . . 0.0 111.15 174.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -153.5 115.52 4.32 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.906 166.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.7 p -121.04 127.76 75.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 121.259 0.552 . . . . 0.0 110.926 -176.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 138.18 -140.21 10.97 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -123.95 132.9 53.79 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.051 0.453 . . . . 0.0 110.542 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -100.6 137.9 38.39 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 171.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.13 118.67 30.62 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.961 -174.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 30' ' ' ASN . 21.2 p -137.34 148.68 46.48 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 168.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.7 m -148.89 89.0 1.64 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.408 0.623 . . . . 0.0 111.381 -175.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -109.67 -19.8 13.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.527 173.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -177.61 163.92 1.97 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -169.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -118.28 92.99 3.97 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.156 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.659 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 15.3 m-85 -122.67 101.09 40.27 Favored Pre-proline 0 N--CA 1.441 -0.911 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 164.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.59 140.04 11.62 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 121.345 1.363 . . . . 0.0 112.487 -172.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' A' ' 25' ' ' TYR . 27.2 m -143.29 170.91 9.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.98 0.419 . . . . 0.0 109.944 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 18.5 t -123.63 139.41 54.03 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.495 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -94.5 156.96 22.27 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.285 177.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.871 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 64.1 m -57.22 -12.67 2.45 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -174.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -76.71 -7.92 56.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.841 0.829 . . . . 0.0 109.712 173.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.04 28.68 36.55 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -173.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.514 HG11 ' CE2' ' A' ' 25' ' ' TYR . 2.7 p -101.48 140.8 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 121.066 0.46 . . . . 0.0 111.427 -172.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.515 HG21 ' N ' ' A' ' 50' ' ' CYS . 1.3 m -82.49 117.27 22.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.252 -177.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.514 ' CE2' HG11 ' A' ' 23' ' ' VAL . 52.3 m-85 -106.56 130.42 54.33 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-O 121.269 0.556 . . . . 0.0 110.744 176.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.4 t -70.29 -26.86 64.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.746 -174.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.675 ' HB2' ' HD2' ' A' ' 28' ' ' PRO . 26.1 p-10 178.25 173.9 0.38 Allowed Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -173.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.675 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 79.6 Cg_exo -47.8 -49.48 13.56 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 123.219 2.613 . . . . 0.0 114.901 -176.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.455 ' SG ' ' ND2' ' A' ' 27' ' ' ASN . 7.8 p -59.27 -35.77 74.34 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.044 0.45 . . . . 0.0 111.058 -177.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.402 ' N ' ' SG ' ' A' ' 10' ' ' CYS . 2.1 t-20 -64.84 -46.02 83.66 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.946 -178.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.422 ' HD2' ' CD2' ' A' ' 25' ' ' TYR . 65.0 t80 -65.4 -47.92 74.62 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.129 0.49 . . . . 0.0 109.726 178.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.8 t -64.03 -51.71 62.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.905 -175.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.47 ' O ' ' HG2' ' A' ' 37' ' ' GLN . . . -69.01 -44.09 73.46 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.088 0.47 . . . . 0.0 111.452 -175.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -62.47 -41.66 98.93 Favored 'General case' 0 C--O 1.215 -0.715 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.949 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.637 ' NE2' HD12 ' A' ' 42' ' ' ILE . 61.9 mt-30 -78.69 -35.91 44.33 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 33' ' ' ALA . 12.8 pt-20 -61.94 -27.94 69.18 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.797 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.616 ' HG3' ' SG ' ' A' ' 38' ' ' CYS . 20.6 pt20 -100.85 -38.06 8.41 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 119.488 -0.885 . . . . 0.0 112.793 174.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.616 ' SG ' ' HG3' ' A' ' 37' ' ' GLN . 17.7 m -96.12 -77.98 0.47 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.897 -169.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 5.8 t0 -124.13 89.76 51.46 Favored Pre-proline 0 C--N 1.331 -0.207 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.06 -175.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.32 -11.8 32.27 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 123.315 2.677 . . . . 0.0 112.836 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -79.66 -21.81 44.28 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -167.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.871 ' HB ' ' HB2' ' A' ' 20' ' ' SER . 9.0 pt -85.62 161.91 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.406 -175.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.96 169.5 12.04 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.258 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.4 mt -65.4 117.89 6.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.242 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.84 -44.24 50.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.005 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -166.96 151.58 7.23 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.38 176.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -73.54 139.4 45.61 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 108.67 145.14 11.24 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -171.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.46 ' HB2' ' CG2' ' A' ' 24' ' ' THR . 0.9 OUTLIER -73.97 145.64 44.48 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.996 0.398 . . . . 0.0 110.692 -175.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.515 ' N ' HG21 ' A' ' 24' ' ' THR . 1.3 m . . . . . 0 C--O 1.242 0.697 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.32 173.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -103.64 -36.89 7.74 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.149 0.499 . . . . 0.0 110.098 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -124.59 113.78 18.5 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.39 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 38' ' ' CYS . 0.5 OUTLIER -152.43 116.39 4.87 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.719 -179.653 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.9 t -107.35 124.02 62.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.04 0.447 . . . . 0.0 110.425 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 147.26 -138.7 7.4 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.5 ttp180 -129.11 133.66 47.74 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.037 0.446 . . . . 0.0 110.911 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.8 mmtt -98.88 130.49 45.28 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 172.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.55 115.42 16.29 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.49 -173.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 48.8 t -139.98 146.1 38.68 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 167.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -168.0 56.17 0.06 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.642 0.734 . . . . 0.0 110.641 -172.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -80.72 -23.81 39.23 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.265 175.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -163.31 157.66 20.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.612 -1.176 . . . . 0.0 107.923 -177.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 71.2 t-105 -112.42 94.43 4.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.403 0.62 . . . . 0.0 111.038 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.555 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 30.4 m-85 -120.33 100.02 47.78 Favored Pre-proline 0 N--CA 1.442 -0.852 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 165.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -81.36 138.37 10.99 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 120.996 1.131 . . . . 0.0 113.266 -168.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.23 174.15 6.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.504 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.0 t -126.7 138.61 53.42 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.447 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.83 153.14 21.79 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 175.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.565 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 16.2 m -56.81 -15.17 4.22 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -174.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -74.01 -7.82 53.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.691 0.758 . . . . 0.0 109.968 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.09 27.89 29.84 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -175.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.418 HG11 ' CE2' ' A' ' 25' ' ' TYR . 3.6 p -105.73 140.73 22.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.269 -0.466 . . . . 0.0 111.18 -172.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.404 HG21 ' HA ' ' A' ' 49' ' ' GLU . 42.0 m -85.05 122.19 28.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.98 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.418 ' CE2' HG11 ' A' ' 23' ' ' VAL . 29.7 m-85 -109.91 133.07 53.57 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.225 177.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.8 m -65.97 -34.6 78.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.586 -173.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 8.2 p30 -178.07 177.23 0.43 Allowed Pre-proline 0 C--O 1.237 0.403 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.532 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 95.7 Cg_exo -46.03 -43.21 20.48 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 122.821 2.347 . . . . 0.0 114.765 -177.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 29.1 p -60.96 -37.33 82.0 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.222 0.465 . . . . 0.0 110.695 -177.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -67.89 -46.27 72.09 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.541 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.526 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 62.7 t80 -65.95 -46.7 77.19 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 176.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 39.3 t -63.39 -50.88 68.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.515 -176.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.56 ' O ' ' HG2' ' A' ' 37' ' ' GLN . . . -68.07 -44.79 75.5 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 120.78 0.324 . . . . 0.0 111.018 -175.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.8 tp60 -65.85 -35.4 80.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.223 0.535 . . . . 0.0 110.246 -177.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.782 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -77.43 -36.7 52.85 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.365 -177.665 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.487 ' HG2' ' HA ' ' A' ' 33' ' ' ALA . 9.5 pt-20 -70.92 -28.05 64.23 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.105 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.61 ' HG3' ' SG ' ' A' ' 38' ' ' CYS . 9.7 pt20 -99.79 -35.16 9.88 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.069 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.61 ' SG ' ' HG3' ' A' ' 37' ' ' GLN . 25.0 m -104.49 -77.57 0.58 Allowed 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.805 -172.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 9.2 t70 -118.08 99.3 51.89 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.885 0.374 . . . . 0.0 111.136 -175.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.23 -13.95 25.68 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 123.111 2.541 . . . . 0.0 112.92 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -86.43 -21.75 26.93 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -164.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.782 HD11 ' NE2' ' A' ' 35' ' ' GLN . 23.5 pt -85.67 166.21 2.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.608 -177.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.8 p -132.12 170.56 14.8 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.317 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.3 mt -65.77 118.16 7.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 175.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.26 -43.55 27.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.52 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -164.38 157.69 17.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.545 177.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.77 138.48 36.28 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 175.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 110.69 151.89 12.77 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -173.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.404 ' HA ' HG21 ' A' ' 24' ' ' THR . 14.2 pt-20 -65.54 149.4 50.12 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.75 0.31 . . . . 0.0 111.269 -178.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.134 0 CA-C-O 119.225 -0.417 . . . . 0.0 110.464 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 120.77 0.319 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -127.67 -34.44 2.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.626 171.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -115.64 112.12 21.65 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 38' ' ' CYS . 0.8 OUTLIER -154.32 134.73 13.38 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.719 175.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.2 p -129.19 132.98 66.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.781 -177.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 132.0 -131.42 6.28 Favored Glycine 0 N--CA 1.439 -1.14 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.853 175.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -130.11 128.5 41.96 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.337 0.589 . . . . 0.0 110.973 -176.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -100.36 133.46 44.74 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.448 172.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.08 121.96 27.23 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.358 0.599 . . . . 0.0 112.286 -171.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 46.8 t -136.32 147.44 47.43 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 170.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.0 m -153.42 67.21 0.77 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.406 0.622 . . . . 0.0 111.805 -174.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.3 ptt85 -110.87 -3.05 15.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.236 0.541 . . . . 0.0 109.82 172.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 174.63 151.33 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.592 -1.186 . . . . 0.0 108.396 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -110.02 94.62 5.11 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.143 0.497 . . . . 0.0 110.366 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.751 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 31.2 m-85 -120.52 100.44 47.06 Favored Pre-proline 0 N--CA 1.441 -0.901 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 167.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.93 138.52 10.4 Favored 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 121.02 1.146 . . . . 0.0 111.744 -172.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.2 m -143.75 176.98 2.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.125 0.488 . . . . 0.0 110.292 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.2 t -124.7 130.25 52.06 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.319 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.67 147.71 29.81 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 174.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.89 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 32.7 t -57.85 -12.58 3.24 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -172.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -77.59 -7.95 57.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.702 0.763 . . . . 0.0 110.214 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.14 24.96 20.94 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -176.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.431 HG12 ' CE2' ' A' ' 25' ' ' TYR . 3.2 p -106.01 140.96 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 120.934 0.397 . . . . 0.0 111.269 -174.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.9 m -83.73 124.52 30.96 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.383 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.497 ' HE1' ' HG2' ' A' ' 34' ' ' GLN . 29.9 m-85 -113.05 135.85 53.34 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.421 177.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.1 m -69.24 -29.07 66.92 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.422 -173.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.751 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 28.6 p30 -170.17 168.8 4.13 Favored Pre-proline 0 C--O 1.236 0.353 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.518 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 72.3 Cg_exo -50.6 -38.19 54.51 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.515 2.143 . . . . 0.0 112.515 177.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.428 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 7.6 t -55.21 -50.9 68.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.551 176.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -62.14 -45.26 94.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.735 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.526 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 58.7 t80 -61.17 -49.13 78.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.305 0.098 . . . . 0.0 111.028 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.492 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 16.2 t -65.86 -51.0 62.55 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.485 0.18 . . . . 0.0 111.485 -177.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.66 -43.51 93.37 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.487 0.661 . . . . 0.0 110.995 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.497 ' HG2' ' HE1' ' A' ' 25' ' ' TYR . 9.5 tp60 -64.68 -36.92 85.85 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.166 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.71 ' HG3' ' O ' ' A' ' 39' ' ' ASP . 2.2 mp0 -72.81 -44.39 61.53 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.383 -176.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 32' ' ' SER . 9.3 pt-20 -63.68 -31.01 72.05 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.092 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.481 ' NE2' ' HG3' ' A' ' 36' ' ' GLU . 2.9 mp0 -87.32 -35.09 18.61 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 177.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 4' ' ' CYS . 18.7 m -108.59 -80.7 0.57 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -171.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.71 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 55.8 t0 -126.14 83.91 62.61 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 120.871 0.367 . . . . 0.0 110.662 -172.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -67.99 -12.64 35.89 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 123.446 2.764 . . . . 0.0 114.13 -170.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -99.54 11.71 38.43 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -169.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.89 ' HB ' ' HB3' ' A' ' 20' ' ' SER . 12.5 pt -97.31 151.36 4.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.371 174.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -107.54 167.67 9.78 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.361 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.2 mt -70.33 118.94 15.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 173.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.24 -51.07 16.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.473 -176.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -160.75 158.43 28.61 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.271 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.4 tpt -71.3 145.03 49.76 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.003 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.35 154.45 30.75 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.609 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -62.53 149.28 43.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.821 0.344 . . . . 0.0 110.699 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.86 -0.59 . . . . 0.0 110.842 -173.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -132.39 -35.75 1.15 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.979 176.279 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -116.78 114.23 23.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.057 0.456 . . . . 0.0 110.341 174.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.618 ' HB2' ' HE2' ' A' ' 8' ' ' LYS . 19.3 p -151.76 139.74 20.06 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 172.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.0 p -128.93 132.37 67.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.433 0.635 . . . . 0.0 111.325 -171.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 109.49 -117.99 5.03 Favored Glycine 0 N--CA 1.44 -1.079 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.589 ' HA ' ' OE1' ' A' ' 34' ' ' GLN . 24.7 ptt180 -131.39 134.16 45.99 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.032 0.444 . . . . 0.0 110.435 171.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.618 ' HE2' ' HB2' ' A' ' 4' ' ' CYS . 65.2 mmtt -99.52 123.2 43.57 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 171.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.69 120.44 21.08 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.872 0.844 . . . . 0.0 113.104 -162.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 43.4 t -128.55 147.2 50.68 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 168.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.9 m -150.21 61.98 0.97 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.554 0.693 . . . . 0.0 111.326 -175.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -91.52 -13.38 32.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.697 174.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -173.71 157.5 3.12 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -173.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 67.2 t-105 -119.07 92.99 3.93 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.038 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.723 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 14.6 m-85 -122.15 101.06 41.88 Favored Pre-proline 0 CA--C 1.501 -0.92 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 166.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -80.88 138.1 11.44 Favored 'Trans proline' 0 N--CA 1.443 -1.475 0 C-N-CA 120.697 0.931 . . . . 0.0 111.767 -172.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.4 m -142.77 -179.9 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.361 -177.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.4 t -127.98 134.57 49.28 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.583 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.47 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -82.69 147.58 25.36 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 174.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.639 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 10.6 t -57.88 -13.77 4.98 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -172.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.446 ' HB2' HG22 ' A' ' 42' ' ' ILE . 18.6 t70 -76.83 -8.53 57.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.531 0.681 . . . . 0.0 109.931 175.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.49 26.39 17.99 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.377 -177.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.593 HG11 ' CE2' ' A' ' 25' ' ' TYR . 2.5 p -106.57 141.93 20.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 120.698 0.285 . . . . 0.0 111.721 -174.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.7 m -83.63 126.86 33.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.23 -176.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.593 ' CE2' HG11 ' A' ' 23' ' ' VAL . 51.2 m-85 -117.07 137.99 51.9 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.408 0.623 . . . . 0.0 111.894 177.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.7 m -70.21 -28.37 65.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.121 -175.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.723 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 26.6 p30 -173.84 169.33 2.04 Favored Pre-proline 0 C--O 1.234 0.285 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.549 -177.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.543 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 78.3 Cg_exo -51.47 -42.13 56.76 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.473 2.115 . . . . 0.0 112.416 177.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 41.5 t -54.72 -45.36 74.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.093 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.462 ' C ' HD21 ' A' ' 30' ' ' ASN . 0.2 OUTLIER -62.43 -47.58 83.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.953 -179.521 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.58 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 55.3 t80 -66.57 -48.11 70.64 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.569 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.422 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 22.2 t -63.79 -50.63 68.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.052 -174.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.92 -45.43 74.37 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.169 0.509 . . . . 0.0 111.126 -175.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.589 ' OE1' ' HA ' ' A' ' 7' ' ' ARG . 22.0 tt0 -65.57 -31.9 73.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.172 0.511 . . . . 0.0 110.695 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.773 ' NE2' HD13 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -78.15 -46.97 19.18 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.367 -177.136 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.619 ' HG3' ' HG3' ' A' ' 37' ' ' GLN . 11.7 pt-20 -61.57 -30.59 70.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.875 0.369 . . . . 0.0 110.481 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.619 ' HG3' ' HG3' ' A' ' 36' ' ' GLU . 10.9 mt-30 -94.29 -34.81 12.7 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.57 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 59.8 m -120.13 -65.82 1.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -170.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.495 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 0.7 OUTLIER -116.19 74.66 5.7 Favored Pre-proline 0 N--CA 1.465 0.312 0 CA-C-O 120.729 0.299 . . . . 0.0 111.667 -173.005 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.57 ' HD3' ' O ' ' A' ' 38' ' ' CYS . 6.9 Cg_exo -72.62 -13.11 27.21 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 123.131 2.554 . . . . 0.0 112.698 -174.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -77.36 -20.99 53.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.346 -169.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.773 HD13 ' NE2' ' A' ' 35' ' ' GLN . 10.9 pt -95.32 153.13 3.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.597 -175.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.426 ' O ' ' HB2' ' A' ' 20' ' ' SER . 22.1 p -112.23 168.21 9.8 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.624 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.0 mt -65.93 118.71 9.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.97 -50.82 11.4 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.699 -176.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -166.0 163.27 18.35 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.2 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 86.5 mmm -74.89 146.59 41.74 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 173.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.52 146.37 18.41 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.658 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.41 149.19 50.78 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.718 0.294 . . . . 0.0 110.983 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.976 -0.535 . . . . 0.0 110.978 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.51 ' HB2' ' HB3' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 120.23 0.062 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 2.0 mp0 70.36 -68.37 0.21 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.388 0.675 . . . . 0.0 111.373 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -119.8 112.03 18.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.079 0.466 . . . . 0.0 111.007 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.9 p -153.85 124.72 7.25 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 169.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.8 t -101.6 126.15 55.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.239 -172.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 116.66 -118.12 4.07 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.17 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.483 ' HA ' ' HG2' ' A' ' 34' ' ' GLN . 22.5 ptt180 -131.87 134.26 45.53 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 174.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -100.72 122.6 43.63 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 168.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.24 128.86 35.77 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -162.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 36.7 t -119.01 147.72 43.78 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 170.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.7 m -153.35 79.59 1.17 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.19 0.519 . . . . 0.0 111.919 -175.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -115.33 -29.09 6.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.4 0.619 . . . . 0.0 109.783 170.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -148.11 158.88 44.32 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -118.17 93.79 4.26 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.15 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.737 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 67.3 m-85 -121.39 99.78 45.35 Favored Pre-proline 0 CA--C 1.504 -0.799 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 164.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -81.77 139.61 11.17 Favored 'Trans proline' 0 N--CA 1.442 -1.537 0 C-N-CA 121.132 1.221 . . . . 0.0 112.558 -171.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.5 m -138.71 172.28 13.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 176.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 29.6 t -116.38 130.61 56.86 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.859 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.647 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -83.65 142.09 20.75 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 172.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.528 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 4.5 t -60.04 -11.04 4.95 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -171.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.472 ' HB2' HG21 ' A' ' 42' ' ' ILE . 19.2 t70 -74.28 -8.21 55.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.487 0.66 . . . . 0.0 109.504 173.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.1 24.91 23.5 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.357 -177.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.542 HG12 ' CE2' ' A' ' 25' ' ' TYR . 2.3 p -105.35 138.52 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 121.061 0.458 . . . . 0.0 111.423 -175.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.516 HG22 ' N ' ' A' ' 50' ' ' CYS . 7.6 m -85.06 116.46 23.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.564 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.647 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 47.5 m-85 -101.37 133.0 46.65 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.337 0.589 . . . . 0.0 111.704 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.9 m -64.18 -30.25 71.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.299 -1.319 . . . . 0.0 112.384 -175.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.737 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 22.1 p30 -174.58 169.6 1.72 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.463 -175.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.658 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 9.2 Cg_endo -52.39 -38.76 74.14 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.599 2.2 . . . . 0.0 112.022 176.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 33.3 t -55.22 -45.01 75.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.451 176.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.482 ' O ' ' HB3' ' A' ' 34' ' ' GLN . 0.2 OUTLIER -66.31 -46.26 77.52 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.961 -178.622 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.451 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 61.3 t80 -65.87 -48.06 72.82 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.517 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.58 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 19.9 t -64.37 -52.09 60.06 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.415 -175.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.524 ' O ' ' HB2' ' A' ' 37' ' ' GLN . . . -68.02 -42.85 80.01 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.014 0.435 . . . . 0.0 111.27 -174.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.483 ' HG2' ' HA ' ' A' ' 7' ' ' ARG . 42.4 tp60 -63.92 -34.64 78.43 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.416 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.766 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -78.01 -50.22 12.54 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.316 -178.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' A' ' 32' ' ' SER . 12.2 pt-20 -65.27 -26.51 68.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.732 0.301 . . . . 0.0 111.055 -177.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.524 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 2.4 mp0 -92.38 -33.84 14.4 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 82.4 m -133.49 -58.2 0.88 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -169.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.537 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 16.2 m-20 -114.54 68.98 1.98 Allowed Pre-proline 0 N--CA 1.467 0.386 0 CA-C-N 117.996 0.362 . . . . 0.0 111.764 -173.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.25 -14.25 28.44 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.42 2.08 . . . . 0.0 112.614 -174.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -89.06 -6.85 56.83 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -167.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.766 HD11 ' NE2' ' A' ' 35' ' ' GLN . 10.2 pt -91.7 170.79 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 119.964 -0.695 . . . . 0.0 110.941 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.3 p -126.61 168.64 14.03 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.733 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mp -72.27 119.47 18.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.528 ' HB2' ' HA ' ' A' ' 20' ' ' SER . . . -81.79 -46.72 13.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.751 -176.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 34.8 p80 -167.08 156.69 10.78 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.219 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 96.9 mmm -74.22 156.47 37.22 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 175.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.9 156.76 28.04 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.088 -1.053 . . . . 0.0 110.551 -173.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.449 ' HB2' ' CG2' ' A' ' 24' ' ' THR . 11.6 pt-20 -65.52 135.26 54.91 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.013 0.435 . . . . 0.0 110.292 -177.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.516 ' N ' HG22 ' A' ' 24' ' ' THR . 1.6 t . . . . . 0 C--O 1.251 1.171 0 CA-C-O 118.4 -0.809 . . . . 0.0 110.746 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -114.53 -34.3 5.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.97 0.414 . . . . 0.0 110.199 176.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -120.88 111.78 17.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.305 0.574 . . . . 0.0 110.223 175.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.0 p -153.91 142.76 21.06 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 172.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.04 130.99 66.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 121.115 0.483 . . . . 0.0 111.063 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 124.69 -117.92 3.19 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -130.34 140.14 50.65 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.105 0.479 . . . . 0.0 110.932 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 8' ' ' LYS . 64.2 mmtt -99.6 123.22 43.67 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 166.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.79 119.41 19.75 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -162.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 78.4 m -127.55 146.08 50.64 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 165.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.2 m -154.22 28.95 0.45 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.215 1.007 . . . . 0.0 110.29 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -82.82 -5.06 58.78 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.865 177.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -171.76 150.94 2.75 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -167.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -128.81 93.62 3.66 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.666 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.69 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 77.0 m-85 -121.73 100.48 43.72 Favored Pre-proline 0 CA--C 1.501 -0.915 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 164.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.47 138.11 10.72 Favored 'Trans proline' 0 N--CA 1.441 -1.605 0 C-N-CA 120.555 0.837 . . . . 0.0 111.59 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.4 m -141.42 176.12 4.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.7 t -123.09 128.99 50.87 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.617 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.437 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -81.09 146.46 26.56 Favored Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 174.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.628 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 8.6 t -58.91 -12.79 4.91 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -172.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -74.08 -8.63 56.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.641 0.734 . . . . 0.0 110.128 173.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.92 26.84 23.25 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.12 -176.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.433 HG11 ' CE2' ' A' ' 25' ' ' TYR . 3.3 p -106.54 141.08 22.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.808 0.337 . . . . 0.0 111.384 -174.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.457 HG21 ' HA ' ' A' ' 49' ' ' GLU . 90.1 m -84.43 123.23 30.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.057 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.437 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 35.8 m-85 -109.84 136.13 49.64 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.563 0.697 . . . . 0.0 111.525 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.3 m -70.17 -32.07 69.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.323 -1.308 . . . . 0.0 112.361 -173.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.726 ' HB2' ' HD2' ' A' ' 28' ' ' PRO . 27.5 p30 -175.61 171.92 1.12 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.216 -174.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.726 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 6.1 Cg_endo -49.47 -41.49 43.87 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.736 2.291 . . . . 0.0 112.616 176.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.409 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 48.2 t -54.8 -50.62 68.09 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.163 0.506 . . . . 0.0 110.296 177.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -63.32 -45.92 89.05 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.296 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -65.74 -47.26 75.86 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.61 0.243 . . . . 0.0 110.818 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.434 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 41.6 t -63.61 -51.43 65.31 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.291 -176.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.45 -43.71 84.82 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 120.814 0.34 . . . . 0.0 110.828 -174.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.54 ' OE1' ' HA ' ' A' ' 34' ' ' GLN . 6.6 tp60 -64.06 -37.78 88.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.317 0.58 . . . . 0.0 110.576 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.814 ' NE2' HD13 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -74.8 -50.32 17.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.967 -178.017 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 32' ' ' SER . 12.8 pt-20 -64.8 -26.15 68.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.559 0.218 . . . . 0.0 111.477 -176.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -93.33 -35.94 12.8 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 98.9 m -124.74 -54.67 1.64 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -167.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -133.58 85.68 41.98 Favored Pre-proline 0 N--CA 1.465 0.313 0 CA-C-N 119.094 0.861 . . . . 0.0 111.38 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.98 -12.97 23.93 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 123.314 2.676 . . . . 0.0 112.751 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -81.72 -14.22 56.8 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.354 -165.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.814 HD13 ' NE2' ' A' ' 35' ' ' GLN . 9.9 pt -86.53 157.05 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.605 0.717 . . . . 0.0 111.0 -178.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.4 p -110.99 167.39 10.29 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.783 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mp -70.1 119.27 15.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 173.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.31 -48.7 19.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.279 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -168.93 158.69 8.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.31 176.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 25.9 ttt -77.75 140.07 39.44 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 172.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 110.68 161.15 17.7 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -172.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.457 ' HA ' HG21 ' A' ' 24' ' ' THR . 9.6 pt-20 -75.4 149.24 38.65 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.041 0.448 . . . . 0.0 111.234 -176.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.749 -0.643 . . . . 0.0 111.051 -177.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -109.64 -21.07 12.6 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 174.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -120.78 112.3 18.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.414 0.626 . . . . 0.0 110.648 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.423 ' O ' ' HB3' ' A' ' 38' ' ' CYS . 0.5 OUTLIER -153.1 128.86 10.15 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.933 -1.031 . . . . 0.0 108.975 176.094 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.3 t -123.76 127.02 73.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.023 0.439 . . . . 0.0 111.25 -174.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 130.18 -135.6 8.43 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 176.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.56 137.25 54.41 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.09 0.472 . . . . 0.0 109.778 175.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -98.36 121.97 40.95 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 174.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.71 122.63 24.29 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.687 0.756 . . . . 0.0 112.366 -168.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 34.8 t -134.37 147.85 50.58 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 172.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.73 44.75 0.68 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -172.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -84.45 -13.82 50.97 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.593 0.711 . . . . 0.0 109.51 173.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -170.7 151.84 3.62 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.529 ' CZ3' ' HB3' ' A' ' 26' ' ' SER . 57.7 t-105 -118.82 91.84 3.66 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.008 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.708 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 10.4 m-85 -123.73 100.77 37.2 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 164.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -80.59 143.36 15.06 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 121.236 1.291 . . . . 0.0 112.499 -170.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.0 m -137.04 -179.03 2.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.944 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 18.8 t -129.35 131.88 46.97 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.34 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.9 151.19 36.95 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 176.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.608 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 31.2 t -59.65 -12.69 7.33 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -171.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -80.24 -8.49 59.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.26 0.553 . . . . 0.0 110.101 174.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.22 28.77 10.28 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 -175.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.441 HG13 ' CE2' ' A' ' 25' ' ' TYR . 3.6 p -104.86 141.73 19.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.03 0.443 . . . . 0.0 111.592 -172.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.55 HG22 ' N ' ' A' ' 50' ' ' CYS . 0.9 OUTLIER -82.43 121.78 27.17 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.2 -175.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.441 ' CE2' HG13 ' A' ' 23' ' ' VAL . 23.9 m-85 -116.67 134.0 55.34 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.241 0.543 . . . . 0.0 111.137 176.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.529 ' HB3' ' CZ3' ' A' ' 14' ' ' TRP . 16.9 m -67.28 -26.27 66.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.005 -173.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.708 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 25.7 p30 -179.62 175.6 0.42 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.114 -172.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.65 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 71.6 Cg_exo -51.67 -49.23 17.89 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.487 2.125 . . . . 0.0 113.636 177.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.8 p -62.38 -32.04 72.79 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.662 0.267 . . . . 0.0 111.117 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.457 ' C ' HD21 ' A' ' 30' ' ' ASN . 0.2 OUTLIER -63.38 -46.32 87.01 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.865 175.152 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.496 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 42.5 t80 -66.19 -47.48 73.78 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.329 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.3 m -62.43 -49.8 74.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.768 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.39 -44.07 79.81 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.323 0.582 . . . . 0.0 111.114 -177.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.1 tp60 -67.71 -34.39 76.79 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.263 -177.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.785 ' NE2' HD12 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -77.41 -37.98 50.71 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.282 -178.217 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.588 ' HG3' ' HG3' ' A' ' 37' ' ' GLN . 10.2 pt-20 -70.09 -29.89 66.98 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.631 -0.427 . . . . 0.0 111.052 -177.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.588 ' HG3' ' HG3' ' A' ' 36' ' ' GLU . 9.7 mt-30 -103.05 -35.99 8.33 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -177.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 4' ' ' CYS . 10.0 m -107.64 -66.96 0.99 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -169.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -126.29 85.59 59.67 Favored Pre-proline 0 C--N 1.328 -0.33 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.9 -175.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.56 -13.12 27.38 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 123.119 2.546 . . . . 0.0 112.696 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -97.95 19.53 13.74 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -168.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.785 HD12 ' NE2' ' A' ' 35' ' ' GLN . 10.9 pt -115.74 156.67 16.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.736 172.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.449 ' H ' ' CB ' ' A' ' 20' ' ' SER . 0.2 OUTLIER -109.05 168.49 9.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.147 178.775 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.9 mp -66.25 119.24 10.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.498 ' HB1' ' HA ' ' A' ' 20' ' ' SER . . . -82.47 -47.42 12.24 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.094 0.473 . . . . 0.0 110.333 -177.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -168.47 158.55 9.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.198 176.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 82.5 mtp -81.55 154.2 26.36 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.08 135.56 8.82 Favored Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -170.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.457 ' HB2' ' CG2' ' A' ' 24' ' ' THR . 9.6 pt-20 -68.84 141.09 55.21 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.078 0.466 . . . . 0.0 111.266 -175.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.55 ' N ' HG22 ' A' ' 24' ' ' THR . 3.9 m . . . . . 0 C--O 1.245 0.825 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.179 172.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.418 ' HB1' ' SG ' ' A' ' 4' ' ' CYS . . . . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 111.215 0.08 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 72.55 -52.8 0.7 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.56 0.744 . . . . 0.0 111.178 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -116.94 109.42 17.01 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.264 0.554 . . . . 0.0 110.606 173.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.418 ' SG ' ' HB1' ' A' ' 1' ' ' ALA . 0.8 OUTLIER -157.08 130.89 8.18 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.349 171.262 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.5 p -128.52 130.01 68.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 C-N-CA 119.813 -0.755 . . . . 0.0 112.205 -174.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 111.99 -112.45 3.08 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.037 173.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 25.4 ttp180 -130.43 122.29 27.48 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.951 0.405 . . . . 0.0 110.166 -174.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.597 ' HG2' HE22 ' A' ' 37' ' ' GLN . 24.4 tptp -97.38 123.51 41.24 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 176.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.91 117.29 16.6 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 122.025 0.917 . . . . 0.0 112.852 -160.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.5 t -138.96 144.09 38.85 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 166.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.5 m -162.26 71.96 0.34 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.398 0.618 . . . . 0.0 110.621 -174.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.9 ppt_? -115.17 6.95 15.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.423 0.63 . . . . 0.0 109.953 176.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 178.99 148.22 0.21 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -174.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 64.2 t-105 -118.41 95.28 4.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.42 0.629 . . . . 0.0 111.814 -177.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.65 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 48.1 m-85 -120.31 99.78 47.99 Favored Pre-proline 0 CA--C 1.505 -0.778 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 165.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -82.55 137.54 9.16 Favored 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 120.981 1.121 . . . . 0.0 112.616 -171.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.0 m -141.85 175.92 4.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.589 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 52.6 t -127.45 123.86 37.03 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.699 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -78.08 150.37 35.53 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 177.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.774 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 26.9 t -58.04 -12.25 3.21 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -171.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -74.96 -10.12 59.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.706 0.765 . . . . 0.0 109.612 173.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.04 21.07 34.15 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.382 -176.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.7 p -106.94 140.36 25.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.787 -176.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.524 ' OG1' ' HA ' ' A' ' 49' ' ' GLU . 1.6 t -87.72 131.28 34.53 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.58 0.705 . . . . 0.0 111.003 -176.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.699 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 69.7 m-85 -106.09 132.38 52.23 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.729 177.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.1 t -63.2 -26.73 68.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.998 -176.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.65 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 26.0 p30 -176.23 171.15 1.1 Allowed Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.154 -175.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.576 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 74.4 Cg_exo -50.76 -43.77 44.59 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.359 2.039 . . . . 0.0 112.247 177.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.3 t -54.62 -43.38 72.18 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.203 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -66.18 -46.08 78.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.006 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -66.41 -47.19 74.06 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.431 0.159 . . . . 0.0 111.431 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.6 p -63.34 -50.0 71.72 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.016 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.15 -43.92 85.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.944 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.579 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 9.5 tp60 -64.17 -41.15 97.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.805 -177.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.688 ' NE2' HD11 ' A' ' 42' ' ' ILE . 2.6 mp0 -72.93 -37.42 67.18 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.888 -176.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.48 -26.88 62.88 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.706 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.597 HE22 ' HG2' ' A' ' 8' ' ' LYS . 18.5 mt-30 -87.55 -31.6 19.82 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.6 m -117.14 -75.93 0.58 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -168.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.519 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 2.7 t70 -130.53 87.64 49.46 Favored Pre-proline 0 N--CA 1.463 0.206 0 CA-C-O 120.781 0.324 . . . . 0.0 111.073 -173.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -62.95 -13.32 34.27 Favored 'Trans proline' 0 N--CA 1.473 0.289 0 C-N-CA 123.578 2.852 . . . . 0.0 113.499 -176.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -84.56 -21.33 30.48 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -167.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.774 ' HB ' ' HB3' ' A' ' 20' ' ' SER . 3.0 pt -77.53 151.18 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.924 -177.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.3 p -110.75 168.2 9.65 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.114 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.4 mt -70.53 118.47 15.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 173.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.43 ' HB3' ' HA ' ' A' ' 20' ' ' SER . . . -75.38 -43.91 47.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.502 -176.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 26.8 p80 -167.79 155.94 9.0 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.668 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 22.7 ttt -77.04 145.14 38.14 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 174.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.33 167.45 16.67 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.26 -0.972 . . . . 0.0 112.042 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.524 ' HA ' ' OG1' ' A' ' 24' ' ' THR . 24.6 mt-10 -82.9 124.36 30.27 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.135 0.493 . . . . 0.0 111.524 -175.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.427 ' H ' ' CB ' ' A' ' 24' ' ' THR . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.124 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.844 173.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.723 ' HB2' ' HB3' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 120.663 0.268 . . . . 0.0 110.713 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 72.0 -58.46 0.59 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.255 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -113.68 112.17 23.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.051 0.453 . . . . 0.0 110.409 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.476 ' SG ' ' HG3' ' A' ' 34' ' ' GLN . 30.5 p -153.46 116.13 4.47 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 170.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.2 p -113.33 126.38 70.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.518 0.675 . . . . 0.0 111.027 -173.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 109.02 -102.6 1.68 Allowed Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.546 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -134.48 129.01 34.55 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -175.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.438 ' HD3' ' HA ' ' A' ' 8' ' ' LYS . 55.4 mmtt -100.56 127.22 47.0 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 166.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.86 119.22 20.33 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.388 0.613 . . . . 0.0 112.485 -165.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.49 ' SG ' ' HG3' ' A' ' 12' ' ' ARG . 43.6 t -138.32 146.78 42.81 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 171.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.47 62.49 0.75 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.685 0.755 . . . . 0.0 111.568 -177.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.49 ' HG3' ' SG ' ' A' ' 10' ' ' CYS . 6.2 mtm180 -95.42 -3.47 46.9 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 174.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 179.05 156.26 0.49 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.599 -163.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -128.86 91.93 3.31 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.034 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.729 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 60.3 m-85 -122.73 101.2 39.95 Favored Pre-proline 0 CA--C 1.503 -0.864 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 165.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -80.37 140.0 13.36 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 120.933 1.089 . . . . 0.0 111.695 -172.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.1 m -143.82 -175.49 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.373 0.606 . . . . 0.0 110.596 -177.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.3 t -128.59 134.48 48.6 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.694 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.527 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -82.26 148.23 26.55 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 175.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.735 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 32.3 t -59.16 -13.74 8.26 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -170.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.412 ' HD2' ' CG1' ' A' ' 23' ' ' VAL . 9.2 p-10 -91.06 6.56 44.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.102 0.477 . . . . 0.0 110.599 175.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.22 28.74 16.56 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.507 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.5 HG13 ' CE2' ' A' ' 25' ' ' TYR . 7.1 p -105.37 144.08 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.088 0.47 . . . . 0.0 111.972 -173.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.504 ' CG2' ' HB2' ' A' ' 49' ' ' GLU . 1.3 m -82.39 122.39 27.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.012 -176.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.527 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 31.0 m-85 -114.59 132.81 56.22 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 121.497 0.665 . . . . 0.0 111.633 176.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.0 m -70.81 -28.73 64.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.862 -176.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.729 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 28.4 p30 -172.5 166.83 3.32 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.464 -175.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.489 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 75.0 Cg_exo -50.77 -44.11 42.82 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.336 2.024 . . . . 0.0 112.619 178.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 14.4 t -54.91 -45.91 74.79 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.159 0.504 . . . . 0.0 111.493 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.414 ' OD1' ' HD1' ' A' ' 25' ' ' TYR . 1.5 t-20 -59.26 -45.34 91.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.536 177.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.406 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 55.1 t80 -66.33 -48.92 68.72 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.802 178.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.2 p -64.65 -49.18 72.02 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -174.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.44 ' HA ' ' HG2' ' A' ' 36' ' ' GLU . . . -66.42 -44.74 82.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.728 0.299 . . . . 0.0 111.151 -177.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.476 ' HG3' ' SG ' ' A' ' 4' ' ' CYS . 36.0 tt0 -67.64 -33.36 74.81 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.54 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.804 ' NE2' HD12 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -72.96 -43.33 62.42 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.114 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.44 ' HG2' ' HA ' ' A' ' 33' ' ' ALA . 14.1 pt-20 -67.41 -29.46 68.96 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.394 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.723 ' HB3' ' HB2' ' A' ' 1' ' ' ALA . 16.5 mt-30 -84.31 -34.66 23.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.84 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 91.7 m -127.5 -66.46 0.88 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -164.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -120.56 90.17 45.42 Favored Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.271 -176.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -72.6 -11.77 26.43 Favored 'Trans proline' 0 CA--C 1.529 0.251 0 C-N-CA 123.287 2.658 . . . . 0.0 112.407 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -90.23 -22.53 21.6 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -167.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.804 HD12 ' NE2' ' A' ' 35' ' ' GLN . 17.5 pt -80.68 162.76 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.27 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.507 ' H ' ' HB2' ' A' ' 20' ' ' SER . 15.4 p -123.8 167.73 13.67 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.692 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.3 mt -67.93 118.77 12.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 173.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.42 -49.9 11.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.659 -176.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -160.36 161.94 33.28 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 79.0 mtp -84.57 150.24 25.35 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.76 150.32 26.7 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -170.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.504 ' HB2' ' CG2' ' A' ' 24' ' ' THR . 0.3 OUTLIER -61.93 138.52 58.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.211 0.529 . . . . 0.0 110.581 -176.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.417 ' N ' HG21 ' A' ' 24' ' ' THR . 0.7 OUTLIER . . . . . 0 C--O 1.244 0.803 0 CA-C-O 118.661 -0.685 . . . . 0.0 110.481 -178.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.669 ' HB2' ' HB3' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.477 0.908 0 CA-C-O 121.013 0.435 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -131.69 -37.39 1.19 Allowed 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 171.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -112.11 113.12 25.21 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.321 172.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -153.75 116.52 4.46 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.452 174.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.7 p -117.65 127.86 74.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.425 0.631 . . . . 0.0 110.855 -176.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 124.04 -108.96 1.21 Allowed Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.383 176.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -131.74 140.92 49.38 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.222 0.534 . . . . 0.0 111.766 -176.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.687 ' HB2' ' OE1' ' A' ' 34' ' ' GLN . 2.3 tmtp? -97.87 122.3 40.82 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 168.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.84 115.68 16.83 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.458 -172.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.401 ' C ' ' HG1' ' A' ' 11' ' ' THR . 44.2 t -139.02 147.12 41.69 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 171.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.401 ' HG1' ' C ' ' A' ' 10' ' ' CYS . 1.9 m -157.91 63.48 0.46 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.348 0.594 . . . . 0.0 110.396 -177.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -93.85 -18.9 21.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.249 174.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -173.03 156.9 3.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.034 -0.984 . . . . 0.0 108.357 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 28.2 t-105 -111.58 93.07 4.28 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.964 178.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.724 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 14.5 m-85 -121.56 100.08 44.58 Favored Pre-proline 0 CA--C 1.504 -0.802 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 163.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -82.61 143.27 11.98 Favored 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 121.125 1.216 . . . . 0.0 112.749 -169.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.6 m -133.47 169.06 22.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 33.6 t -121.52 122.61 40.09 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.134 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.89 144.19 28.53 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 176.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.506 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 59.1 m -57.26 -12.07 2.14 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -172.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -78.85 -2.42 39.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.615 0.721 . . . . 0.0 109.773 174.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.68 28.73 45.96 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -175.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.45 HG12 ' CE2' ' A' ' 25' ' ' TYR . 2.7 p -104.59 129.19 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 121.088 0.47 . . . . 0.0 110.922 -175.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.602 ' OG1' ' HB2' ' A' ' 50' ' ' CYS . 26.8 m -82.24 116.52 21.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.051 -169.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.544 ' HE1' ' HG2' ' A' ' 34' ' ' GLN . 33.9 m-85 -104.52 131.21 52.18 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.476 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.1 t -68.28 -27.08 66.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.975 -173.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.724 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 21.2 p30 -174.98 172.87 1.09 Allowed Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.211 -174.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.568 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 72.6 Cg_exo -52.24 -46.55 32.06 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.369 2.046 . . . . 0.0 113.465 178.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.2 p -61.95 -31.37 71.69 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.017 0.437 . . . . 0.0 111.327 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -65.82 -47.56 74.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.852 175.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -66.62 -47.51 72.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.816 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.0 m -63.18 -50.19 71.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.851 -175.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.445 ' HA ' ' HG2' ' A' ' 36' ' ' GLU . . . -68.32 -43.06 78.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.164 0.506 . . . . 0.0 111.239 -177.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.687 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 44.0 tp60 -64.24 -35.49 81.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.022 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.814 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -77.98 -43.96 28.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.638 -178.311 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.445 ' HG2' ' HA ' ' A' ' 33' ' ' ALA . 11.4 pt-20 -66.11 -30.85 71.43 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.281 -177.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.669 ' HB3' ' HB2' ' A' ' 1' ' ' ALA . 16.4 mt-30 -93.74 -35.47 12.77 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.997 -178.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.3 m -109.35 -75.34 0.63 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.825 -169.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 12.4 t0 -124.39 91.23 49.81 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.843 0.354 . . . . 0.0 110.654 -176.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.45 -13.25 27.68 Favored 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 123.123 2.549 . . . . 0.0 112.868 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -82.62 -21.74 34.99 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -166.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.814 HD11 ' NE2' ' A' ' 35' ' ' GLN . 10.9 pt -78.34 164.41 3.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.04 -177.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.09 169.45 9.09 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.985 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.5 mt -72.19 117.47 15.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 167.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.419 ' HB3' ' HA ' ' A' ' 20' ' ' SER . . . -77.05 -42.48 38.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 -175.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -168.5 158.71 9.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.422 176.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.0 tpt -72.66 139.77 47.52 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 175.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.26 153.67 26.19 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.458 -175.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.557 ' HB2' HG22 ' A' ' 24' ' ' THR . 6.9 pt-20 -67.44 149.34 50.36 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.665 0.269 . . . . 0.0 111.421 -177.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.602 ' HB2' ' OG1' ' A' ' 24' ' ' THR . 60.3 m . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.873 -0.584 . . . . 0.0 111.243 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.963 0 CA-C-O 120.758 0.313 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -123.27 -36.04 2.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.139 0.495 . . . . 0.0 109.938 173.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -114.6 129.34 56.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.949 174.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.544 ' SG ' ' HG3' ' A' ' 34' ' ' GLN . 28.5 p -151.17 116.13 5.25 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.61 129.59 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 121.687 0.756 . . . . 0.0 111.528 -172.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.01 -96.1 1.82 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 173.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -131.77 136.34 47.49 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 174.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -99.67 120.27 39.44 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 171.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.75 120.22 21.61 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.439 0.638 . . . . 0.0 112.362 -167.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.47 ' SG ' ' N ' ' A' ' 30' ' ' ASN . 16.9 p -136.14 148.45 48.22 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 166.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.1 m -148.81 83.89 1.46 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.344 0.592 . . . . 0.0 111.385 -172.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.639 HH21 ' HB2' ' A' ' 28' ' ' PRO . 27.5 ptt180 -115.57 -10.25 11.9 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.262 176.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 177.51 159.04 0.41 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -174.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -114.0 93.69 4.48 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.802 176.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.668 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 50.2 m-85 -119.53 99.93 49.66 Favored Pre-proline 0 CA--C 1.502 -0.887 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 165.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.74 138.58 10.66 Favored 'Trans proline' 0 N--CA 1.438 -1.792 0 C-N-CA 120.69 0.927 . . . . 0.0 112.146 -171.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.3 m -140.99 168.87 15.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 45.1 t -119.68 126.95 52.35 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.696 -178.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.6 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -77.16 145.97 31.43 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 175.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.416 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 28.2 t -57.84 -11.8 2.6 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -172.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -78.75 -8.93 59.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.357 0.598 . . . . 0.0 110.31 174.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.73 28.26 11.48 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.666 -177.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.543 HG13 ' CE2' ' A' ' 25' ' ' TYR . 2.1 p -106.21 141.79 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -174.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.1 m -83.45 122.53 28.64 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.482 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.6 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 49.6 m-85 -111.27 136.82 49.82 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.429 0.633 . . . . 0.0 112.195 177.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.7 m -70.62 -38.68 73.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.31 -1.314 . . . . 0.0 112.401 -174.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.668 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 6.3 p30 -173.35 175.45 0.97 Allowed Pre-proline 0 C--N 1.329 -0.326 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.639 ' HB2' HH21 ' A' ' 12' ' ' ARG . 92.6 Cg_exo -46.01 -42.01 20.79 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 122.911 2.407 . . . . 0.0 114.944 -176.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.5 p -63.79 -33.39 75.57 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.626 0.648 . . . . 0.0 111.083 -177.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.47 ' N ' ' SG ' ' A' ' 10' ' ' CYS . 1.8 t-20 -67.56 -47.1 70.78 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.421 -176.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.532 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 62.4 t80 -66.49 -46.94 74.63 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.698 175.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.5 t -60.86 -50.89 71.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.424 -175.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.418 ' HA ' ' HG2' ' A' ' 36' ' ' GLU . . . -68.8 -47.39 66.22 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.484 -175.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.565 ' O ' ' HB2' ' A' ' 38' ' ' CYS . 31.9 tt0 -65.63 -31.35 72.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.367 0.603 . . . . 0.0 110.203 -176.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.827 ' NE2' HD12 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -78.15 -44.62 25.47 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.595 -178.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.418 ' HG2' ' HA ' ' A' ' 33' ' ' ALA . 10.7 pt-20 -65.25 -36.67 84.86 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.293 -176.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.617 ' HG3' ' SG ' ' A' ' 38' ' ' CYS . 12.8 pt20 -98.21 -34.14 10.84 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.994 -176.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.617 ' SG ' ' HG3' ' A' ' 37' ' ' GLN . 62.2 m -108.43 -67.58 0.96 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -170.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -123.66 86.59 52.76 Favored Pre-proline 0 N--CA 1.465 0.31 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.043 -176.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -73.61 -11.95 24.42 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 123.076 2.518 . . . . 0.0 113.115 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -86.02 -12.39 50.4 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -167.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.827 HD12 ' NE2' ' A' ' 35' ' ' GLN . 11.6 pt -93.97 159.17 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.05 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.5 p -121.35 168.0 12.14 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.381 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.9 mt -69.1 119.98 15.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.09 -50.94 7.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.859 -177.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 27.6 p80 -162.08 159.12 25.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.157 177.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 80.7 mtp -76.94 148.79 36.15 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 175.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.1 150.96 22.64 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -175.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -71.06 148.99 46.97 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.961 0.41 . . . . 0.0 111.023 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.73 -178.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.644 ' HB1' ' HB3' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 120.402 0.144 . . . . 0.0 110.803 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 69.84 -78.36 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.322 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -121.01 113.84 20.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.336 0.589 . . . . 0.0 110.591 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.7 p -153.02 140.04 19.24 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 171.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.0 p -114.02 123.93 70.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.153 -173.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.505 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . 103.47 -90.32 0.75 Allowed Glycine 0 N--CA 1.439 -1.114 0 CA-C-N 114.997 -1.002 . . . . 0.0 112.077 169.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.481 ' H ' ' HD3' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -132.99 140.18 47.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.919 0.39 . . . . 0.0 110.903 179.78 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.405 ' HG2' ' OE1' ' A' ' 34' ' ' GLN . 23.5 mmtt -98.73 131.61 44.75 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 168.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.33 119.6 17.79 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.581 0.705 . . . . 0.0 112.009 -169.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 44.8 t -137.56 146.2 43.78 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 174.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 m -156.38 53.71 0.55 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.284 0.564 . . . . 0.0 111.414 -174.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 23.7 ptt85 -100.84 -0.04 37.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.461 0.648 . . . . 0.0 110.037 173.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -172.56 155.15 3.29 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -175.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -129.3 93.32 3.54 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.447 177.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.644 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 50.7 m-85 -122.72 102.35 38.65 Favored Pre-proline 0 CA--C 1.5 -0.973 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 165.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -81.26 137.84 10.83 Favored 'Trans proline' 0 N--CA 1.439 -1.719 0 C-N-CA 120.732 0.955 . . . . 0.0 112.283 -172.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.0 m -140.8 172.28 11.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.329 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 47.7 t -121.25 132.7 54.97 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.59 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.58 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -84.48 149.74 25.04 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 174.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.455 ' HA ' ' HB1' ' A' ' 45' ' ' ALA . 8.2 t -59.28 -12.46 5.59 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -171.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.421 ' HB2' HG22 ' A' ' 42' ' ' ILE . 23.3 t70 -77.08 -7.26 55.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.58 0.705 . . . . 0.0 109.599 174.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.39 25.13 24.53 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.279 -177.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.525 HG13 ' CE2' ' A' ' 25' ' ' TYR . 3.5 p -105.51 140.99 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 121.13 0.491 . . . . 0.0 111.557 -172.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.0 m -82.78 121.66 27.19 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.183 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.58 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 51.6 m-85 -105.65 132.93 51.19 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.995 177.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.4 m -70.46 -26.42 63.63 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.765 -1.107 . . . . 0.0 112.181 -174.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.689 ' HB2' ' HD2' ' A' ' 28' ' ' PRO . 30.3 p30 -173.93 170.4 1.78 Allowed Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.689 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 9.3 Cg_endo -52.63 -37.28 74.4 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.569 2.179 . . . . 0.0 111.866 175.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.476 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 12.8 t -54.42 -51.55 64.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.375 175.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.423 ' CG ' ' HD1' ' A' ' 25' ' ' TYR . 1.8 t-20 -63.93 -44.8 91.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.13 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.507 ' HD1' ' CD2' ' A' ' 25' ' ' TYR . 64.8 t80 -63.21 -50.06 71.77 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 120.895 0.378 . . . . 0.0 110.466 -178.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.466 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 34.8 t -64.88 -52.2 57.86 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.141 -176.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.54 -40.88 89.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.881 0.372 . . . . 0.0 111.502 -173.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 6' ' ' GLY . 49.4 tp60 -62.69 -42.04 99.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.393 0.616 . . . . 0.0 110.485 -178.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.597 ' NE2' HD12 ' A' ' 42' ' ' ILE . 43.5 mt-30 -78.96 -41.3 29.58 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -176.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 32' ' ' SER . 12.6 pt-20 -69.14 -25.6 64.46 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.827 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.644 ' HB3' ' HB1' ' A' ' 1' ' ' ALA . 20.2 mt-30 -95.58 -27.76 15.18 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 78.8 m -137.77 -50.8 0.61 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -172.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.532 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 57.9 m-20 -119.92 68.81 12.8 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 118.229 0.468 . . . . 0.0 111.492 -170.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.55 -13.78 35.74 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.526 2.151 . . . . 0.0 113.73 -170.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -94.38 10.04 35.89 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -166.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.597 HD12 ' NE2' ' A' ' 35' ' ' GLN . 7.7 pt -109.59 156.6 10.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 118.981 -1.088 . . . . 0.0 111.47 175.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.0 p -118.53 168.58 10.54 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.562 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.7 mt -64.8 119.45 9.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.455 ' HB1' ' HA ' ' A' ' 20' ' ' SER . . . -84.31 -44.98 13.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.953 -177.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -168.37 156.89 8.67 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.736 175.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 95.8 mmm -74.62 144.72 43.77 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.18 148.44 24.07 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 110.614 -0.995 . . . . 0.0 110.614 -174.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.85 149.27 45.38 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.003 0.43 . . . . 0.0 111.037 -176.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.011 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.584 -171.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.628 ' HB2' ' OE1' ' A' ' 34' ' ' GLN . 19.5 tptm . . . . . 0 N--CA 1.445 -0.68 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.59 120.59 20.36 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.732 0.777 . . . . 0.0 112.218 -166.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 51.0 t -136.57 145.68 45.24 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 169.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.9 m -147.77 63.13 1.13 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.499 0.666 . . . . 0.0 110.769 -172.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.444 ' HG3' ' HB3' ' A' ' 13' ' ' GLU . 7.6 ptt180 -88.73 -18.72 27.24 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.147 176.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.444 ' HB3' ' HG3' ' A' ' 12' ' ' ARG . 37.8 tt0 -179.76 161.45 0.99 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.739 -1.119 . . . . 0.0 107.994 -163.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -121.11 92.03 3.66 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.896 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.578 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 16.5 m-85 -121.06 99.22 46.76 Favored Pre-proline 0 CA--C 1.501 -0.925 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 164.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -83.23 138.71 8.98 Favored 'Trans proline' 0 N--CA 1.437 -1.83 0 C-N-CA 121.17 1.247 . . . . 0.0 112.614 -171.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -140.23 164.52 22.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.126 177.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.5 t -116.35 131.3 56.98 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.527 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -85.74 156.04 29.76 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.416 -0.897 . . . . 0.0 111.113 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.803 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 68.5 m -57.71 -11.68 2.36 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -175.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -77.23 -6.8 54.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.664 0.745 . . . . 0.0 109.914 173.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.03 28.29 37.95 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 -174.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.473 HG13 ' CE2' ' A' ' 25' ' ' TYR . 3.1 p -105.61 140.94 22.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 120.945 0.402 . . . . 0.0 111.975 -172.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.7 m -84.29 120.98 26.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.327 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.527 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 59.2 m-85 -107.51 128.47 54.54 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.845 175.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.6 m -66.77 -25.66 66.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.315 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.587 ' OD1' ' HB3' ' A' ' 29' ' ' CYS . 7.4 p30 -171.54 170.36 2.7 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -177.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.53 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 79.3 Cg_exo -50.19 -42.13 47.77 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.46 2.107 . . . . 0.0 112.454 176.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.587 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 35.7 t -57.77 -40.75 80.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.883 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.4 ' ND2' ' HD1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -62.51 -45.03 94.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.049 177.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -64.32 -48.42 75.66 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.013 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.4 t -63.99 -52.21 60.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.39 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.43 -45.33 84.25 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 120.961 0.41 . . . . 0.0 111.508 -173.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.628 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 7.7 tp60 -64.12 -41.23 97.31 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.283 -177.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.664 ' NE2' HD11 ' A' ' 42' ' ' ILE . 59.7 mt-30 -77.76 -36.6 50.42 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -176.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -64.52 -26.13 68.29 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.276 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.587 HE22 ' HG2' ' A' ' 8' ' ' LYS . 8.2 mt-30 -86.84 -36.86 18.24 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.75 0.31 . . . . 0.0 111.661 173.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.6 m -112.26 -79.15 0.58 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -169.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.439 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 8.8 t70 -126.43 91.44 47.61 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.515 -172.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -68.96 -12.12 33.58 Favored 'Trans proline' 0 C--N 1.332 -0.301 0 C-N-CA 122.858 2.372 . . . . 0.0 112.142 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -88.67 -12.94 40.99 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -166.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.803 ' HB ' ' HB2' ' A' ' 20' ' ' SER . 10.5 pt -80.35 162.29 3.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.581 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.7 p -121.54 169.2 10.9 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.148 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.1 mt -69.98 117.83 13.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.7 -48.37 26.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.287 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -160.75 154.69 22.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.839 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -73.56 140.34 46.22 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.82 141.21 10.42 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.391 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -56.92 144.19 34.66 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 122.447 0.299 . . . . 0.0 111.143 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.915 -0.564 . . . . 0.0 111.203 -176.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? . . . . . 0 N--CA 1.449 -0.475 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.08 117.95 17.49 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.795 0.807 . . . . 0.0 112.706 -165.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 36.5 t -138.55 145.58 40.84 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 168.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.8 m -157.83 66.29 0.48 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.814 0.816 . . . . 0.0 110.602 -177.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -101.26 8.89 42.29 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 173.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 178.03 154.58 0.34 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 113.984 -1.462 . . . . 0.0 107.896 -171.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -128.32 92.52 3.45 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.494 174.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.681 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 30.9 m-85 -122.54 101.29 40.43 Favored Pre-proline 0 N--CA 1.441 -0.917 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 164.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -81.78 138.68 10.67 Favored 'Trans proline' 0 N--CA 1.439 -1.703 0 C-N-CA 120.92 1.08 . . . . 0.0 111.586 -172.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.7 m -140.32 169.69 15.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.131 0.491 . . . . 0.0 109.997 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.6 t -117.03 129.61 56.13 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.318 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.06 144.69 26.35 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 174.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.465 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 50.8 p -61.29 -11.42 9.63 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -171.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -73.88 -10.18 59.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.501 0.667 . . . . 0.0 109.662 171.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.85 25.64 14.53 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.744 -178.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.531 HG13 ' CE2' ' A' ' 25' ' ' TYR . 3.1 p -106.73 142.0 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.438 -175.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.554 HG23 ' HA ' ' A' ' 49' ' ' GLU . 85.8 m -84.21 119.47 25.06 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 120.959 0.409 . . . . 0.0 110.643 -178.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.531 ' CE2' HG13 ' A' ' 23' ' ' VAL . 37.0 m-85 -106.87 132.91 52.29 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.525 0.678 . . . . 0.0 111.08 177.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.3 t -64.88 -31.37 72.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.186 -172.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.681 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 26.8 p30 -175.5 170.7 1.3 Allowed Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.554 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 82.0 Cg_exo -50.2 -40.92 51.36 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.316 2.011 . . . . 0.0 112.508 176.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 35.2 t -54.46 -48.64 71.51 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.094 0.473 . . . . 0.0 110.569 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -66.62 -46.37 76.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.486 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.511 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 38.3 t80 -63.73 -48.09 78.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.521 0.201 . . . . 0.0 110.947 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.5 p -64.1 -50.65 67.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.013 -175.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.501 ' HA ' ' HG2' ' A' ' 36' ' ' GLU . . . -65.3 -44.44 87.92 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.071 0.462 . . . . 0.0 110.937 -176.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -63.52 -37.38 87.07 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.446 0.641 . . . . 0.0 110.395 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.588 ' HG3' ' O ' ' A' ' 39' ' ' ASP . 2.1 mp0 -77.61 -37.59 49.95 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.873 -177.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.501 ' HG2' ' HA ' ' A' ' 33' ' ' ALA . 12.8 pt-20 -73.62 -27.76 61.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.842 0.353 . . . . 0.0 110.762 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -91.36 -34.09 15.02 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.774 -178.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 64.2 m -119.96 -74.88 0.59 Allowed 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.068 -0.653 . . . . 0.0 112.761 -169.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.588 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 4.8 t0 -115.33 97.96 49.51 Favored Pre-proline 0 C--N 1.326 -0.444 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.113 -175.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 39' ' ' ASP . 41.8 Cg_endo -71.14 -13.23 31.06 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 123.2 2.6 . . . . 0.0 113.698 -177.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -85.57 -21.85 28.34 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -163.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.577 HD11 ' NE2' ' A' ' 35' ' ' GLN . 6.5 pt -87.99 154.1 3.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 119.294 -0.963 . . . . 0.0 111.126 -175.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.5 p -127.88 169.68 13.66 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.515 -1.221 . . . . 0.0 109.036 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.483 ' H ' HD12 ' A' ' 44' ' ' ILE . 4.5 mp -68.87 119.41 14.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.53 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.465 ' HB2' ' HA ' ' A' ' 20' ' ' SER . . . -81.18 -46.15 15.3 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.428 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -168.02 157.13 9.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.561 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 87.7 mtp -79.99 130.56 35.37 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.63 162.2 11.56 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 -173.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.554 ' HA ' HG23 ' A' ' 24' ' ' THR . 0.5 OUTLIER -73.35 147.93 43.92 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.067 0.46 . . . . 0.0 111.095 -178.8 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.832 -0.604 . . . . 0.0 111.033 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.537 ' HB2' ' OE1' ' A' ' 34' ' ' GLN . 6.6 tmtm? . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.44 117.63 16.48 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.896 0.855 . . . . 0.0 112.184 -166.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.542 ' SG ' ' HG3' ' A' ' 12' ' ' ARG . 44.5 t -138.51 146.38 41.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.103 -1.408 . . . . 0.0 107.494 172.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.2 m -152.54 64.22 0.81 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.79 0.805 . . . . 0.0 110.144 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.542 ' HG3' ' SG ' ' A' ' 10' ' ' CYS . 21.2 mtm180 -104.27 0.78 29.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.291 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 177.02 153.16 0.21 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 113.837 -1.529 . . . . 0.0 107.129 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 65.2 t-105 -117.45 92.21 3.78 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.847 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.666 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 37.3 m-85 -122.87 101.9 38.71 Favored Pre-proline 0 N--CA 1.434 -1.237 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 164.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.16 137.95 12.43 Favored 'Trans proline' 0 N--CA 1.441 -1.606 0 C-N-CA 120.546 0.83 . . . . 0.0 111.566 -172.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.0 m -138.01 173.86 11.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.044 0.45 . . . . 0.0 110.101 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.1 t -122.73 132.5 54.27 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.634 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.11 146.5 25.26 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 173.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.627 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 10.0 t -57.95 -13.92 5.4 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -172.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.466 ' HB2' HG21 ' A' ' 42' ' ' ILE . 31.4 t70 -74.94 -8.41 56.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.51 0.671 . . . . 0.0 109.924 174.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.47 25.38 21.24 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.287 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.5 p -105.73 140.88 22.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.921 0.391 . . . . 0.0 111.285 -173.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.431 HG23 ' HA ' ' A' ' 49' ' ' GLU . 36.8 m -85.15 123.77 31.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.19 0.519 . . . . 0.0 111.239 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -111.51 137.47 49.3 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.933 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 65.5 m -68.4 -26.09 65.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.229 -175.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.666 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 30.8 p30 -172.67 171.96 1.8 Allowed Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.551 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 75.5 Cg_exo -52.34 -39.87 71.92 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.379 2.053 . . . . 0.0 112.597 176.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.431 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 21.5 t -55.14 -44.91 75.52 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.959 0.409 . . . . 0.0 110.558 176.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.435 HD22 ' C ' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -61.68 -46.45 89.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.367 179.207 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -65.96 -47.9 73.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.928 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.7 t -63.58 -49.26 74.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.571 -174.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.469 ' HA ' ' HG2' ' A' ' 36' ' ' GLU . . . -64.78 -44.92 88.44 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.706 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.537 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 7.5 tp60 -62.65 -40.79 98.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.543 0.687 . . . . 0.0 110.398 -177.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.565 ' HG3' ' O ' ' A' ' 39' ' ' ASP . 2.2 mp0 -76.08 -36.29 59.01 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.98 -177.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.469 ' HG2' ' HA ' ' A' ' 33' ' ' ALA . 11.1 pt-20 -67.08 -42.92 83.83 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.364 -178.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -111.74 5.85 19.42 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -175.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 34' ' ' GLN . 66.5 m -135.0 -63.25 0.7 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.158 0.89 . . . . 0.0 113.0 175.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.565 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 8.6 t0 -116.94 92.57 39.31 Favored Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 118.808 0.731 . . . . 0.0 110.7 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -72.08 -12.95 28.53 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.43 2.753 . . . . 0.0 113.374 -177.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -92.62 -21.86 19.8 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -163.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.627 ' HB ' ' HB3' ' A' ' 20' ' ' SER . 19.0 pt -90.72 160.04 2.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.835 0.826 . . . . 0.0 112.363 -174.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.5 p -123.22 169.37 11.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.323 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.5 mt -65.17 119.29 9.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 175.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.53 -50.69 10.35 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.523 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -164.76 161.43 20.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 44.7 tpp -75.92 139.25 41.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.025 173.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 107.33 159.73 21.17 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.53 -176.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.437 ' CD ' ' H ' ' A' ' 49' ' ' GLU . 0.8 OUTLIER -73.69 149.12 42.11 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.916 0.389 . . . . 0.0 111.04 -178.64 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.331 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.13 118.67 30.62 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.961 -174.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 30' ' ' ASN . 21.2 p -137.34 148.68 46.48 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 168.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.7 m -148.89 89.0 1.64 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.408 0.623 . . . . 0.0 111.381 -175.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -109.67 -19.8 13.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.527 173.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -177.61 163.92 1.97 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -169.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -118.28 92.99 3.97 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.156 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.669 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 15.3 m-85 -122.67 101.09 40.27 Favored Pre-proline 0 N--CA 1.441 -0.911 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 164.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.59 140.04 11.62 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 121.345 1.363 . . . . 0.0 112.487 -172.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 25' ' ' TYR . 27.2 m -143.29 170.91 9.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.98 0.419 . . . . 0.0 109.944 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 18.5 t -123.63 139.41 54.03 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.5 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -94.5 156.96 22.27 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.285 177.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.856 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 64.1 m -57.22 -12.67 2.45 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -174.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -76.71 -7.92 56.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.841 0.829 . . . . 0.0 109.712 173.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.04 28.68 36.55 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -173.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.516 HG13 ' CE2' ' A' ' 25' ' ' TYR . 2.7 p -101.48 140.8 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 121.066 0.46 . . . . 0.0 111.427 -172.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.526 HG23 ' N ' ' A' ' 50' ' ' CYS . 1.3 m -82.49 117.27 22.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.252 -177.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.516 ' CE2' HG13 ' A' ' 23' ' ' VAL . 52.3 m-85 -106.56 130.42 54.33 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-O 121.269 0.556 . . . . 0.0 110.744 176.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.4 t -70.29 -26.86 64.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.746 -174.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.672 ' HB2' ' HD2' ' A' ' 28' ' ' PRO . 26.1 p-10 178.25 173.9 0.38 Allowed Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -173.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.672 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 79.6 Cg_exo -47.8 -49.48 13.56 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 123.219 2.613 . . . . 0.0 114.901 -176.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.455 ' SG ' ' ND2' ' A' ' 27' ' ' ASN . 7.8 p -59.27 -35.77 74.34 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.044 0.45 . . . . 0.0 111.058 -177.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.403 ' OD1' ' HA ' ' A' ' 25' ' ' TYR . 2.1 t-20 -64.84 -46.02 83.66 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.946 -178.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.42 ' HD2' ' CD2' ' A' ' 25' ' ' TYR . 65.0 t80 -65.4 -47.92 74.62 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.129 0.49 . . . . 0.0 109.726 178.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.8 t -64.03 -51.71 62.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.905 -175.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.465 ' O ' ' HG2' ' A' ' 36' ' ' GLU . . . -69.01 -44.09 73.46 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.088 0.47 . . . . 0.0 111.452 -175.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -62.47 -41.66 98.93 Favored 'General case' 0 C--O 1.215 -0.715 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.949 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.632 ' NE2' HD11 ' A' ' 42' ' ' ILE . 61.9 mt-30 -78.69 -35.91 44.33 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 33' ' ' ALA . 12.8 pt-20 -61.94 -27.94 69.18 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.797 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.63 ' HG3' ' SG ' ' A' ' 38' ' ' CYS . 20.6 pt20 -100.85 -38.06 8.41 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 119.488 -0.885 . . . . 0.0 112.793 174.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.63 ' SG ' ' HG3' ' A' ' 37' ' ' GLN . 17.7 m -96.12 -77.98 0.47 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.897 -169.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.463 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 5.8 t0 -124.13 89.76 51.46 Favored Pre-proline 0 C--N 1.331 -0.207 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.06 -175.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.32 -11.8 32.27 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 123.315 2.677 . . . . 0.0 112.836 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -79.66 -21.81 44.28 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -167.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.856 ' HB ' ' HB2' ' A' ' 20' ' ' SER . 9.0 pt -85.62 161.91 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.406 -175.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.96 169.5 12.04 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.258 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.4 mt -65.4 117.89 6.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.242 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.84 -44.24 50.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.005 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -166.96 151.58 7.23 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.38 176.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -73.54 139.4 45.61 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 108.67 145.14 11.24 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -171.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.459 ' HB2' ' CG2' ' A' ' 24' ' ' THR . 0.9 OUTLIER -73.97 145.64 44.48 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.996 0.398 . . . . 0.0 110.692 -175.902 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.526 ' N ' HG23 ' A' ' 24' ' ' THR . 1.3 m . . . . . 0 C--O 1.242 0.697 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.32 173.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.8 mmtt . . . . . 0 CA--C 1.512 -0.481 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.55 115.42 16.29 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.49 -173.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 48.8 t -139.98 146.1 38.68 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 167.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -168.0 56.17 0.06 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.642 0.734 . . . . 0.0 110.641 -172.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -80.72 -23.81 39.23 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.265 175.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -163.31 157.66 20.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.612 -1.176 . . . . 0.0 107.923 -177.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 71.2 t-105 -112.42 94.43 4.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.403 0.62 . . . . 0.0 111.038 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.568 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 30.4 m-85 -120.33 100.02 47.78 Favored Pre-proline 0 N--CA 1.442 -0.852 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 165.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -81.36 138.37 10.99 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 120.996 1.131 . . . . 0.0 113.266 -168.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.23 174.15 6.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.504 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.0 t -126.7 138.61 53.42 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.447 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.83 153.14 21.79 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 175.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.547 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 16.2 m -56.81 -15.17 4.22 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -174.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -74.01 -7.82 53.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.691 0.758 . . . . 0.0 109.968 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.09 27.89 29.84 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -175.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.428 HG13 ' CE2' ' A' ' 25' ' ' TYR . 3.6 p -105.73 140.73 22.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.269 -0.466 . . . . 0.0 111.18 -172.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.422 HG23 ' HA ' ' A' ' 49' ' ' GLU . 42.0 m -85.05 122.19 28.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.98 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.428 ' CE2' HG13 ' A' ' 23' ' ' VAL . 29.7 m-85 -109.91 133.07 53.57 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.225 177.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.8 m -65.97 -34.6 78.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.586 -173.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.568 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 8.2 p30 -178.07 177.23 0.43 Allowed Pre-proline 0 C--O 1.237 0.403 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.528 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 95.7 Cg_exo -46.03 -43.21 20.48 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 122.821 2.347 . . . . 0.0 114.765 -177.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 29.1 p -60.96 -37.33 82.0 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.222 0.465 . . . . 0.0 110.695 -177.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -67.89 -46.27 72.09 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.541 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.51 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 62.7 t80 -65.95 -46.7 77.19 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 176.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 39.3 t -63.39 -50.88 68.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.515 -176.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.55 ' O ' ' HG2' ' A' ' 37' ' ' GLN . . . -68.07 -44.79 75.5 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 120.78 0.324 . . . . 0.0 111.018 -175.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.8 tp60 -65.85 -35.4 80.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.223 0.535 . . . . 0.0 110.246 -177.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.772 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -77.43 -36.7 52.85 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.365 -177.665 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.506 ' HG2' ' HA ' ' A' ' 33' ' ' ALA . 9.5 pt-20 -70.92 -28.05 64.23 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.105 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.629 ' HG3' ' SG ' ' A' ' 38' ' ' CYS . 9.7 pt20 -99.79 -35.16 9.88 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.069 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.629 ' SG ' ' HG3' ' A' ' 37' ' ' GLN . 25.0 m -104.49 -77.57 0.58 Allowed 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.805 -172.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 9.2 t70 -118.08 99.3 51.89 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.885 0.374 . . . . 0.0 111.136 -175.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.23 -13.95 25.68 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 123.111 2.541 . . . . 0.0 112.92 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -86.43 -21.75 26.93 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -164.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.772 HD11 ' NE2' ' A' ' 35' ' ' GLN . 23.5 pt -85.67 166.21 2.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.608 -177.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.8 p -132.12 170.56 14.8 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.317 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.3 mt -65.77 118.16 7.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 175.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.26 -43.55 27.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.52 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -164.38 157.69 17.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.545 177.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.77 138.48 36.28 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 175.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 110.69 151.89 12.77 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -173.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.422 ' HA ' HG23 ' A' ' 24' ' ' THR . 14.2 pt-20 -65.54 149.4 50.12 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.75 0.31 . . . . 0.0 111.269 -178.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.134 0 CA-C-O 119.225 -0.417 . . . . 0.0 110.464 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp . . . . . 0 N--CA 1.455 -0.208 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.08 121.96 27.23 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.358 0.599 . . . . 0.0 112.286 -171.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 46.8 t -136.32 147.44 47.43 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 170.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.0 m -153.42 67.21 0.77 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.406 0.622 . . . . 0.0 111.805 -174.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.3 ptt85 -110.87 -3.05 15.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.236 0.541 . . . . 0.0 109.82 172.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 174.63 151.33 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.592 -1.186 . . . . 0.0 108.396 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -110.02 94.62 5.11 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.143 0.497 . . . . 0.0 110.366 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.756 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 31.2 m-85 -120.52 100.44 47.06 Favored Pre-proline 0 N--CA 1.441 -0.901 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 167.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.93 138.52 10.4 Favored 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 121.02 1.146 . . . . 0.0 111.744 -172.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.2 m -143.75 176.98 2.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.125 0.488 . . . . 0.0 110.292 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.2 t -124.7 130.25 52.06 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.319 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.67 147.71 29.81 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 174.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.908 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 32.7 t -57.85 -12.58 3.24 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -172.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -77.59 -7.95 57.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.702 0.763 . . . . 0.0 110.214 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.14 24.96 20.94 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -176.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.41 HG13 ' CE2' ' A' ' 25' ' ' TYR . 3.2 p -106.01 140.96 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 120.934 0.397 . . . . 0.0 111.269 -174.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.9 m -83.73 124.52 30.96 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.383 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.494 ' HE1' ' HG2' ' A' ' 34' ' ' GLN . 29.9 m-85 -113.05 135.85 53.34 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.421 177.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.1 m -69.24 -29.07 66.92 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.422 -173.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.756 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 28.6 p30 -170.17 168.8 4.13 Favored Pre-proline 0 C--O 1.236 0.353 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.518 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 72.3 Cg_exo -50.6 -38.19 54.51 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.515 2.143 . . . . 0.0 112.515 177.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.432 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 7.6 t -55.21 -50.9 68.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.551 176.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -62.14 -45.26 94.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.735 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.513 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 58.7 t80 -61.17 -49.13 78.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.305 0.098 . . . . 0.0 111.028 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.484 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 16.2 t -65.86 -51.0 62.55 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.485 0.18 . . . . 0.0 111.485 -177.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.66 -43.51 93.37 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.487 0.661 . . . . 0.0 110.995 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.494 ' HG2' ' HE1' ' A' ' 25' ' ' TYR . 9.5 tp60 -64.68 -36.92 85.85 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.166 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.725 ' HG3' ' O ' ' A' ' 39' ' ' ASP . 2.2 mp0 -72.81 -44.39 61.53 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.383 -176.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.492 ' HG3' ' NE2' ' A' ' 37' ' ' GLN . 9.3 pt-20 -63.68 -31.01 72.05 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.092 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.492 ' NE2' ' HG3' ' A' ' 36' ' ' GLU . 2.9 mp0 -87.32 -35.09 18.61 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 177.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 18.7 m -108.59 -80.7 0.57 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -171.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.725 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 55.8 t0 -126.14 83.91 62.61 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 120.871 0.367 . . . . 0.0 110.662 -172.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -67.99 -12.64 35.89 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 123.446 2.764 . . . . 0.0 114.13 -170.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -99.54 11.71 38.43 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -169.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.908 ' HB ' ' HB3' ' A' ' 20' ' ' SER . 12.5 pt -97.31 151.36 4.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.371 174.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.428 ' H ' ' HB2' ' A' ' 20' ' ' SER . 0.3 OUTLIER -107.54 167.67 9.78 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.361 -179.526 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.2 mt -70.33 118.94 15.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 173.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.24 -51.07 16.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.473 -176.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -160.75 158.43 28.61 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.271 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.4 tpt -71.3 145.03 49.76 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.003 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.35 154.45 30.75 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.609 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -62.53 149.28 43.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.821 0.344 . . . . 0.0 110.699 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.86 -0.59 . . . . 0.0 110.842 -173.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.463 ' HD3' ' HA ' ' A' ' 8' ' ' LYS . 65.2 mmtt . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.69 120.44 21.08 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.872 0.844 . . . . 0.0 113.104 -162.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 43.4 t -128.55 147.2 50.68 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 168.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.9 m -150.21 61.98 0.97 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.554 0.693 . . . . 0.0 111.326 -175.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -91.52 -13.38 32.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.697 174.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -173.71 157.5 3.12 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -173.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 67.2 t-105 -119.07 92.99 3.93 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.038 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.732 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 14.6 m-85 -122.15 101.06 41.88 Favored Pre-proline 0 CA--C 1.501 -0.92 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 166.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -80.88 138.1 11.44 Favored 'Trans proline' 0 N--CA 1.443 -1.475 0 C-N-CA 120.697 0.931 . . . . 0.0 111.767 -172.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.4 m -142.77 -179.9 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.361 -177.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.4 t -127.98 134.57 49.28 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.583 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.48 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -82.69 147.58 25.36 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 174.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.655 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 10.6 t -57.88 -13.77 4.98 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -172.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.462 ' HB2' HG21 ' A' ' 42' ' ' ILE . 18.6 t70 -76.83 -8.53 57.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.531 0.681 . . . . 0.0 109.931 175.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.49 26.39 17.99 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.377 -177.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.613 HG13 ' CE2' ' A' ' 25' ' ' TYR . 2.5 p -106.57 141.93 20.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 120.698 0.285 . . . . 0.0 111.721 -174.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.7 m -83.63 126.86 33.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.23 -176.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.613 ' CE2' HG13 ' A' ' 23' ' ' VAL . 51.2 m-85 -117.07 137.99 51.9 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.408 0.623 . . . . 0.0 111.894 177.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.7 m -70.21 -28.37 65.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.121 -175.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.732 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 26.6 p30 -173.84 169.33 2.04 Favored Pre-proline 0 C--O 1.234 0.285 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.549 -177.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.545 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 78.3 Cg_exo -51.47 -42.13 56.76 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.473 2.115 . . . . 0.0 112.416 177.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 41.5 t -54.72 -45.36 74.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.093 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -62.43 -47.58 83.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.953 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.561 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 55.3 t80 -66.57 -48.11 70.64 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.569 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.408 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 22.2 t -63.79 -50.63 68.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.052 -174.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.92 -45.43 74.37 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.169 0.509 . . . . 0.0 111.126 -175.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.417 ' OE1' ' HE1' ' A' ' 25' ' ' TYR . 22.0 tt0 -65.57 -31.9 73.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.172 0.511 . . . . 0.0 110.695 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.778 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -78.15 -46.97 19.18 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.367 -177.136 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.646 ' HG3' ' HG3' ' A' ' 37' ' ' GLN . 11.7 pt-20 -61.57 -30.59 70.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.875 0.369 . . . . 0.0 110.481 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.646 ' HG3' ' HG3' ' A' ' 36' ' ' GLU . 74.4 mt-30 -94.29 -34.81 12.7 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.593 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 59.8 m -120.13 -65.82 1.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -170.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.501 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 0.7 OUTLIER -116.19 74.66 5.7 Favored Pre-proline 0 N--CA 1.465 0.312 0 CA-C-O 120.729 0.299 . . . . 0.0 111.667 -173.005 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.593 ' HD3' ' O ' ' A' ' 38' ' ' CYS . 6.9 Cg_exo -72.62 -13.11 27.21 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 123.131 2.554 . . . . 0.0 112.698 -174.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -77.36 -20.99 53.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.346 -169.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.778 HD11 ' NE2' ' A' ' 35' ' ' GLN . 10.9 pt -95.32 153.13 3.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.597 -175.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.43 ' O ' ' HB2' ' A' ' 20' ' ' SER . 22.1 p -112.23 168.21 9.8 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.624 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.0 mt -65.93 118.71 9.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.97 -50.82 11.4 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.699 -176.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -166.0 163.27 18.35 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.2 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 86.5 mmm -74.89 146.59 41.74 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 173.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.52 146.37 18.41 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.658 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.41 149.19 50.78 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.718 0.294 . . . . 0.0 110.983 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.976 -0.535 . . . . 0.0 110.978 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.439 -1.025 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.24 128.86 35.77 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -162.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 36.7 t -119.01 147.72 43.78 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 170.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.7 m -153.35 79.59 1.17 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.19 0.519 . . . . 0.0 111.919 -175.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -115.33 -29.09 6.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.4 0.619 . . . . 0.0 109.783 170.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -148.11 158.88 44.32 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -118.17 93.79 4.26 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.15 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.746 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 67.3 m-85 -121.39 99.78 45.35 Favored Pre-proline 0 CA--C 1.504 -0.799 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 164.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -81.77 139.61 11.17 Favored 'Trans proline' 0 N--CA 1.442 -1.537 0 C-N-CA 121.132 1.221 . . . . 0.0 112.558 -171.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.5 m -138.71 172.28 13.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 176.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 29.6 t -116.38 130.61 56.86 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.859 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.656 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -83.65 142.09 20.75 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 172.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.566 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 4.5 t -60.04 -11.04 4.95 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -171.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.579 ' HB2' HG21 ' A' ' 42' ' ' ILE . 19.2 t70 -74.28 -8.21 55.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.487 0.66 . . . . 0.0 109.504 173.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.1 24.91 23.5 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.357 -177.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.572 HG13 ' CE2' ' A' ' 25' ' ' TYR . 2.3 p -105.35 138.52 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 121.061 0.458 . . . . 0.0 111.423 -175.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.52 HG23 ' N ' ' A' ' 50' ' ' CYS . 7.6 m -85.06 116.46 23.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.564 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.656 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 47.5 m-85 -101.37 133.0 46.65 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.337 0.589 . . . . 0.0 111.704 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.9 m -64.18 -30.25 71.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.299 -1.319 . . . . 0.0 112.384 -175.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.746 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 22.1 p30 -174.58 169.6 1.72 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.463 -175.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.657 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 9.2 Cg_endo -52.39 -38.76 74.14 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.599 2.2 . . . . 0.0 112.022 176.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 33.3 t -55.22 -45.01 75.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.451 176.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.49 ' O ' ' HB3' ' A' ' 34' ' ' GLN . 0.2 OUTLIER -66.31 -46.26 77.52 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.961 -178.622 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.434 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 61.3 t80 -65.87 -48.06 72.82 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.517 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.569 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 19.9 t -64.37 -52.09 60.06 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.415 -175.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.512 ' O ' ' HB2' ' A' ' 37' ' ' GLN . . . -68.02 -42.85 80.01 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.014 0.435 . . . . 0.0 111.27 -174.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.49 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 42.4 tp60 -63.92 -34.64 78.43 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.416 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.768 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -78.01 -50.22 12.54 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.316 -178.849 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 32' ' ' SER . 12.2 pt-20 -65.27 -26.51 68.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.732 0.301 . . . . 0.0 111.055 -177.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.512 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 2.4 mp0 -92.38 -33.84 14.4 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 82.4 m -133.49 -58.2 0.88 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -169.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.537 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 16.2 m-20 -114.54 68.98 1.98 Allowed Pre-proline 0 N--CA 1.467 0.386 0 CA-C-N 117.996 0.362 . . . . 0.0 111.764 -173.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.25 -14.25 28.44 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.42 2.08 . . . . 0.0 112.614 -174.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -89.06 -6.85 56.83 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -167.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.768 HD11 ' NE2' ' A' ' 35' ' ' GLN . 10.2 pt -91.7 170.79 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 119.964 -0.695 . . . . 0.0 110.941 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.3 p -126.61 168.64 14.03 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.733 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.497 ' H ' HD12 ' A' ' 44' ' ' ILE . 4.5 mp -72.27 119.47 18.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.566 ' HB2' ' HA ' ' A' ' 20' ' ' SER . . . -81.79 -46.72 13.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.751 -176.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 34.8 p80 -167.08 156.69 10.78 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.219 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 96.9 mmm -74.22 156.47 37.22 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 175.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.9 156.76 28.04 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.088 -1.053 . . . . 0.0 110.551 -173.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.453 ' HB2' ' CG2' ' A' ' 24' ' ' THR . 11.6 pt-20 -65.52 135.26 54.91 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.013 0.435 . . . . 0.0 110.292 -177.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.52 ' N ' HG23 ' A' ' 24' ' ' THR . 1.6 t . . . . . 0 C--O 1.251 1.171 0 CA-C-O 118.4 -0.809 . . . . 0.0 110.746 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.437 ' HA ' ' HD3' ' A' ' 8' ' ' LYS . 64.2 mmtt . . . . . 0 N--CA 1.455 -0.221 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.79 119.41 19.75 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -162.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 78.4 m -127.55 146.08 50.64 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 165.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.2 m -154.22 28.95 0.45 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.215 1.007 . . . . 0.0 110.29 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -82.82 -5.06 58.78 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.865 177.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -171.76 150.94 2.75 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -167.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -128.81 93.62 3.66 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.666 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.693 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 77.0 m-85 -121.73 100.48 43.72 Favored Pre-proline 0 CA--C 1.501 -0.915 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 164.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.47 138.11 10.72 Favored 'Trans proline' 0 N--CA 1.441 -1.605 0 C-N-CA 120.555 0.837 . . . . 0.0 111.59 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.4 m -141.42 176.12 4.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.7 t -123.09 128.99 50.87 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.617 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.448 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -81.09 146.46 26.56 Favored Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 174.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.658 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 8.6 t -58.91 -12.79 4.91 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -172.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -74.08 -8.63 56.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.641 0.734 . . . . 0.0 110.128 173.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.92 26.84 23.25 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.12 -176.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.455 HG13 ' CE2' ' A' ' 25' ' ' TYR . 3.3 p -106.54 141.08 22.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.808 0.337 . . . . 0.0 111.384 -174.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.477 HG23 ' HA ' ' A' ' 49' ' ' GLU . 90.1 m -84.43 123.23 30.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.057 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.455 ' CE2' HG13 ' A' ' 23' ' ' VAL . 35.8 m-85 -109.84 136.13 49.64 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.563 0.697 . . . . 0.0 111.525 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.3 m -70.17 -32.07 69.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.323 -1.308 . . . . 0.0 112.361 -173.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.718 ' HB2' ' HD2' ' A' ' 28' ' ' PRO . 27.5 p30 -175.61 171.92 1.12 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.216 -174.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.718 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 6.1 Cg_endo -49.47 -41.49 43.87 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.736 2.291 . . . . 0.0 112.616 176.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.42 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 48.2 t -54.8 -50.62 68.09 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.163 0.506 . . . . 0.0 110.296 177.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -63.32 -45.92 89.05 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.296 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -65.74 -47.26 75.86 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.61 0.243 . . . . 0.0 110.818 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.419 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 41.6 t -63.61 -51.43 65.31 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.291 -176.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.45 -43.71 84.82 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 120.814 0.34 . . . . 0.0 110.828 -174.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.557 ' HA ' ' OE1' ' A' ' 34' ' ' GLN . 6.6 tp60 -64.06 -37.78 88.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.317 0.58 . . . . 0.0 110.576 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.819 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -74.8 -50.32 17.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.967 -178.017 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 32' ' ' SER . 12.8 pt-20 -64.8 -26.15 68.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.559 0.218 . . . . 0.0 111.477 -176.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -93.33 -35.94 12.8 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 98.9 m -124.74 -54.67 1.64 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -167.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -133.58 85.68 41.98 Favored Pre-proline 0 N--CA 1.465 0.313 0 CA-C-N 119.094 0.861 . . . . 0.0 111.38 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.98 -12.97 23.93 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 123.314 2.676 . . . . 0.0 112.751 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -81.72 -14.22 56.8 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.354 -165.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.819 HD11 ' NE2' ' A' ' 35' ' ' GLN . 9.9 pt -86.53 157.05 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.605 0.717 . . . . 0.0 111.0 -178.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.4 p -110.99 167.39 10.29 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.783 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.444 ' H ' HD12 ' A' ' 44' ' ' ILE . 4.5 mp -70.1 119.27 15.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 173.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.31 -48.7 19.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.279 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -168.93 158.69 8.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.31 176.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 25.9 ttt -77.75 140.07 39.44 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 172.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 110.68 161.15 17.7 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -172.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.477 ' HA ' HG23 ' A' ' 24' ' ' THR . 9.6 pt-20 -75.4 149.24 38.65 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.041 0.448 . . . . 0.0 111.234 -176.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.749 -0.643 . . . . 0.0 111.051 -177.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.0 tptp . . . . . 0 N--CA 1.446 -0.643 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.71 122.63 24.29 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.687 0.756 . . . . 0.0 112.366 -168.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 34.8 t -134.37 147.85 50.58 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 172.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.73 44.75 0.68 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -172.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -84.45 -13.82 50.97 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.593 0.711 . . . . 0.0 109.51 173.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -170.7 151.84 3.62 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.526 ' CZ3' ' HB3' ' A' ' 26' ' ' SER . 57.7 t-105 -118.82 91.84 3.66 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.008 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.721 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 10.4 m-85 -123.73 100.77 37.2 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 164.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -80.59 143.36 15.06 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 121.236 1.291 . . . . 0.0 112.499 -170.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.0 m -137.04 -179.03 2.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.944 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 18.8 t -129.35 131.88 46.97 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.34 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.9 151.19 36.95 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 176.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.634 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 31.2 t -59.65 -12.69 7.33 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -171.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -80.24 -8.49 59.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.26 0.553 . . . . 0.0 110.101 174.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.22 28.77 10.28 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 -175.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.431 HG13 ' CE2' ' A' ' 25' ' ' TYR . 3.6 p -104.86 141.73 19.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.03 0.443 . . . . 0.0 111.592 -172.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.565 HG23 ' N ' ' A' ' 50' ' ' CYS . 0.9 OUTLIER -82.43 121.78 27.17 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.2 -175.9 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.431 ' CE2' HG13 ' A' ' 23' ' ' VAL . 23.9 m-85 -116.67 134.0 55.34 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.241 0.543 . . . . 0.0 111.137 176.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.526 ' HB3' ' CZ3' ' A' ' 14' ' ' TRP . 16.9 m -67.28 -26.27 66.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.005 -173.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.721 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 25.7 p30 -179.62 175.6 0.42 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.114 -172.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.654 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 71.6 Cg_exo -51.67 -49.23 17.89 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.487 2.125 . . . . 0.0 113.636 177.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.8 p -62.38 -32.04 72.79 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.662 0.267 . . . . 0.0 111.117 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.461 HD22 ' C ' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -63.38 -46.32 87.01 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.865 175.152 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.476 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 42.5 t80 -66.19 -47.48 73.78 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.329 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.3 m -62.43 -49.8 74.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.768 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.42 ' HA ' ' HG2' ' A' ' 36' ' ' GLU . . . -67.39 -44.07 79.81 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.323 0.582 . . . . 0.0 111.114 -177.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.1 tp60 -67.71 -34.39 76.79 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.263 -177.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.788 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -77.41 -37.98 50.71 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.282 -178.217 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.599 ' HG3' ' HG3' ' A' ' 37' ' ' GLN . 10.2 pt-20 -70.09 -29.89 66.98 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.631 -0.427 . . . . 0.0 111.052 -177.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.599 ' HG3' ' HG3' ' A' ' 36' ' ' GLU . 68.5 mt-30 -103.05 -35.99 8.33 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -177.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 10.0 m -107.64 -66.96 0.99 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -169.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.401 ' OD1' HG23 ' A' ' 42' ' ' ILE . 4.2 t70 -126.29 85.59 59.67 Favored Pre-proline 0 C--N 1.328 -0.33 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.9 -175.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.56 -13.12 27.38 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 123.119 2.546 . . . . 0.0 112.696 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -97.95 19.53 13.74 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -168.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.788 HD11 ' NE2' ' A' ' 35' ' ' GLN . 10.9 pt -115.74 156.67 16.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.736 172.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.487 ' H ' ' CB ' ' A' ' 20' ' ' SER . 0.2 OUTLIER -109.05 168.49 9.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.147 178.775 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.55 ' H ' HD12 ' A' ' 44' ' ' ILE . 4.9 mp -66.25 119.24 10.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.526 ' HB2' ' HA ' ' A' ' 20' ' ' SER . . . -82.47 -47.42 12.24 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.094 0.473 . . . . 0.0 110.333 -177.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -168.47 158.55 9.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.198 176.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 82.5 mtp -81.55 154.2 26.36 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.08 135.56 8.82 Favored Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -170.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.457 ' HB2' ' CG2' ' A' ' 24' ' ' THR . 9.6 pt-20 -68.84 141.09 55.21 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.078 0.466 . . . . 0.0 111.266 -175.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.565 ' N ' HG23 ' A' ' 24' ' ' THR . 3.9 m . . . . . 0 C--O 1.245 0.825 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.179 172.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.589 ' HB2' ' OE1' ' A' ' 34' ' ' GLN . 24.4 tptp . . . . . 0 N--CA 1.446 -0.667 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.91 117.29 16.6 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 122.025 0.917 . . . . 0.0 112.852 -160.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.5 t -138.96 144.09 38.85 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 166.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.5 m -162.26 71.96 0.34 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.398 0.618 . . . . 0.0 110.621 -174.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.9 ppt_? -115.17 6.95 15.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.423 0.63 . . . . 0.0 109.953 176.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 178.99 148.22 0.21 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -174.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 64.2 t-105 -118.41 95.28 4.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.42 0.629 . . . . 0.0 111.814 -177.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.65 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 48.1 m-85 -120.31 99.78 47.99 Favored Pre-proline 0 CA--C 1.505 -0.778 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 165.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -82.55 137.54 9.16 Favored 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 120.981 1.121 . . . . 0.0 112.616 -171.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.0 m -141.85 175.92 4.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.589 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 52.6 t -127.45 123.86 37.03 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.705 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -78.08 150.37 35.53 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 177.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.805 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 26.9 t -58.04 -12.25 3.21 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -171.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -74.96 -10.12 59.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.706 0.765 . . . . 0.0 109.612 173.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.04 21.07 34.15 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.382 -176.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.7 p -106.94 140.36 25.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.787 -176.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.533 ' OG1' ' HA ' ' A' ' 49' ' ' GLU . 1.6 t -87.72 131.28 34.53 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.58 0.705 . . . . 0.0 111.003 -176.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.705 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 69.7 m-85 -106.09 132.38 52.23 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.729 177.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.1 t -63.2 -26.73 68.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.998 -176.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.65 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 26.0 p30 -176.23 171.15 1.1 Allowed Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.154 -175.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.577 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 74.4 Cg_exo -50.76 -43.77 44.59 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.359 2.039 . . . . 0.0 112.247 177.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.3 t -54.62 -43.38 72.18 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.203 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -66.18 -46.08 78.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.006 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -66.41 -47.19 74.06 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.431 0.159 . . . . 0.0 111.431 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.6 p -63.34 -50.0 71.72 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.016 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.15 -43.92 85.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.944 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.589 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 9.5 tp60 -64.17 -41.15 97.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.805 -177.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.659 ' NE2' HD11 ' A' ' 42' ' ' ILE . 2.6 mp0 -72.93 -37.42 67.18 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.888 -176.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.48 -26.88 62.88 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.706 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -87.55 -31.6 19.82 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.6 m -117.14 -75.93 0.58 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -168.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.526 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 2.7 t70 -130.53 87.64 49.46 Favored Pre-proline 0 N--CA 1.463 0.206 0 CA-C-O 120.781 0.324 . . . . 0.0 111.073 -173.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -62.95 -13.32 34.27 Favored 'Trans proline' 0 N--CA 1.473 0.289 0 C-N-CA 123.578 2.852 . . . . 0.0 113.499 -176.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -84.56 -21.33 30.48 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -167.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.805 ' HB ' ' HB3' ' A' ' 20' ' ' SER . 3.0 pt -77.53 151.18 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.924 -177.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.3 p -110.75 168.2 9.65 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.114 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.4 mt -70.53 118.47 15.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 173.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.457 ' HB2' ' HA ' ' A' ' 20' ' ' SER . . . -75.38 -43.91 47.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.502 -176.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 26.8 p80 -167.79 155.94 9.0 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.668 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 22.7 ttt -77.04 145.14 38.14 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 174.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.33 167.45 16.67 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.26 -0.972 . . . . 0.0 112.042 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.533 ' HA ' ' OG1' ' A' ' 24' ' ' THR . 24.6 mt-10 -82.9 124.36 30.27 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.135 0.493 . . . . 0.0 111.524 -175.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.47 ' H ' ' CB ' ' A' ' 24' ' ' THR . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.124 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.844 173.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.465 ' HA ' ' HD3' ' A' ' 8' ' ' LYS . 55.4 mmtt . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.86 119.22 20.33 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.388 0.613 . . . . 0.0 112.485 -165.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.51 ' SG ' ' HG3' ' A' ' 12' ' ' ARG . 43.6 t -138.32 146.78 42.81 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 171.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.47 62.49 0.75 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.685 0.755 . . . . 0.0 111.568 -177.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.51 ' HG3' ' SG ' ' A' ' 10' ' ' CYS . 6.2 mtm180 -95.42 -3.47 46.9 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 174.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 179.05 156.26 0.49 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.599 -163.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -128.86 91.93 3.31 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.034 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.739 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 60.3 m-85 -122.73 101.2 39.95 Favored Pre-proline 0 CA--C 1.503 -0.864 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 165.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -80.37 140.0 13.36 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 120.933 1.089 . . . . 0.0 111.695 -172.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.1 m -143.82 -175.49 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.373 0.606 . . . . 0.0 110.596 -177.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.3 t -128.59 134.48 48.6 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.694 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.538 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -82.26 148.23 26.55 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 175.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.757 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 32.3 t -59.16 -13.74 8.26 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -170.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -91.06 6.56 44.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.102 0.477 . . . . 0.0 110.599 175.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.22 28.74 16.56 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.507 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.536 HG13 ' CE2' ' A' ' 25' ' ' TYR . 7.1 p -105.37 144.08 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.088 0.47 . . . . 0.0 111.972 -173.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.505 ' CG2' ' HB2' ' A' ' 49' ' ' GLU . 1.3 m -82.39 122.39 27.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.012 -176.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.538 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 31.0 m-85 -114.59 132.81 56.22 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 121.497 0.665 . . . . 0.0 111.633 176.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.0 m -70.81 -28.73 64.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.862 -176.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.739 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 28.4 p30 -172.5 166.83 3.32 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.464 -175.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.494 ' HD3' ' HB2' ' A' ' 15' ' ' TYR . 75.0 Cg_exo -50.77 -44.11 42.82 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.336 2.024 . . . . 0.0 112.619 178.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 14.4 t -54.91 -45.91 74.79 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.159 0.504 . . . . 0.0 111.493 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.411 ' OD1' ' HD1' ' A' ' 25' ' ' TYR . 1.5 t-20 -59.26 -45.34 91.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.536 177.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -66.33 -48.92 68.72 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.802 178.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.2 p -64.65 -49.18 72.02 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -174.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.453 ' HA ' ' HG2' ' A' ' 36' ' ' GLU . . . -66.42 -44.74 82.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.728 0.299 . . . . 0.0 111.151 -177.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.455 ' OE1' ' HE1' ' A' ' 25' ' ' TYR . 36.0 tt0 -67.64 -33.36 74.81 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.54 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.768 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -72.96 -43.33 62.42 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.114 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.453 ' HG2' ' HA ' ' A' ' 33' ' ' ALA . 14.1 pt-20 -67.41 -29.46 68.96 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.394 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -84.31 -34.66 23.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.84 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 91.7 m -127.5 -66.46 0.88 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -164.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -120.56 90.17 45.42 Favored Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.271 -176.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -72.6 -11.77 26.43 Favored 'Trans proline' 0 CA--C 1.529 0.251 0 C-N-CA 123.287 2.658 . . . . 0.0 112.407 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -90.23 -22.53 21.6 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -167.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.768 HD11 ' NE2' ' A' ' 35' ' ' GLN . 17.5 pt -80.68 162.76 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.27 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.6 ' H ' ' HB2' ' A' ' 20' ' ' SER . 15.4 p -123.8 167.73 13.67 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.692 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.3 mt -67.93 118.77 12.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 173.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.42 -49.9 11.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.659 -176.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -160.36 161.94 33.28 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 79.0 mtp -84.57 150.24 25.35 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.76 150.32 26.7 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -170.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.505 ' HB2' ' CG2' ' A' ' 24' ' ' THR . 0.3 OUTLIER -61.93 138.52 58.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.211 0.529 . . . . 0.0 110.581 -176.918 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.43 ' N ' HG23 ' A' ' 24' ' ' THR . 0.7 OUTLIER . . . . . 0 C--O 1.244 0.803 0 CA-C-O 118.661 -0.685 . . . . 0.0 110.481 -178.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.678 ' HB2' ' OE1' ' A' ' 34' ' ' GLN . 2.3 tmtp? . . . . . 0 CA--C 1.515 -0.388 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.84 115.68 16.83 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.458 -172.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 44.2 t -139.02 147.12 41.69 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 171.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.9 m -157.91 63.48 0.46 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.348 0.594 . . . . 0.0 110.396 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -93.85 -18.9 21.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.249 174.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -173.03 156.9 3.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.034 -0.984 . . . . 0.0 108.357 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 28.2 t-105 -111.58 93.07 4.28 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.964 178.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.731 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 14.5 m-85 -121.56 100.08 44.58 Favored Pre-proline 0 CA--C 1.504 -0.802 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 163.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -82.61 143.27 11.98 Favored 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 121.125 1.216 . . . . 0.0 112.749 -169.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.6 m -133.47 169.06 22.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 33.6 t -121.52 122.61 40.09 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.134 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.89 144.19 28.53 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 176.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.498 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 59.1 m -57.26 -12.07 2.14 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -172.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -78.85 -2.42 39.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.615 0.721 . . . . 0.0 109.773 174.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.68 28.73 45.96 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -175.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.453 HG13 ' CE2' ' A' ' 25' ' ' TYR . 2.7 p -104.59 129.19 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 121.088 0.47 . . . . 0.0 110.922 -175.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.595 ' OG1' ' HB2' ' A' ' 50' ' ' CYS . 26.8 m -82.24 116.52 21.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.051 -169.081 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.543 ' HE1' ' HG2' ' A' ' 34' ' ' GLN . 33.9 m-85 -104.52 131.21 52.18 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.476 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.1 t -68.28 -27.08 66.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.975 -173.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.731 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 21.2 p30 -174.98 172.87 1.09 Allowed Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.211 -174.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.574 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 72.6 Cg_exo -52.24 -46.55 32.06 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.369 2.046 . . . . 0.0 113.465 178.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.2 p -61.95 -31.37 71.69 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.017 0.437 . . . . 0.0 111.327 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.402 ' C ' HD22 ' A' ' 30' ' ' ASN . 0.3 OUTLIER -65.82 -47.56 74.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.852 175.77 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -66.62 -47.51 72.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.816 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.0 m -63.18 -50.19 71.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.851 -175.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.471 ' HA ' ' HG2' ' A' ' 36' ' ' GLU . . . -68.32 -43.06 78.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.164 0.506 . . . . 0.0 111.239 -177.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.678 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 44.0 tp60 -64.24 -35.49 81.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.022 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.815 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -77.98 -43.96 28.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.638 -178.311 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.477 ' HG3' ' HG3' ' A' ' 37' ' ' GLN . 11.4 pt-20 -66.11 -30.85 71.43 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.281 -177.074 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.477 ' HG3' ' HG3' ' A' ' 36' ' ' GLU . 86.6 mt-30 -93.74 -35.47 12.77 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.997 -178.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.3 m -109.35 -75.34 0.63 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.825 -169.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.414 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 12.4 t0 -124.39 91.23 49.81 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.843 0.354 . . . . 0.0 110.654 -176.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.45 -13.25 27.68 Favored 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 123.123 2.549 . . . . 0.0 112.868 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -82.62 -21.74 34.99 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -166.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.815 HD11 ' NE2' ' A' ' 35' ' ' GLN . 10.9 pt -78.34 164.41 3.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.04 -177.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.09 169.45 9.09 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.985 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.5 mt -72.19 117.47 15.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 167.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.447 ' HB2' ' HA ' ' A' ' 20' ' ' SER . . . -77.05 -42.48 38.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 -175.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -168.5 158.71 9.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.422 176.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.0 tpt -72.66 139.77 47.52 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 175.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.26 153.67 26.19 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.458 -175.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.563 ' HB2' HG23 ' A' ' 24' ' ' THR . 6.9 pt-20 -67.44 149.34 50.36 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.665 0.269 . . . . 0.0 111.421 -177.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.595 ' HB2' ' OG1' ' A' ' 24' ' ' THR . 60.3 m . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.873 -0.584 . . . . 0.0 111.243 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.7 tptp . . . . . 0 N--CA 1.449 -0.503 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.75 120.22 21.61 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.439 0.638 . . . . 0.0 112.362 -167.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.47 ' SG ' ' N ' ' A' ' 30' ' ' ASN . 16.9 p -136.14 148.45 48.22 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 166.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.1 m -148.81 83.89 1.46 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.344 0.592 . . . . 0.0 111.385 -172.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.654 HH21 ' HB2' ' A' ' 28' ' ' PRO . 27.5 ptt180 -115.57 -10.25 11.9 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.262 176.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 177.51 159.04 0.41 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -174.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -114.0 93.69 4.48 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.802 176.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.662 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 50.2 m-85 -119.53 99.93 49.66 Favored Pre-proline 0 CA--C 1.502 -0.887 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 165.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.74 138.58 10.66 Favored 'Trans proline' 0 N--CA 1.438 -1.792 0 C-N-CA 120.69 0.927 . . . . 0.0 112.146 -171.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.3 m -140.99 168.87 15.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 45.1 t -119.68 126.95 52.35 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.696 -178.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.619 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -77.16 145.97 31.43 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 175.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.44 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 28.2 t -57.84 -11.8 2.6 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -172.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -78.75 -8.93 59.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.357 0.598 . . . . 0.0 110.31 174.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.73 28.26 11.48 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.666 -177.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.559 HG13 ' CE2' ' A' ' 25' ' ' TYR . 2.1 p -106.21 141.79 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -174.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.1 m -83.45 122.53 28.64 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.482 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.619 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 49.6 m-85 -111.27 136.82 49.82 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.429 0.633 . . . . 0.0 112.195 177.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.7 m -70.62 -38.68 73.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.31 -1.314 . . . . 0.0 112.401 -174.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.662 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 6.3 p30 -173.35 175.45 0.97 Allowed Pre-proline 0 C--N 1.329 -0.326 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.654 ' HB2' HH21 ' A' ' 12' ' ' ARG . 92.6 Cg_exo -46.01 -42.01 20.79 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 122.911 2.407 . . . . 0.0 114.944 -176.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.5 p -63.79 -33.39 75.57 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.626 0.648 . . . . 0.0 111.083 -177.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.47 ' N ' ' SG ' ' A' ' 10' ' ' CYS . 1.8 t-20 -67.56 -47.1 70.78 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.421 -176.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.512 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 62.4 t80 -66.49 -46.94 74.63 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.698 175.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.5 t -60.86 -50.89 71.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.424 -175.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.437 ' HA ' ' HG2' ' A' ' 36' ' ' GLU . . . -68.8 -47.39 66.22 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.484 -175.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.548 ' O ' ' HB2' ' A' ' 38' ' ' CYS . 31.9 tt0 -65.63 -31.35 72.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.367 0.603 . . . . 0.0 110.203 -176.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.827 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -78.15 -44.62 25.47 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.595 -178.972 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.437 ' HG2' ' HA ' ' A' ' 33' ' ' ALA . 10.7 pt-20 -65.25 -36.67 84.86 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.293 -176.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.637 ' HG3' ' SG ' ' A' ' 38' ' ' CYS . 2.9 pt20 -98.21 -34.14 10.84 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.994 -176.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.637 ' SG ' ' HG3' ' A' ' 37' ' ' GLN . 62.2 m -108.43 -67.58 0.96 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -170.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -123.66 86.59 52.76 Favored Pre-proline 0 N--CA 1.465 0.31 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.043 -176.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -73.61 -11.95 24.42 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 123.076 2.518 . . . . 0.0 113.115 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -86.02 -12.39 50.4 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -167.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.827 HD11 ' NE2' ' A' ' 35' ' ' GLN . 11.6 pt -93.97 159.17 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.05 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.5 p -121.35 168.0 12.14 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.381 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.9 mt -69.1 119.98 15.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.09 -50.94 7.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.859 -177.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 27.6 p80 -162.08 159.12 25.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.157 177.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 80.7 mtp -76.94 148.79 36.15 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 175.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.1 150.96 22.64 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -175.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.451 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 1.2 pm0 -71.06 148.99 46.97 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.961 0.41 . . . . 0.0 111.023 -178.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.73 -178.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 8' ' ' LYS . 23.5 mmtt . . . . . 0 N--CA 1.451 -0.415 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.33 119.6 17.79 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.581 0.705 . . . . 0.0 112.009 -169.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 44.8 t -137.56 146.2 43.78 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 174.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 m -156.38 53.71 0.55 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.284 0.564 . . . . 0.0 111.414 -174.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 23.7 ptt85 -100.84 -0.04 37.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.461 0.648 . . . . 0.0 110.037 173.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -172.56 155.15 3.29 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -175.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -129.3 93.32 3.54 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.447 177.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.65 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 50.7 m-85 -122.72 102.35 38.65 Favored Pre-proline 0 CA--C 1.5 -0.973 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 165.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -81.26 137.84 10.83 Favored 'Trans proline' 0 N--CA 1.439 -1.719 0 C-N-CA 120.732 0.955 . . . . 0.0 112.283 -172.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.0 m -140.8 172.28 11.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.329 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 47.7 t -121.25 132.7 54.97 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.59 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.591 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -84.48 149.74 25.04 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 174.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.492 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 8.2 t -59.28 -12.46 5.59 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -171.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.481 ' HB2' HG21 ' A' ' 42' ' ' ILE . 23.3 t70 -77.08 -7.26 55.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.58 0.705 . . . . 0.0 109.599 174.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.39 25.13 24.53 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.279 -177.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.565 HG13 ' CE2' ' A' ' 25' ' ' TYR . 3.5 p -105.51 140.99 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 121.13 0.491 . . . . 0.0 111.557 -172.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.0 m -82.78 121.66 27.19 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.183 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.591 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 51.6 m-85 -105.65 132.93 51.19 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.995 177.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.4 m -70.46 -26.42 63.63 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.765 -1.107 . . . . 0.0 112.181 -174.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.687 ' HB2' ' HD2' ' A' ' 28' ' ' PRO . 30.3 p30 -173.93 170.4 1.78 Allowed Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.687 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 9.3 Cg_endo -52.63 -37.28 74.4 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.569 2.179 . . . . 0.0 111.866 175.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.483 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 12.8 t -54.42 -51.55 64.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.375 175.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.424 ' CG ' ' HD1' ' A' ' 25' ' ' TYR . 1.8 t-20 -63.93 -44.8 91.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.13 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.501 ' HD1' ' CD2' ' A' ' 25' ' ' TYR . 64.8 t80 -63.21 -50.06 71.77 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 120.895 0.378 . . . . 0.0 110.466 -178.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.453 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 34.8 t -64.88 -52.2 57.86 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.141 -176.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.54 -40.88 89.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.881 0.372 . . . . 0.0 111.502 -173.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.401 ' OE1' ' HG2' ' A' ' 8' ' ' LYS . 49.4 tp60 -62.69 -42.04 99.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.393 0.616 . . . . 0.0 110.485 -178.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.588 ' NE2' HD11 ' A' ' 42' ' ' ILE . 43.5 mt-30 -78.96 -41.3 29.58 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -176.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 32' ' ' SER . 12.6 pt-20 -69.14 -25.6 64.46 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.827 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -95.58 -27.76 15.18 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 78.8 m -137.77 -50.8 0.61 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -172.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.528 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 57.9 m-20 -119.92 68.81 12.8 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 118.229 0.468 . . . . 0.0 111.492 -170.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.55 -13.78 35.74 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.526 2.151 . . . . 0.0 113.73 -170.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -94.38 10.04 35.89 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -166.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.588 HD11 ' NE2' ' A' ' 35' ' ' GLN . 7.7 pt -109.59 156.6 10.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 118.981 -1.088 . . . . 0.0 111.47 175.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.0 p -118.53 168.58 10.54 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.562 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.7 mt -64.8 119.45 9.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.492 ' HB2' ' HA ' ' A' ' 20' ' ' SER . . . -84.31 -44.98 13.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.953 -177.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -168.37 156.89 8.67 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.736 175.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 95.8 mmm -74.62 144.72 43.77 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.18 148.44 24.07 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 110.614 -0.995 . . . . 0.0 110.614 -174.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.434 ' HG3' ' H ' ' A' ' 49' ' ' GLU . 0.4 OUTLIER -71.85 149.27 45.38 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.003 0.43 . . . . 0.0 111.037 -176.605 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.011 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.584 -171.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 120.379 0.133 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 70.57 -66.85 0.27 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.705 0.802 . . . . 0.0 111.7 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -119.48 113.19 20.37 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.448 0.642 . . . . 0.0 110.298 -177.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -153.64 145.04 23.12 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.636 -1.166 . . . . 0.0 108.765 174.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.4 t -128.24 132.04 68.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 120.984 0.421 . . . . 0.0 111.55 -173.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.14 -136.48 9.61 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 173.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.0 ptt180 -126.2 140.45 52.54 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 173.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.628 ' HB2' ' OE1' ' A' ' 34' ' ' GLN . 19.5 tptm -97.86 123.76 41.97 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 175.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.59 120.59 20.36 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.732 0.777 . . . . 0.0 112.218 -166.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 51.0 t -136.57 145.68 45.24 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 169.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.9 m -147.77 63.13 1.13 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.499 0.666 . . . . 0.0 110.769 -172.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.444 ' HG3' ' HB3' ' A' ' 13' ' ' GLU . 7.6 ptt180 -88.73 -18.72 27.24 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.147 176.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.444 ' HB3' ' HG3' ' A' ' 12' ' ' ARG . 37.8 tt0 -179.76 161.45 0.99 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.739 -1.119 . . . . 0.0 107.994 -163.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -121.11 92.03 3.66 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.896 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.578 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 16.5 m-85 -121.06 99.22 46.76 Favored Pre-proline 0 CA--C 1.501 -0.925 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 164.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -83.23 138.71 8.98 Favored 'Trans proline' 0 N--CA 1.437 -1.83 0 C-N-CA 121.17 1.247 . . . . 0.0 112.614 -171.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -140.23 164.52 22.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.126 177.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.5 t -116.35 131.3 56.98 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.527 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -85.74 156.04 29.76 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.416 -0.897 . . . . 0.0 111.113 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.803 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 68.5 m -57.71 -11.68 2.36 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -175.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -77.23 -6.8 54.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.664 0.745 . . . . 0.0 109.914 173.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.03 28.29 37.95 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 -174.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.473 HG13 ' CE2' ' A' ' 25' ' ' TYR . 3.1 p -105.61 140.94 22.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 120.945 0.402 . . . . 0.0 111.975 -172.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.7 m -84.29 120.98 26.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.327 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.527 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 59.2 m-85 -107.51 128.47 54.54 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.845 175.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.6 m -66.77 -25.66 66.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.315 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.587 ' OD1' ' HB3' ' A' ' 29' ' ' CYS . 7.4 p30 -171.54 170.36 2.7 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -177.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.53 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 79.3 Cg_exo -50.19 -42.13 47.77 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.46 2.107 . . . . 0.0 112.454 176.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.587 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 35.7 t -57.77 -40.75 80.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.883 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.4 ' ND2' ' HD1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -62.51 -45.03 94.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.049 177.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -64.32 -48.42 75.66 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.013 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.4 t -63.99 -52.21 60.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.39 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.43 -45.33 84.25 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 120.961 0.41 . . . . 0.0 111.508 -173.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.628 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 7.7 tp60 -64.12 -41.23 97.31 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.283 -177.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.664 ' NE2' HD11 ' A' ' 42' ' ' ILE . 59.7 mt-30 -77.76 -36.6 50.42 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -176.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -64.52 -26.13 68.29 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.276 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.587 HE22 ' HG2' ' A' ' 8' ' ' LYS . 8.2 mt-30 -86.84 -36.86 18.24 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.75 0.31 . . . . 0.0 111.661 173.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.6 m -112.26 -79.15 0.58 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -169.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.439 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 8.8 t70 -126.43 91.44 47.61 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.515 -172.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -68.96 -12.12 33.58 Favored 'Trans proline' 0 C--N 1.332 -0.301 0 C-N-CA 122.858 2.372 . . . . 0.0 112.142 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -88.67 -12.94 40.99 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -166.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.803 ' HB ' ' HB2' ' A' ' 20' ' ' SER . 10.5 pt -80.35 162.29 3.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.581 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.7 p -121.54 169.2 10.9 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.148 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.1 mt -69.98 117.83 13.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.7 -48.37 26.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.287 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -160.75 154.69 22.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.839 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -73.56 140.34 46.22 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.82 141.21 10.42 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.391 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -56.92 144.19 34.66 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 122.447 0.299 . . . . 0.0 111.143 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.915 -0.564 . . . . 0.0 111.203 -176.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 111.386 0.143 . . . . 0.0 111.386 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 38' ' ' CYS . 2.2 mp0 66.63 -72.98 0.08 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.274 0.63 . . . . 0.0 111.211 -177.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -125.68 119.45 28.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.828 -178.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.418 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . 31.7 p -150.97 116.01 5.29 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.164 0.507 . . . . 0.0 109.918 173.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -112.13 132.28 61.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.997 177.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 122.03 -123.0 5.3 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.068 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -130.51 130.9 44.76 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.359 0.599 . . . . 0.0 111.399 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.418 ' HD3' ' HB2' ' A' ' 4' ' ' CYS . 2.0 mmmp? -100.48 123.48 44.75 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 168.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.08 117.95 17.49 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.795 0.807 . . . . 0.0 112.706 -165.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 36.5 t -138.55 145.58 40.84 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 168.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.8 m -157.83 66.29 0.48 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.814 0.816 . . . . 0.0 110.602 -177.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -101.26 8.89 42.29 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 173.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 178.03 154.58 0.34 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 113.984 -1.462 . . . . 0.0 107.896 -171.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -128.32 92.52 3.45 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.494 174.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.681 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 30.9 m-85 -122.54 101.29 40.43 Favored Pre-proline 0 N--CA 1.441 -0.917 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 164.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -81.78 138.68 10.67 Favored 'Trans proline' 0 N--CA 1.439 -1.703 0 C-N-CA 120.92 1.08 . . . . 0.0 111.586 -172.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.7 m -140.32 169.69 15.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.131 0.491 . . . . 0.0 109.997 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.6 t -117.03 129.61 56.13 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.318 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.06 144.69 26.35 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 174.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.465 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 50.8 p -61.29 -11.42 9.63 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -171.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -73.88 -10.18 59.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.501 0.667 . . . . 0.0 109.662 171.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.85 25.64 14.53 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.744 -178.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.531 HG13 ' CE2' ' A' ' 25' ' ' TYR . 3.1 p -106.73 142.0 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.438 -175.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.554 HG23 ' HA ' ' A' ' 49' ' ' GLU . 85.8 m -84.21 119.47 25.06 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 120.959 0.409 . . . . 0.0 110.643 -178.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.531 ' CE2' HG13 ' A' ' 23' ' ' VAL . 37.0 m-85 -106.87 132.91 52.29 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.525 0.678 . . . . 0.0 111.08 177.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.3 t -64.88 -31.37 72.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.186 -172.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.681 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 26.8 p30 -175.5 170.7 1.3 Allowed Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.554 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 82.0 Cg_exo -50.2 -40.92 51.36 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.316 2.011 . . . . 0.0 112.508 176.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 35.2 t -54.46 -48.64 71.51 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.094 0.473 . . . . 0.0 110.569 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -66.62 -46.37 76.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.486 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.511 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 38.3 t80 -63.73 -48.09 78.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.521 0.201 . . . . 0.0 110.947 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.5 p -64.1 -50.65 67.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.013 -175.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.501 ' HA ' ' HG2' ' A' ' 36' ' ' GLU . . . -65.3 -44.44 87.92 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.071 0.462 . . . . 0.0 110.937 -176.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -63.52 -37.38 87.07 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.446 0.641 . . . . 0.0 110.395 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.588 ' HG3' ' O ' ' A' ' 39' ' ' ASP . 2.1 mp0 -77.61 -37.59 49.95 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.873 -177.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.501 ' HG2' ' HA ' ' A' ' 33' ' ' ALA . 12.8 pt-20 -73.62 -27.76 61.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.842 0.353 . . . . 0.0 110.762 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -91.36 -34.09 15.02 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.774 -178.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 2' ' ' GLU . 64.2 m -119.96 -74.88 0.59 Allowed 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.068 -0.653 . . . . 0.0 112.761 -169.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.588 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 4.8 t0 -115.33 97.96 49.51 Favored Pre-proline 0 C--N 1.326 -0.444 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.113 -175.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 39' ' ' ASP . 41.8 Cg_endo -71.14 -13.23 31.06 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 123.2 2.6 . . . . 0.0 113.698 -177.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -85.57 -21.85 28.34 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -163.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.577 HD11 ' NE2' ' A' ' 35' ' ' GLN . 6.5 pt -87.99 154.1 3.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 119.294 -0.963 . . . . 0.0 111.126 -175.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.5 p -127.88 169.68 13.66 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.515 -1.221 . . . . 0.0 109.036 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.483 ' H ' HD12 ' A' ' 44' ' ' ILE . 4.5 mp -68.87 119.41 14.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.53 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.465 ' HB2' ' HA ' ' A' ' 20' ' ' SER . . . -81.18 -46.15 15.3 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.428 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -168.02 157.13 9.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.561 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 87.7 mtp -79.99 130.56 35.37 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.63 162.2 11.56 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 -173.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.554 ' HA ' HG23 ' A' ' 24' ' ' THR . 0.5 OUTLIER -73.35 147.93 43.92 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.067 0.46 . . . . 0.0 111.095 -178.8 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.832 -0.604 . . . . 0.0 111.033 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 120.941 0.4 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -117.14 -49.61 2.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.427 178.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -125.87 115.57 20.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.695 174.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.1 p -149.67 117.96 6.43 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.158 0.504 . . . . 0.0 110.512 177.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.8 p -103.85 119.82 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 121.34 0.591 . . . . 0.0 110.161 176.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 140.58 -125.31 2.83 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -131.1 139.64 49.89 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.128 0.49 . . . . 0.0 110.318 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.537 ' HB2' ' OE1' ' A' ' 34' ' ' GLN . 6.6 tmtm? -98.86 122.4 42.05 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 174.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.44 117.63 16.48 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.896 0.855 . . . . 0.0 112.184 -166.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.542 ' SG ' ' HG3' ' A' ' 12' ' ' ARG . 44.5 t -138.51 146.38 41.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.103 -1.408 . . . . 0.0 107.494 172.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.2 m -152.54 64.22 0.81 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.79 0.805 . . . . 0.0 110.144 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.542 ' HG3' ' SG ' ' A' ' 10' ' ' CYS . 21.2 mtm180 -104.27 0.78 29.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.291 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 177.02 153.16 0.21 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 113.837 -1.529 . . . . 0.0 107.129 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 65.2 t-105 -117.45 92.21 3.78 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.847 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.666 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 37.3 m-85 -122.87 101.9 38.71 Favored Pre-proline 0 N--CA 1.434 -1.237 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 164.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.16 137.95 12.43 Favored 'Trans proline' 0 N--CA 1.441 -1.606 0 C-N-CA 120.546 0.83 . . . . 0.0 111.566 -172.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.0 m -138.01 173.86 11.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.044 0.45 . . . . 0.0 110.101 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.1 t -122.73 132.5 54.27 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.634 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.11 146.5 25.26 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 173.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.627 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 10.0 t -57.95 -13.92 5.4 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -172.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.466 ' HB2' HG21 ' A' ' 42' ' ' ILE . 31.4 t70 -74.94 -8.41 56.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.51 0.671 . . . . 0.0 109.924 174.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.47 25.38 21.24 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.287 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.5 p -105.73 140.88 22.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.921 0.391 . . . . 0.0 111.285 -173.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.431 HG23 ' HA ' ' A' ' 49' ' ' GLU . 36.8 m -85.15 123.77 31.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.19 0.519 . . . . 0.0 111.239 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -111.51 137.47 49.3 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.933 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 65.5 m -68.4 -26.09 65.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.229 -175.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.666 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 30.8 p30 -172.67 171.96 1.8 Allowed Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.551 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 75.5 Cg_exo -52.34 -39.87 71.92 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.379 2.053 . . . . 0.0 112.597 176.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.431 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 21.5 t -55.14 -44.91 75.52 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.959 0.409 . . . . 0.0 110.558 176.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.435 HD22 ' C ' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -61.68 -46.45 89.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.367 179.207 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -65.96 -47.9 73.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.928 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.7 t -63.58 -49.26 74.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.571 -174.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.469 ' HA ' ' HG2' ' A' ' 36' ' ' GLU . . . -64.78 -44.92 88.44 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.706 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.537 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 7.5 tp60 -62.65 -40.79 98.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.543 0.687 . . . . 0.0 110.398 -177.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.565 ' HG3' ' O ' ' A' ' 39' ' ' ASP . 2.2 mp0 -76.08 -36.29 59.01 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.98 -177.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.469 ' HG2' ' HA ' ' A' ' 33' ' ' ALA . 11.1 pt-20 -67.08 -42.92 83.83 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.364 -178.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -111.74 5.85 19.42 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -175.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 34' ' ' GLN . 66.5 m -135.0 -63.25 0.7 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.158 0.89 . . . . 0.0 113.0 175.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.565 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 8.6 t0 -116.94 92.57 39.31 Favored Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 118.808 0.731 . . . . 0.0 110.7 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -72.08 -12.95 28.53 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.43 2.753 . . . . 0.0 113.374 -177.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -92.62 -21.86 19.8 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -163.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.627 ' HB ' ' HB3' ' A' ' 20' ' ' SER . 19.0 pt -90.72 160.04 2.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.835 0.826 . . . . 0.0 112.363 -174.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.5 p -123.22 169.37 11.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.323 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.5 mt -65.17 119.29 9.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 175.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.53 -50.69 10.35 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.523 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -164.76 161.43 20.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 44.7 tpp -75.92 139.25 41.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.025 173.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 107.33 159.73 21.17 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.53 -176.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.437 ' CD ' ' H ' ' A' ' 49' ' ' GLU . 0.8 OUTLIER -73.69 149.12 42.11 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.916 0.389 . . . . 0.0 111.04 -178.64 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.331 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -55.29 -27.29 45.74 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.779 -176.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -125.86 111.39 14.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.345 0.593 . . . . 0.0 111.15 174.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -153.5 115.52 4.32 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.906 166.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.7 p -121.04 127.76 75.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 121.259 0.552 . . . . 0.0 110.926 -176.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 138.18 -140.21 10.97 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -123.95 132.9 53.79 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.051 0.453 . . . . 0.0 110.542 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -100.6 137.9 38.39 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 171.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.13 118.67 30.62 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.961 -174.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 30' ' ' ASN . 21.2 p -137.34 148.68 46.48 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 168.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.7 m -148.89 89.0 1.64 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.408 0.623 . . . . 0.0 111.381 -175.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -109.67 -19.8 13.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.527 173.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -177.61 163.92 1.97 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -169.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -118.28 92.99 3.97 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.156 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.669 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 15.3 m-85 -122.67 101.09 40.27 Favored Pre-proline 0 N--CA 1.441 -0.911 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 164.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.59 140.04 11.62 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 121.345 1.363 . . . . 0.0 112.487 -172.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 25' ' ' TYR . 27.2 m -143.29 170.91 9.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.98 0.419 . . . . 0.0 109.944 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 18.5 t -123.63 139.41 54.03 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.5 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -94.5 156.96 22.27 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.285 177.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.856 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 64.1 m -57.22 -12.67 2.45 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -174.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -76.71 -7.92 56.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.841 0.829 . . . . 0.0 109.712 173.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.04 28.68 36.55 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -173.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.516 HG13 ' CE2' ' A' ' 25' ' ' TYR . 2.7 p -101.48 140.8 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 121.066 0.46 . . . . 0.0 111.427 -172.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.526 HG23 ' N ' ' A' ' 50' ' ' CYS . 1.3 m -82.49 117.27 22.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.252 -177.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.516 ' CE2' HG13 ' A' ' 23' ' ' VAL . 52.3 m-85 -106.56 130.42 54.33 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-O 121.269 0.556 . . . . 0.0 110.744 176.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.4 t -70.29 -26.86 64.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.746 -174.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.672 ' HB2' ' HD2' ' A' ' 28' ' ' PRO . 26.1 p-10 178.25 173.9 0.38 Allowed Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -173.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.672 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 79.6 Cg_exo -47.8 -49.48 13.56 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 123.219 2.613 . . . . 0.0 114.901 -176.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.455 ' SG ' ' ND2' ' A' ' 27' ' ' ASN . 7.8 p -59.27 -35.77 74.34 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.044 0.45 . . . . 0.0 111.058 -177.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.403 ' OD1' ' HA ' ' A' ' 25' ' ' TYR . 2.1 t-20 -64.84 -46.02 83.66 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.946 -178.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.42 ' HD2' ' CD2' ' A' ' 25' ' ' TYR . 65.0 t80 -65.4 -47.92 74.62 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.129 0.49 . . . . 0.0 109.726 178.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.8 t -64.03 -51.71 62.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.905 -175.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.465 ' O ' ' HG2' ' A' ' 36' ' ' GLU . . . -69.01 -44.09 73.46 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.088 0.47 . . . . 0.0 111.452 -175.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -62.47 -41.66 98.93 Favored 'General case' 0 C--O 1.215 -0.715 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.949 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.632 ' NE2' HD11 ' A' ' 42' ' ' ILE . 61.9 mt-30 -78.69 -35.91 44.33 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 33' ' ' ALA . 12.8 pt-20 -61.94 -27.94 69.18 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.797 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.63 ' HG3' ' SG ' ' A' ' 38' ' ' CYS . 20.6 pt20 -100.85 -38.06 8.41 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 119.488 -0.885 . . . . 0.0 112.793 174.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.63 ' SG ' ' HG3' ' A' ' 37' ' ' GLN . 17.7 m -96.12 -77.98 0.47 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.897 -169.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.463 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 5.8 t0 -124.13 89.76 51.46 Favored Pre-proline 0 C--N 1.331 -0.207 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.06 -175.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.32 -11.8 32.27 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 123.315 2.677 . . . . 0.0 112.836 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -79.66 -21.81 44.28 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -167.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.856 ' HB ' ' HB2' ' A' ' 20' ' ' SER . 9.0 pt -85.62 161.91 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.406 -175.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.96 169.5 12.04 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.258 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.4 mt -65.4 117.89 6.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.242 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.84 -44.24 50.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.005 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -166.96 151.58 7.23 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.38 176.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -73.54 139.4 45.61 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 108.67 145.14 11.24 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -171.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.459 ' HB2' ' CG2' ' A' ' 24' ' ' THR . 0.9 OUTLIER -73.97 145.64 44.48 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.996 0.398 . . . . 0.0 110.692 -175.902 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.526 ' N ' HG23 ' A' ' 24' ' ' THR . 1.3 m . . . . . 0 C--O 1.242 0.697 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.32 173.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -103.64 -36.89 7.74 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.149 0.499 . . . . 0.0 110.098 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -124.59 113.78 18.5 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.39 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 38' ' ' CYS . 0.5 OUTLIER -152.43 116.39 4.87 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.719 -179.653 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.9 t -107.35 124.02 62.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.04 0.447 . . . . 0.0 110.425 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 147.26 -138.7 7.4 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.5 ttp180 -129.11 133.66 47.74 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.037 0.446 . . . . 0.0 110.911 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.8 mmtt -98.88 130.49 45.28 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 172.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.55 115.42 16.29 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.49 -173.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 48.8 t -139.98 146.1 38.68 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 167.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -168.0 56.17 0.06 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.642 0.734 . . . . 0.0 110.641 -172.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -80.72 -23.81 39.23 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.265 175.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -163.31 157.66 20.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.612 -1.176 . . . . 0.0 107.923 -177.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 71.2 t-105 -112.42 94.43 4.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.403 0.62 . . . . 0.0 111.038 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.568 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 30.4 m-85 -120.33 100.02 47.78 Favored Pre-proline 0 N--CA 1.442 -0.852 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 165.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -81.36 138.37 10.99 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 120.996 1.131 . . . . 0.0 113.266 -168.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.23 174.15 6.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.504 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.0 t -126.7 138.61 53.42 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.447 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.83 153.14 21.79 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 175.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.547 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 16.2 m -56.81 -15.17 4.22 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -174.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -74.01 -7.82 53.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.691 0.758 . . . . 0.0 109.968 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.09 27.89 29.84 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -175.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.428 HG13 ' CE2' ' A' ' 25' ' ' TYR . 3.6 p -105.73 140.73 22.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.269 -0.466 . . . . 0.0 111.18 -172.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.422 HG23 ' HA ' ' A' ' 49' ' ' GLU . 42.0 m -85.05 122.19 28.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.98 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.428 ' CE2' HG13 ' A' ' 23' ' ' VAL . 29.7 m-85 -109.91 133.07 53.57 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.225 177.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.8 m -65.97 -34.6 78.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.586 -173.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.568 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 8.2 p30 -178.07 177.23 0.43 Allowed Pre-proline 0 C--O 1.237 0.403 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.528 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 95.7 Cg_exo -46.03 -43.21 20.48 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 122.821 2.347 . . . . 0.0 114.765 -177.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 29.1 p -60.96 -37.33 82.0 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.222 0.465 . . . . 0.0 110.695 -177.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -67.89 -46.27 72.09 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.541 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.51 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 62.7 t80 -65.95 -46.7 77.19 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 176.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 39.3 t -63.39 -50.88 68.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.515 -176.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.55 ' O ' ' HG2' ' A' ' 37' ' ' GLN . . . -68.07 -44.79 75.5 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 120.78 0.324 . . . . 0.0 111.018 -175.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.8 tp60 -65.85 -35.4 80.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.223 0.535 . . . . 0.0 110.246 -177.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.772 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -77.43 -36.7 52.85 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.365 -177.665 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.506 ' HG2' ' HA ' ' A' ' 33' ' ' ALA . 9.5 pt-20 -70.92 -28.05 64.23 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.105 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.629 ' HG3' ' SG ' ' A' ' 38' ' ' CYS . 9.7 pt20 -99.79 -35.16 9.88 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.069 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.629 ' SG ' ' HG3' ' A' ' 37' ' ' GLN . 25.0 m -104.49 -77.57 0.58 Allowed 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.805 -172.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 9.2 t70 -118.08 99.3 51.89 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.885 0.374 . . . . 0.0 111.136 -175.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.23 -13.95 25.68 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 123.111 2.541 . . . . 0.0 112.92 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -86.43 -21.75 26.93 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -164.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.772 HD11 ' NE2' ' A' ' 35' ' ' GLN . 23.5 pt -85.67 166.21 2.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.608 -177.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.8 p -132.12 170.56 14.8 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.317 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.3 mt -65.77 118.16 7.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 175.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.26 -43.55 27.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.52 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -164.38 157.69 17.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.545 177.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.77 138.48 36.28 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 175.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 110.69 151.89 12.77 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -173.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.422 ' HA ' HG23 ' A' ' 24' ' ' THR . 14.2 pt-20 -65.54 149.4 50.12 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.75 0.31 . . . . 0.0 111.269 -178.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.134 0 CA-C-O 119.225 -0.417 . . . . 0.0 110.464 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 120.77 0.319 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -127.67 -34.44 2.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.626 171.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -115.64 112.12 21.65 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 38' ' ' CYS . 0.8 OUTLIER -154.32 134.73 13.38 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.719 175.907 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.2 p -129.19 132.98 66.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.781 -177.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 132.0 -131.42 6.28 Favored Glycine 0 N--CA 1.439 -1.14 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.853 175.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -130.11 128.5 41.96 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.337 0.589 . . . . 0.0 110.973 -176.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -100.36 133.46 44.74 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.448 172.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.08 121.96 27.23 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.358 0.599 . . . . 0.0 112.286 -171.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 46.8 t -136.32 147.44 47.43 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 170.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.0 m -153.42 67.21 0.77 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.406 0.622 . . . . 0.0 111.805 -174.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.3 ptt85 -110.87 -3.05 15.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.236 0.541 . . . . 0.0 109.82 172.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 174.63 151.33 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.592 -1.186 . . . . 0.0 108.396 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -110.02 94.62 5.11 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.143 0.497 . . . . 0.0 110.366 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.756 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 31.2 m-85 -120.52 100.44 47.06 Favored Pre-proline 0 N--CA 1.441 -0.901 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 167.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.93 138.52 10.4 Favored 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 121.02 1.146 . . . . 0.0 111.744 -172.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.2 m -143.75 176.98 2.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.125 0.488 . . . . 0.0 110.292 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.2 t -124.7 130.25 52.06 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.319 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.67 147.71 29.81 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 174.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.908 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 32.7 t -57.85 -12.58 3.24 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -172.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -77.59 -7.95 57.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.702 0.763 . . . . 0.0 110.214 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.14 24.96 20.94 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -176.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.41 HG13 ' CE2' ' A' ' 25' ' ' TYR . 3.2 p -106.01 140.96 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 120.934 0.397 . . . . 0.0 111.269 -174.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.9 m -83.73 124.52 30.96 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.383 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.494 ' HE1' ' HG2' ' A' ' 34' ' ' GLN . 29.9 m-85 -113.05 135.85 53.34 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.421 177.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.1 m -69.24 -29.07 66.92 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.422 -173.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.756 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 28.6 p30 -170.17 168.8 4.13 Favored Pre-proline 0 C--O 1.236 0.353 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.518 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 72.3 Cg_exo -50.6 -38.19 54.51 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.515 2.143 . . . . 0.0 112.515 177.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.432 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 7.6 t -55.21 -50.9 68.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.551 176.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -62.14 -45.26 94.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.735 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.513 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 58.7 t80 -61.17 -49.13 78.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.305 0.098 . . . . 0.0 111.028 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.484 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 16.2 t -65.86 -51.0 62.55 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.485 0.18 . . . . 0.0 111.485 -177.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.66 -43.51 93.37 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.487 0.661 . . . . 0.0 110.995 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.494 ' HG2' ' HE1' ' A' ' 25' ' ' TYR . 9.5 tp60 -64.68 -36.92 85.85 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.166 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.725 ' HG3' ' O ' ' A' ' 39' ' ' ASP . 2.2 mp0 -72.81 -44.39 61.53 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.383 -176.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.492 ' HG3' ' NE2' ' A' ' 37' ' ' GLN . 9.3 pt-20 -63.68 -31.01 72.05 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.092 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.492 ' NE2' ' HG3' ' A' ' 36' ' ' GLU . 2.9 mp0 -87.32 -35.09 18.61 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 177.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 4' ' ' CYS . 18.7 m -108.59 -80.7 0.57 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -171.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.725 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 55.8 t0 -126.14 83.91 62.61 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 120.871 0.367 . . . . 0.0 110.662 -172.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -67.99 -12.64 35.89 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 123.446 2.764 . . . . 0.0 114.13 -170.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -99.54 11.71 38.43 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -169.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.908 ' HB ' ' HB3' ' A' ' 20' ' ' SER . 12.5 pt -97.31 151.36 4.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.371 174.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.428 ' H ' ' HB2' ' A' ' 20' ' ' SER . 0.3 OUTLIER -107.54 167.67 9.78 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.361 -179.526 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.2 mt -70.33 118.94 15.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 173.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.24 -51.07 16.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.473 -176.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -160.75 158.43 28.61 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.271 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.4 tpt -71.3 145.03 49.76 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.003 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.35 154.45 30.75 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.609 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -62.53 149.28 43.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.821 0.344 . . . . 0.0 110.699 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.86 -0.59 . . . . 0.0 110.842 -173.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -132.39 -35.75 1.15 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.979 176.279 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -116.78 114.23 23.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.057 0.456 . . . . 0.0 110.341 174.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.637 ' HB2' ' HE2' ' A' ' 8' ' ' LYS . 19.3 p -151.76 139.74 20.06 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 172.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.0 p -128.93 132.37 67.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.433 0.635 . . . . 0.0 111.325 -171.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 109.49 -117.99 5.03 Favored Glycine 0 N--CA 1.44 -1.079 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.589 ' HA ' ' OE1' ' A' ' 34' ' ' GLN . 24.7 ptt180 -131.39 134.16 45.99 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.032 0.444 . . . . 0.0 110.435 171.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.637 ' HE2' ' HB2' ' A' ' 4' ' ' CYS . 65.2 mmtt -99.52 123.2 43.57 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 171.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.69 120.44 21.08 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.872 0.844 . . . . 0.0 113.104 -162.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 43.4 t -128.55 147.2 50.68 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 168.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.9 m -150.21 61.98 0.97 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.554 0.693 . . . . 0.0 111.326 -175.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -91.52 -13.38 32.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.697 174.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -173.71 157.5 3.12 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -173.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 67.2 t-105 -119.07 92.99 3.93 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.038 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.732 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 14.6 m-85 -122.15 101.06 41.88 Favored Pre-proline 0 CA--C 1.501 -0.92 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 166.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -80.88 138.1 11.44 Favored 'Trans proline' 0 N--CA 1.443 -1.475 0 C-N-CA 120.697 0.931 . . . . 0.0 111.767 -172.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.4 m -142.77 -179.9 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.361 -177.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.4 t -127.98 134.57 49.28 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.583 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.48 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -82.69 147.58 25.36 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 174.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.655 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 10.6 t -57.88 -13.77 4.98 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -172.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.462 ' HB2' HG21 ' A' ' 42' ' ' ILE . 18.6 t70 -76.83 -8.53 57.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.531 0.681 . . . . 0.0 109.931 175.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.49 26.39 17.99 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.377 -177.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.613 HG13 ' CE2' ' A' ' 25' ' ' TYR . 2.5 p -106.57 141.93 20.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 120.698 0.285 . . . . 0.0 111.721 -174.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.7 m -83.63 126.86 33.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.23 -176.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.613 ' CE2' HG13 ' A' ' 23' ' ' VAL . 51.2 m-85 -117.07 137.99 51.9 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.408 0.623 . . . . 0.0 111.894 177.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.7 m -70.21 -28.37 65.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.121 -175.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.732 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 26.6 p30 -173.84 169.33 2.04 Favored Pre-proline 0 C--O 1.234 0.285 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.549 -177.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.545 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 78.3 Cg_exo -51.47 -42.13 56.76 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.473 2.115 . . . . 0.0 112.416 177.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 41.5 t -54.72 -45.36 74.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.093 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.466 HD22 ' C ' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -62.43 -47.58 83.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.953 -179.521 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.561 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 55.3 t80 -66.57 -48.11 70.64 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.569 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.408 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 22.2 t -63.79 -50.63 68.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.052 -174.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.92 -45.43 74.37 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.169 0.509 . . . . 0.0 111.126 -175.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.589 ' OE1' ' HA ' ' A' ' 7' ' ' ARG . 22.0 tt0 -65.57 -31.9 73.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.172 0.511 . . . . 0.0 110.695 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.778 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -78.15 -46.97 19.18 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.367 -177.136 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.646 ' HG3' ' HG3' ' A' ' 37' ' ' GLN . 11.7 pt-20 -61.57 -30.59 70.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.875 0.369 . . . . 0.0 110.481 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.646 ' HG3' ' HG3' ' A' ' 36' ' ' GLU . 74.4 mt-30 -94.29 -34.81 12.7 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.593 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 59.8 m -120.13 -65.82 1.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -170.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.501 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 0.7 OUTLIER -116.19 74.66 5.7 Favored Pre-proline 0 N--CA 1.465 0.312 0 CA-C-O 120.729 0.299 . . . . 0.0 111.667 -173.005 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.593 ' HD3' ' O ' ' A' ' 38' ' ' CYS . 6.9 Cg_exo -72.62 -13.11 27.21 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 123.131 2.554 . . . . 0.0 112.698 -174.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -77.36 -20.99 53.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.346 -169.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.778 HD11 ' NE2' ' A' ' 35' ' ' GLN . 10.9 pt -95.32 153.13 3.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.597 -175.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.43 ' O ' ' HB2' ' A' ' 20' ' ' SER . 22.1 p -112.23 168.21 9.8 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.624 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.0 mt -65.93 118.71 9.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.97 -50.82 11.4 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.699 -176.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -166.0 163.27 18.35 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.2 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 86.5 mmm -74.89 146.59 41.74 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 173.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.52 146.37 18.41 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.658 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.41 149.19 50.78 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.718 0.294 . . . . 0.0 110.983 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.976 -0.535 . . . . 0.0 110.978 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.507 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 120.23 0.062 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 70.36 -68.37 0.21 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.388 0.675 . . . . 0.0 111.373 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -119.8 112.03 18.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.079 0.466 . . . . 0.0 111.007 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.9 p -153.85 124.72 7.25 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 169.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.8 t -101.6 126.15 55.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.239 -172.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 116.66 -118.12 4.07 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.17 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.488 ' HA ' ' HG2' ' A' ' 34' ' ' GLN . 22.5 ptt180 -131.87 134.26 45.53 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 174.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -100.72 122.6 43.63 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 168.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.24 128.86 35.77 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -162.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 36.7 t -119.01 147.72 43.78 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 170.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.7 m -153.35 79.59 1.17 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.19 0.519 . . . . 0.0 111.919 -175.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -115.33 -29.09 6.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.4 0.619 . . . . 0.0 109.783 170.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -148.11 158.88 44.32 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -118.17 93.79 4.26 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.15 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.746 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 67.3 m-85 -121.39 99.78 45.35 Favored Pre-proline 0 CA--C 1.504 -0.799 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 164.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -81.77 139.61 11.17 Favored 'Trans proline' 0 N--CA 1.442 -1.537 0 C-N-CA 121.132 1.221 . . . . 0.0 112.558 -171.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.5 m -138.71 172.28 13.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 176.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 29.6 t -116.38 130.61 56.86 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.859 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.656 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -83.65 142.09 20.75 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 172.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.566 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 4.5 t -60.04 -11.04 4.95 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -171.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.579 ' HB2' HG21 ' A' ' 42' ' ' ILE . 19.2 t70 -74.28 -8.21 55.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.487 0.66 . . . . 0.0 109.504 173.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.1 24.91 23.5 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.357 -177.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.572 HG13 ' CE2' ' A' ' 25' ' ' TYR . 2.3 p -105.35 138.52 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 121.061 0.458 . . . . 0.0 111.423 -175.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.52 HG23 ' N ' ' A' ' 50' ' ' CYS . 7.6 m -85.06 116.46 23.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.564 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.656 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 47.5 m-85 -101.37 133.0 46.65 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.337 0.589 . . . . 0.0 111.704 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.9 m -64.18 -30.25 71.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.299 -1.319 . . . . 0.0 112.384 -175.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.746 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 22.1 p30 -174.58 169.6 1.72 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.463 -175.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.657 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 9.2 Cg_endo -52.39 -38.76 74.14 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.599 2.2 . . . . 0.0 112.022 176.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 33.3 t -55.22 -45.01 75.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.451 176.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.49 ' O ' ' HB3' ' A' ' 34' ' ' GLN . 0.2 OUTLIER -66.31 -46.26 77.52 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.961 -178.622 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.434 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 61.3 t80 -65.87 -48.06 72.82 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.517 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.569 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 19.9 t -64.37 -52.09 60.06 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.415 -175.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.512 ' O ' ' HB2' ' A' ' 37' ' ' GLN . . . -68.02 -42.85 80.01 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.014 0.435 . . . . 0.0 111.27 -174.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.49 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 42.4 tp60 -63.92 -34.64 78.43 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.416 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.768 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -78.01 -50.22 12.54 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.316 -178.849 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 32' ' ' SER . 12.2 pt-20 -65.27 -26.51 68.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.732 0.301 . . . . 0.0 111.055 -177.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.512 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 2.4 mp0 -92.38 -33.84 14.4 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 82.4 m -133.49 -58.2 0.88 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -169.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.537 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 16.2 m-20 -114.54 68.98 1.98 Allowed Pre-proline 0 N--CA 1.467 0.386 0 CA-C-N 117.996 0.362 . . . . 0.0 111.764 -173.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.25 -14.25 28.44 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.42 2.08 . . . . 0.0 112.614 -174.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -89.06 -6.85 56.83 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -167.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.768 HD11 ' NE2' ' A' ' 35' ' ' GLN . 10.2 pt -91.7 170.79 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 119.964 -0.695 . . . . 0.0 110.941 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.3 p -126.61 168.64 14.03 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.733 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.497 ' H ' HD12 ' A' ' 44' ' ' ILE . 4.5 mp -72.27 119.47 18.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.566 ' HB2' ' HA ' ' A' ' 20' ' ' SER . . . -81.79 -46.72 13.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.751 -176.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 34.8 p80 -167.08 156.69 10.78 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.219 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 96.9 mmm -74.22 156.47 37.22 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 175.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.9 156.76 28.04 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.088 -1.053 . . . . 0.0 110.551 -173.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.453 ' HB2' ' CG2' ' A' ' 24' ' ' THR . 11.6 pt-20 -65.52 135.26 54.91 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.013 0.435 . . . . 0.0 110.292 -177.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.52 ' N ' HG23 ' A' ' 24' ' ' THR . 1.6 t . . . . . 0 C--O 1.251 1.171 0 CA-C-O 118.4 -0.809 . . . . 0.0 110.746 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -114.53 -34.3 5.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.97 0.414 . . . . 0.0 110.199 176.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -120.88 111.78 17.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.305 0.574 . . . . 0.0 110.223 175.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.0 p -153.91 142.76 21.06 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 172.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.04 130.99 66.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 121.115 0.483 . . . . 0.0 111.063 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 124.69 -117.92 3.19 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -130.34 140.14 50.65 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.105 0.479 . . . . 0.0 110.932 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.437 ' HA ' ' HD3' ' A' ' 8' ' ' LYS . 64.2 mmtt -99.6 123.22 43.67 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 166.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.79 119.41 19.75 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -162.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 78.4 m -127.55 146.08 50.64 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 165.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.2 m -154.22 28.95 0.45 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.215 1.007 . . . . 0.0 110.29 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -82.82 -5.06 58.78 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.865 177.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -171.76 150.94 2.75 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -167.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -128.81 93.62 3.66 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.666 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.693 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 77.0 m-85 -121.73 100.48 43.72 Favored Pre-proline 0 CA--C 1.501 -0.915 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 164.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.47 138.11 10.72 Favored 'Trans proline' 0 N--CA 1.441 -1.605 0 C-N-CA 120.555 0.837 . . . . 0.0 111.59 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.4 m -141.42 176.12 4.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.7 t -123.09 128.99 50.87 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.617 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.448 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -81.09 146.46 26.56 Favored Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 174.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.658 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 8.6 t -58.91 -12.79 4.91 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -172.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -74.08 -8.63 56.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.641 0.734 . . . . 0.0 110.128 173.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.92 26.84 23.25 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.12 -176.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.455 HG13 ' CE2' ' A' ' 25' ' ' TYR . 3.3 p -106.54 141.08 22.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.808 0.337 . . . . 0.0 111.384 -174.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.477 HG23 ' HA ' ' A' ' 49' ' ' GLU . 90.1 m -84.43 123.23 30.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.057 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.455 ' CE2' HG13 ' A' ' 23' ' ' VAL . 35.8 m-85 -109.84 136.13 49.64 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.563 0.697 . . . . 0.0 111.525 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.3 m -70.17 -32.07 69.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.323 -1.308 . . . . 0.0 112.361 -173.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.718 ' HB2' ' HD2' ' A' ' 28' ' ' PRO . 27.5 p30 -175.61 171.92 1.12 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.216 -174.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.718 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 6.1 Cg_endo -49.47 -41.49 43.87 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.736 2.291 . . . . 0.0 112.616 176.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.42 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 48.2 t -54.8 -50.62 68.09 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.163 0.506 . . . . 0.0 110.296 177.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -63.32 -45.92 89.05 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.296 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -65.74 -47.26 75.86 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.61 0.243 . . . . 0.0 110.818 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.419 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 41.6 t -63.61 -51.43 65.31 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.291 -176.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.45 -43.71 84.82 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 120.814 0.34 . . . . 0.0 110.828 -174.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.557 ' HA ' ' OE1' ' A' ' 34' ' ' GLN . 6.6 tp60 -64.06 -37.78 88.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.317 0.58 . . . . 0.0 110.576 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.819 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -74.8 -50.32 17.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.967 -178.017 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 32' ' ' SER . 12.8 pt-20 -64.8 -26.15 68.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.559 0.218 . . . . 0.0 111.477 -176.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -93.33 -35.94 12.8 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 98.9 m -124.74 -54.67 1.64 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -167.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -133.58 85.68 41.98 Favored Pre-proline 0 N--CA 1.465 0.313 0 CA-C-N 119.094 0.861 . . . . 0.0 111.38 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.98 -12.97 23.93 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 123.314 2.676 . . . . 0.0 112.751 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -81.72 -14.22 56.8 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.354 -165.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.819 HD11 ' NE2' ' A' ' 35' ' ' GLN . 9.9 pt -86.53 157.05 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.605 0.717 . . . . 0.0 111.0 -178.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.4 p -110.99 167.39 10.29 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.783 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.444 ' H ' HD12 ' A' ' 44' ' ' ILE . 4.5 mp -70.1 119.27 15.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 173.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.31 -48.7 19.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.279 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -168.93 158.69 8.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.31 176.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 25.9 ttt -77.75 140.07 39.44 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 172.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 110.68 161.15 17.7 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -172.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.477 ' HA ' HG23 ' A' ' 24' ' ' THR . 9.6 pt-20 -75.4 149.24 38.65 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.041 0.448 . . . . 0.0 111.234 -176.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.749 -0.643 . . . . 0.0 111.051 -177.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -109.64 -21.07 12.6 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 174.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -120.78 112.3 18.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.414 0.626 . . . . 0.0 110.648 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 38' ' ' CYS . 0.5 OUTLIER -153.1 128.86 10.15 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.933 -1.031 . . . . 0.0 108.975 176.094 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.3 t -123.76 127.02 73.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.023 0.439 . . . . 0.0 111.25 -174.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 130.18 -135.6 8.43 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 176.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.56 137.25 54.41 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.09 0.472 . . . . 0.0 109.778 175.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -98.36 121.97 40.95 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 174.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.71 122.63 24.29 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.687 0.756 . . . . 0.0 112.366 -168.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 34.8 t -134.37 147.85 50.58 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 172.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.73 44.75 0.68 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -172.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -84.45 -13.82 50.97 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.593 0.711 . . . . 0.0 109.51 173.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -170.7 151.84 3.62 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.526 ' CZ3' ' HB3' ' A' ' 26' ' ' SER . 57.7 t-105 -118.82 91.84 3.66 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.008 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.721 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 10.4 m-85 -123.73 100.77 37.2 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 164.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -80.59 143.36 15.06 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 121.236 1.291 . . . . 0.0 112.499 -170.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.0 m -137.04 -179.03 2.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.944 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 18.8 t -129.35 131.88 46.97 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.34 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.9 151.19 36.95 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 176.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.634 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 31.2 t -59.65 -12.69 7.33 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -171.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -80.24 -8.49 59.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.26 0.553 . . . . 0.0 110.101 174.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.22 28.77 10.28 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 -175.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.431 HG13 ' CE2' ' A' ' 25' ' ' TYR . 3.6 p -104.86 141.73 19.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.03 0.443 . . . . 0.0 111.592 -172.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.565 HG23 ' N ' ' A' ' 50' ' ' CYS . 0.9 OUTLIER -82.43 121.78 27.17 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.2 -175.9 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.431 ' CE2' HG13 ' A' ' 23' ' ' VAL . 23.9 m-85 -116.67 134.0 55.34 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.241 0.543 . . . . 0.0 111.137 176.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.526 ' HB3' ' CZ3' ' A' ' 14' ' ' TRP . 16.9 m -67.28 -26.27 66.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.005 -173.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.721 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 25.7 p30 -179.62 175.6 0.42 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.114 -172.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.654 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 71.6 Cg_exo -51.67 -49.23 17.89 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.487 2.125 . . . . 0.0 113.636 177.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.8 p -62.38 -32.04 72.79 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.662 0.267 . . . . 0.0 111.117 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.461 HD22 ' C ' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -63.38 -46.32 87.01 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.865 175.152 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.476 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 42.5 t80 -66.19 -47.48 73.78 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.329 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.3 m -62.43 -49.8 74.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.768 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.42 ' HA ' ' HG2' ' A' ' 36' ' ' GLU . . . -67.39 -44.07 79.81 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.323 0.582 . . . . 0.0 111.114 -177.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.1 tp60 -67.71 -34.39 76.79 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.263 -177.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.788 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -77.41 -37.98 50.71 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.282 -178.217 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.599 ' HG3' ' HG3' ' A' ' 37' ' ' GLN . 10.2 pt-20 -70.09 -29.89 66.98 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.631 -0.427 . . . . 0.0 111.052 -177.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.599 ' HG3' ' HG3' ' A' ' 36' ' ' GLU . 68.5 mt-30 -103.05 -35.99 8.33 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -177.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 4' ' ' CYS . 10.0 m -107.64 -66.96 0.99 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -169.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.401 ' OD1' HG23 ' A' ' 42' ' ' ILE . 4.2 t70 -126.29 85.59 59.67 Favored Pre-proline 0 C--N 1.328 -0.33 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.9 -175.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.56 -13.12 27.38 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 123.119 2.546 . . . . 0.0 112.696 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -97.95 19.53 13.74 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -168.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.788 HD11 ' NE2' ' A' ' 35' ' ' GLN . 10.9 pt -115.74 156.67 16.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.736 172.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.487 ' H ' ' CB ' ' A' ' 20' ' ' SER . 0.2 OUTLIER -109.05 168.49 9.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.147 178.775 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.55 ' H ' HD12 ' A' ' 44' ' ' ILE . 4.9 mp -66.25 119.24 10.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.526 ' HB2' ' HA ' ' A' ' 20' ' ' SER . . . -82.47 -47.42 12.24 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.094 0.473 . . . . 0.0 110.333 -177.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -168.47 158.55 9.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.198 176.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 82.5 mtp -81.55 154.2 26.36 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.08 135.56 8.82 Favored Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -170.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.457 ' HB2' ' CG2' ' A' ' 24' ' ' THR . 9.6 pt-20 -68.84 141.09 55.21 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.078 0.466 . . . . 0.0 111.266 -175.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.565 ' N ' HG23 ' A' ' 24' ' ' THR . 3.9 m . . . . . 0 C--O 1.245 0.825 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.179 172.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.425 ' HB3' ' SG ' ' A' ' 4' ' ' CYS . . . . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 111.215 0.08 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 72.55 -52.8 0.7 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.56 0.744 . . . . 0.0 111.178 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -116.94 109.42 17.01 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.264 0.554 . . . . 0.0 110.606 173.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.425 ' SG ' ' HB3' ' A' ' 1' ' ' ALA . 0.8 OUTLIER -157.08 130.89 8.18 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.349 171.262 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.5 p -128.52 130.01 68.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 C-N-CA 119.813 -0.755 . . . . 0.0 112.205 -174.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 111.99 -112.45 3.08 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.037 173.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 25.4 ttp180 -130.43 122.29 27.48 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.951 0.405 . . . . 0.0 110.166 -174.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.589 ' HB2' ' OE1' ' A' ' 34' ' ' GLN . 24.4 tptp -97.38 123.51 41.24 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 176.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.91 117.29 16.6 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 122.025 0.917 . . . . 0.0 112.852 -160.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.5 t -138.96 144.09 38.85 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 166.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.5 m -162.26 71.96 0.34 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.398 0.618 . . . . 0.0 110.621 -174.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.9 ppt_? -115.17 6.95 15.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.423 0.63 . . . . 0.0 109.953 176.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 178.99 148.22 0.21 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -174.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 64.2 t-105 -118.41 95.28 4.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.42 0.629 . . . . 0.0 111.814 -177.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.65 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 48.1 m-85 -120.31 99.78 47.99 Favored Pre-proline 0 CA--C 1.505 -0.778 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 165.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -82.55 137.54 9.16 Favored 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 120.981 1.121 . . . . 0.0 112.616 -171.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.0 m -141.85 175.92 4.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.589 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 52.6 t -127.45 123.86 37.03 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.705 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -78.08 150.37 35.53 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 177.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.805 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 26.9 t -58.04 -12.25 3.21 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -171.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -74.96 -10.12 59.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.706 0.765 . . . . 0.0 109.612 173.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.04 21.07 34.15 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.382 -176.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.7 p -106.94 140.36 25.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.787 -176.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.533 ' OG1' ' HA ' ' A' ' 49' ' ' GLU . 1.6 t -87.72 131.28 34.53 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.58 0.705 . . . . 0.0 111.003 -176.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.705 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 69.7 m-85 -106.09 132.38 52.23 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.729 177.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.1 t -63.2 -26.73 68.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.998 -176.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.65 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 26.0 p30 -176.23 171.15 1.1 Allowed Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.154 -175.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.577 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 74.4 Cg_exo -50.76 -43.77 44.59 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.359 2.039 . . . . 0.0 112.247 177.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.3 t -54.62 -43.38 72.18 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.203 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -66.18 -46.08 78.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.006 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -66.41 -47.19 74.06 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.431 0.159 . . . . 0.0 111.431 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.6 p -63.34 -50.0 71.72 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.016 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.15 -43.92 85.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.944 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.589 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 9.5 tp60 -64.17 -41.15 97.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.805 -177.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.659 ' NE2' HD11 ' A' ' 42' ' ' ILE . 2.6 mp0 -72.93 -37.42 67.18 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.888 -176.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.48 -26.88 62.88 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.706 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -87.55 -31.6 19.82 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.6 m -117.14 -75.93 0.58 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -168.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.526 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 2.7 t70 -130.53 87.64 49.46 Favored Pre-proline 0 N--CA 1.463 0.206 0 CA-C-O 120.781 0.324 . . . . 0.0 111.073 -173.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -62.95 -13.32 34.27 Favored 'Trans proline' 0 N--CA 1.473 0.289 0 C-N-CA 123.578 2.852 . . . . 0.0 113.499 -176.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -84.56 -21.33 30.48 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -167.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.805 ' HB ' ' HB3' ' A' ' 20' ' ' SER . 3.0 pt -77.53 151.18 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.924 -177.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.3 p -110.75 168.2 9.65 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.114 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.4 mt -70.53 118.47 15.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 173.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.457 ' HB2' ' HA ' ' A' ' 20' ' ' SER . . . -75.38 -43.91 47.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.502 -176.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 26.8 p80 -167.79 155.94 9.0 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.668 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 22.7 ttt -77.04 145.14 38.14 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 174.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.33 167.45 16.67 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.26 -0.972 . . . . 0.0 112.042 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.533 ' HA ' ' OG1' ' A' ' 24' ' ' THR . 24.6 mt-10 -82.9 124.36 30.27 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.135 0.493 . . . . 0.0 111.524 -175.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.47 ' H ' ' CB ' ' A' ' 24' ' ' THR . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.124 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.844 173.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.76 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 120.663 0.268 . . . . 0.0 110.713 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 72.0 -58.46 0.59 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.255 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -113.68 112.17 23.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.051 0.453 . . . . 0.0 110.409 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.484 ' SG ' ' HG3' ' A' ' 34' ' ' GLN . 30.5 p -153.46 116.13 4.47 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 170.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.2 p -113.33 126.38 70.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.518 0.675 . . . . 0.0 111.027 -173.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 109.02 -102.6 1.68 Allowed Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.546 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -134.48 129.01 34.55 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -175.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.465 ' HA ' ' HD3' ' A' ' 8' ' ' LYS . 55.4 mmtt -100.56 127.22 47.0 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 166.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.86 119.22 20.33 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.388 0.613 . . . . 0.0 112.485 -165.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.51 ' SG ' ' HG3' ' A' ' 12' ' ' ARG . 43.6 t -138.32 146.78 42.81 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 171.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.47 62.49 0.75 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.685 0.755 . . . . 0.0 111.568 -177.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.51 ' HG3' ' SG ' ' A' ' 10' ' ' CYS . 6.2 mtm180 -95.42 -3.47 46.9 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 174.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 179.05 156.26 0.49 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.599 -163.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -128.86 91.93 3.31 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.034 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.739 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 60.3 m-85 -122.73 101.2 39.95 Favored Pre-proline 0 CA--C 1.503 -0.864 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 165.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -80.37 140.0 13.36 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 120.933 1.089 . . . . 0.0 111.695 -172.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.1 m -143.82 -175.49 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.373 0.606 . . . . 0.0 110.596 -177.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.3 t -128.59 134.48 48.6 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.694 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.538 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -82.26 148.23 26.55 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 175.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.757 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 32.3 t -59.16 -13.74 8.26 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -170.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -91.06 6.56 44.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.102 0.477 . . . . 0.0 110.599 175.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.22 28.74 16.56 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.507 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.536 HG13 ' CE2' ' A' ' 25' ' ' TYR . 7.1 p -105.37 144.08 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.088 0.47 . . . . 0.0 111.972 -173.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.505 ' CG2' ' HB2' ' A' ' 49' ' ' GLU . 1.3 m -82.39 122.39 27.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.012 -176.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.538 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 31.0 m-85 -114.59 132.81 56.22 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 121.497 0.665 . . . . 0.0 111.633 176.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.0 m -70.81 -28.73 64.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.862 -176.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.739 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 28.4 p30 -172.5 166.83 3.32 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.464 -175.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.494 ' HD3' ' HB2' ' A' ' 15' ' ' TYR . 75.0 Cg_exo -50.77 -44.11 42.82 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.336 2.024 . . . . 0.0 112.619 178.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 14.4 t -54.91 -45.91 74.79 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.159 0.504 . . . . 0.0 111.493 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.411 ' OD1' ' HD1' ' A' ' 25' ' ' TYR . 1.5 t-20 -59.26 -45.34 91.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.536 177.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -66.33 -48.92 68.72 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.802 178.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.2 p -64.65 -49.18 72.02 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -174.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.453 ' HA ' ' HG2' ' A' ' 36' ' ' GLU . . . -66.42 -44.74 82.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.728 0.299 . . . . 0.0 111.151 -177.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.484 ' HG3' ' SG ' ' A' ' 4' ' ' CYS . 36.0 tt0 -67.64 -33.36 74.81 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.54 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.768 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -72.96 -43.33 62.42 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.114 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.453 ' HG2' ' HA ' ' A' ' 33' ' ' ALA . 14.1 pt-20 -67.41 -29.46 68.96 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.394 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.76 ' HB3' ' HB3' ' A' ' 1' ' ' ALA . 90.1 mt-30 -84.31 -34.66 23.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.84 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 91.7 m -127.5 -66.46 0.88 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -164.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -120.56 90.17 45.42 Favored Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.271 -176.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -72.6 -11.77 26.43 Favored 'Trans proline' 0 CA--C 1.529 0.251 0 C-N-CA 123.287 2.658 . . . . 0.0 112.407 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -90.23 -22.53 21.6 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -167.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.768 HD11 ' NE2' ' A' ' 35' ' ' GLN . 17.5 pt -80.68 162.76 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.27 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.6 ' H ' ' HB2' ' A' ' 20' ' ' SER . 15.4 p -123.8 167.73 13.67 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.692 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.3 mt -67.93 118.77 12.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 173.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.42 -49.9 11.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.659 -176.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -160.36 161.94 33.28 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 79.0 mtp -84.57 150.24 25.35 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.76 150.32 26.7 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -170.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.505 ' HB2' ' CG2' ' A' ' 24' ' ' THR . 0.3 OUTLIER -61.93 138.52 58.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.211 0.529 . . . . 0.0 110.581 -176.918 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.43 ' N ' HG23 ' A' ' 24' ' ' THR . 0.7 OUTLIER . . . . . 0 C--O 1.244 0.803 0 CA-C-O 118.661 -0.685 . . . . 0.0 110.481 -178.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.636 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.477 0.908 0 CA-C-O 121.013 0.435 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -131.69 -37.39 1.19 Allowed 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 171.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -112.11 113.12 25.21 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.321 172.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -153.75 116.52 4.46 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.452 174.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.7 p -117.65 127.86 74.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.425 0.631 . . . . 0.0 110.855 -176.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 124.04 -108.96 1.21 Allowed Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.383 176.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -131.74 140.92 49.38 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.222 0.534 . . . . 0.0 111.766 -176.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.678 ' HB2' ' OE1' ' A' ' 34' ' ' GLN . 2.3 tmtp? -97.87 122.3 40.82 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 168.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.84 115.68 16.83 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.458 -172.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 44.2 t -139.02 147.12 41.69 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 171.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.9 m -157.91 63.48 0.46 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.348 0.594 . . . . 0.0 110.396 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -93.85 -18.9 21.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.249 174.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -173.03 156.9 3.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.034 -0.984 . . . . 0.0 108.357 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 28.2 t-105 -111.58 93.07 4.28 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.964 178.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.731 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 14.5 m-85 -121.56 100.08 44.58 Favored Pre-proline 0 CA--C 1.504 -0.802 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 163.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -82.61 143.27 11.98 Favored 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 121.125 1.216 . . . . 0.0 112.749 -169.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.6 m -133.47 169.06 22.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 33.6 t -121.52 122.61 40.09 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.134 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.89 144.19 28.53 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 176.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.498 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 59.1 m -57.26 -12.07 2.14 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -172.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -78.85 -2.42 39.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.615 0.721 . . . . 0.0 109.773 174.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.68 28.73 45.96 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -175.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.453 HG13 ' CE2' ' A' ' 25' ' ' TYR . 2.7 p -104.59 129.19 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 121.088 0.47 . . . . 0.0 110.922 -175.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.595 ' OG1' ' HB2' ' A' ' 50' ' ' CYS . 26.8 m -82.24 116.52 21.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.051 -169.081 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.543 ' HE1' ' HG2' ' A' ' 34' ' ' GLN . 33.9 m-85 -104.52 131.21 52.18 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.476 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.1 t -68.28 -27.08 66.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.975 -173.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.731 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 21.2 p30 -174.98 172.87 1.09 Allowed Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.211 -174.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.574 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 72.6 Cg_exo -52.24 -46.55 32.06 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.369 2.046 . . . . 0.0 113.465 178.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.2 p -61.95 -31.37 71.69 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.017 0.437 . . . . 0.0 111.327 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.402 ' C ' HD22 ' A' ' 30' ' ' ASN . 0.3 OUTLIER -65.82 -47.56 74.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.852 175.77 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -66.62 -47.51 72.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.816 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.0 m -63.18 -50.19 71.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.851 -175.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.471 ' HA ' ' HG2' ' A' ' 36' ' ' GLU . . . -68.32 -43.06 78.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.164 0.506 . . . . 0.0 111.239 -177.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.678 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 44.0 tp60 -64.24 -35.49 81.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.022 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.815 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -77.98 -43.96 28.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.638 -178.311 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.477 ' HG3' ' HG3' ' A' ' 37' ' ' GLN . 11.4 pt-20 -66.11 -30.85 71.43 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.281 -177.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.636 ' HB3' ' HB3' ' A' ' 1' ' ' ALA . 86.6 mt-30 -93.74 -35.47 12.77 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.997 -178.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.3 m -109.35 -75.34 0.63 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.825 -169.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.414 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 12.4 t0 -124.39 91.23 49.81 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.843 0.354 . . . . 0.0 110.654 -176.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.45 -13.25 27.68 Favored 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 123.123 2.549 . . . . 0.0 112.868 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -82.62 -21.74 34.99 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -166.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.815 HD11 ' NE2' ' A' ' 35' ' ' GLN . 10.9 pt -78.34 164.41 3.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.04 -177.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.09 169.45 9.09 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.985 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.5 mt -72.19 117.47 15.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 167.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.447 ' HB2' ' HA ' ' A' ' 20' ' ' SER . . . -77.05 -42.48 38.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 -175.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -168.5 158.71 9.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.422 176.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.0 tpt -72.66 139.77 47.52 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 175.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.26 153.67 26.19 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.458 -175.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.563 ' HB2' HG23 ' A' ' 24' ' ' THR . 6.9 pt-20 -67.44 149.34 50.36 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.665 0.269 . . . . 0.0 111.421 -177.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.595 ' HB2' ' OG1' ' A' ' 24' ' ' THR . 60.3 m . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.873 -0.584 . . . . 0.0 111.243 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.963 0 CA-C-O 120.758 0.313 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -123.27 -36.04 2.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.139 0.495 . . . . 0.0 109.938 173.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -114.6 129.34 56.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.949 174.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.541 ' SG ' ' HG3' ' A' ' 34' ' ' GLN . 28.5 p -151.17 116.13 5.25 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.61 129.59 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 121.687 0.756 . . . . 0.0 111.528 -172.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.01 -96.1 1.82 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 173.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -131.77 136.34 47.49 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 174.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -99.67 120.27 39.44 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 171.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.75 120.22 21.61 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.439 0.638 . . . . 0.0 112.362 -167.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.47 ' SG ' ' N ' ' A' ' 30' ' ' ASN . 16.9 p -136.14 148.45 48.22 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 166.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.1 m -148.81 83.89 1.46 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.344 0.592 . . . . 0.0 111.385 -172.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.654 HH21 ' HB2' ' A' ' 28' ' ' PRO . 27.5 ptt180 -115.57 -10.25 11.9 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.262 176.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 177.51 159.04 0.41 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -174.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -114.0 93.69 4.48 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.802 176.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.662 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 50.2 m-85 -119.53 99.93 49.66 Favored Pre-proline 0 CA--C 1.502 -0.887 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 165.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.74 138.58 10.66 Favored 'Trans proline' 0 N--CA 1.438 -1.792 0 C-N-CA 120.69 0.927 . . . . 0.0 112.146 -171.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.3 m -140.99 168.87 15.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 45.1 t -119.68 126.95 52.35 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.696 -178.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.619 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -77.16 145.97 31.43 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 175.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.44 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 28.2 t -57.84 -11.8 2.6 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -172.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -78.75 -8.93 59.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.357 0.598 . . . . 0.0 110.31 174.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.73 28.26 11.48 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.666 -177.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.559 HG13 ' CE2' ' A' ' 25' ' ' TYR . 2.1 p -106.21 141.79 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -174.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.1 m -83.45 122.53 28.64 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.482 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.619 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 49.6 m-85 -111.27 136.82 49.82 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.429 0.633 . . . . 0.0 112.195 177.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.7 m -70.62 -38.68 73.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.31 -1.314 . . . . 0.0 112.401 -174.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.662 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 6.3 p30 -173.35 175.45 0.97 Allowed Pre-proline 0 C--N 1.329 -0.326 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.654 ' HB2' HH21 ' A' ' 12' ' ' ARG . 92.6 Cg_exo -46.01 -42.01 20.79 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 122.911 2.407 . . . . 0.0 114.944 -176.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.5 p -63.79 -33.39 75.57 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.626 0.648 . . . . 0.0 111.083 -177.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.47 ' N ' ' SG ' ' A' ' 10' ' ' CYS . 1.8 t-20 -67.56 -47.1 70.78 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.421 -176.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.512 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 62.4 t80 -66.49 -46.94 74.63 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.698 175.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.5 t -60.86 -50.89 71.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.424 -175.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.437 ' HA ' ' HG2' ' A' ' 36' ' ' GLU . . . -68.8 -47.39 66.22 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.484 -175.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.548 ' O ' ' HB2' ' A' ' 38' ' ' CYS . 31.9 tt0 -65.63 -31.35 72.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.367 0.603 . . . . 0.0 110.203 -176.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.827 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -78.15 -44.62 25.47 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.595 -178.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.437 ' HG2' ' HA ' ' A' ' 33' ' ' ALA . 10.7 pt-20 -65.25 -36.67 84.86 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.293 -176.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.637 ' HG3' ' SG ' ' A' ' 38' ' ' CYS . 2.9 pt20 -98.21 -34.14 10.84 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.994 -176.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.637 ' SG ' ' HG3' ' A' ' 37' ' ' GLN . 62.2 m -108.43 -67.58 0.96 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -170.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -123.66 86.59 52.76 Favored Pre-proline 0 N--CA 1.465 0.31 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.043 -176.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -73.61 -11.95 24.42 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 123.076 2.518 . . . . 0.0 113.115 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -86.02 -12.39 50.4 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -167.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.827 HD11 ' NE2' ' A' ' 35' ' ' GLN . 11.6 pt -93.97 159.17 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.05 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.5 p -121.35 168.0 12.14 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.381 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.9 mt -69.1 119.98 15.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.09 -50.94 7.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.859 -177.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 27.6 p80 -162.08 159.12 25.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.157 177.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 80.7 mtp -76.94 148.79 36.15 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 175.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.1 150.96 22.64 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -175.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.451 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 1.2 pm0 -71.06 148.99 46.97 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.961 0.41 . . . . 0.0 111.023 -178.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.73 -178.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.688 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 120.402 0.144 . . . . 0.0 110.803 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 69.84 -78.36 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.322 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -121.01 113.84 20.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.336 0.589 . . . . 0.0 110.591 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.7 p -153.02 140.04 19.24 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 171.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.0 p -114.02 123.93 70.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.153 -173.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.511 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . 103.47 -90.32 0.75 Allowed Glycine 0 N--CA 1.439 -1.114 0 CA-C-N 114.997 -1.002 . . . . 0.0 112.077 169.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.531 ' HD3' ' H ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -132.99 140.18 47.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.919 0.39 . . . . 0.0 110.903 179.78 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 8' ' ' LYS . 23.5 mmtt -98.73 131.61 44.75 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 168.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.33 119.6 17.79 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.581 0.705 . . . . 0.0 112.009 -169.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 44.8 t -137.56 146.2 43.78 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 174.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 m -156.38 53.71 0.55 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.284 0.564 . . . . 0.0 111.414 -174.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 23.7 ptt85 -100.84 -0.04 37.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.461 0.648 . . . . 0.0 110.037 173.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -172.56 155.15 3.29 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -175.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -129.3 93.32 3.54 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.447 177.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.65 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 50.7 m-85 -122.72 102.35 38.65 Favored Pre-proline 0 CA--C 1.5 -0.973 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 165.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -81.26 137.84 10.83 Favored 'Trans proline' 0 N--CA 1.439 -1.719 0 C-N-CA 120.732 0.955 . . . . 0.0 112.283 -172.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.0 m -140.8 172.28 11.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.329 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 47.7 t -121.25 132.7 54.97 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.59 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.591 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -84.48 149.74 25.04 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 174.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.492 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 8.2 t -59.28 -12.46 5.59 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -171.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.481 ' HB2' HG21 ' A' ' 42' ' ' ILE . 23.3 t70 -77.08 -7.26 55.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.58 0.705 . . . . 0.0 109.599 174.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.39 25.13 24.53 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.279 -177.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.565 HG13 ' CE2' ' A' ' 25' ' ' TYR . 3.5 p -105.51 140.99 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 121.13 0.491 . . . . 0.0 111.557 -172.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.0 m -82.78 121.66 27.19 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.183 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.591 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 51.6 m-85 -105.65 132.93 51.19 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.995 177.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.4 m -70.46 -26.42 63.63 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.765 -1.107 . . . . 0.0 112.181 -174.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.687 ' HB2' ' HD2' ' A' ' 28' ' ' PRO . 30.3 p30 -173.93 170.4 1.78 Allowed Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.687 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 9.3 Cg_endo -52.63 -37.28 74.4 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.569 2.179 . . . . 0.0 111.866 175.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.483 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 12.8 t -54.42 -51.55 64.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.375 175.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.424 ' CG ' ' HD1' ' A' ' 25' ' ' TYR . 1.8 t-20 -63.93 -44.8 91.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.13 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.501 ' HD1' ' CD2' ' A' ' 25' ' ' TYR . 64.8 t80 -63.21 -50.06 71.77 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 120.895 0.378 . . . . 0.0 110.466 -178.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.453 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 34.8 t -64.88 -52.2 57.86 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.141 -176.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.54 -40.88 89.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.881 0.372 . . . . 0.0 111.502 -173.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.511 ' HG2' ' O ' ' A' ' 6' ' ' GLY . 49.4 tp60 -62.69 -42.04 99.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.393 0.616 . . . . 0.0 110.485 -178.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.588 ' NE2' HD11 ' A' ' 42' ' ' ILE . 43.5 mt-30 -78.96 -41.3 29.58 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -176.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 32' ' ' SER . 12.6 pt-20 -69.14 -25.6 64.46 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.827 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.688 ' HB3' ' HB3' ' A' ' 1' ' ' ALA . 95.5 mt-30 -95.58 -27.76 15.18 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 78.8 m -137.77 -50.8 0.61 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -172.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.528 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 57.9 m-20 -119.92 68.81 12.8 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 118.229 0.468 . . . . 0.0 111.492 -170.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.55 -13.78 35.74 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.526 2.151 . . . . 0.0 113.73 -170.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -94.38 10.04 35.89 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -166.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.588 HD11 ' NE2' ' A' ' 35' ' ' GLN . 7.7 pt -109.59 156.6 10.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 118.981 -1.088 . . . . 0.0 111.47 175.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.0 p -118.53 168.58 10.54 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.562 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.7 mt -64.8 119.45 9.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.492 ' HB2' ' HA ' ' A' ' 20' ' ' SER . . . -84.31 -44.98 13.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.953 -177.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -168.37 156.89 8.67 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.736 175.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 95.8 mmm -74.62 144.72 43.77 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.18 148.44 24.07 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 110.614 -0.995 . . . . 0.0 110.614 -174.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.434 ' H ' ' HG3' ' A' ' 49' ' ' GLU . 0.4 OUTLIER -71.85 149.27 45.38 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.003 0.43 . . . . 0.0 111.037 -176.605 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.011 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.584 -171.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.628 ' HB2' ' OE1' ' A' ' 34' ' ' GLN . 19.5 tptm . . . . . 0 N--CA 1.445 -0.68 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.59 120.59 20.36 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.732 0.777 . . . . 0.0 112.218 -166.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 51.0 t -136.57 145.68 45.24 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 169.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.9 m -147.77 63.13 1.13 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.499 0.666 . . . . 0.0 110.769 -172.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.444 ' HG3' ' HB3' ' A' ' 13' ' ' GLU . 7.6 ptt180 -88.73 -18.72 27.24 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.147 176.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.444 ' HB3' ' HG3' ' A' ' 12' ' ' ARG . 37.8 tt0 -179.76 161.45 0.99 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.739 -1.119 . . . . 0.0 107.994 -163.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -121.11 92.03 3.66 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.896 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.578 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 16.5 m-85 -121.06 99.22 46.76 Favored Pre-proline 0 CA--C 1.501 -0.925 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 164.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -83.23 138.71 8.98 Favored 'Trans proline' 0 N--CA 1.437 -1.83 0 C-N-CA 121.17 1.247 . . . . 0.0 112.614 -171.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -140.23 164.52 22.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.126 177.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.5 t -116.35 131.3 56.98 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.527 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -85.74 156.04 29.76 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.416 -0.897 . . . . 0.0 111.113 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.803 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 68.5 m -57.71 -11.68 2.36 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -175.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -77.23 -6.8 54.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.664 0.745 . . . . 0.0 109.914 173.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.03 28.29 37.95 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 -174.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.473 HG13 ' CE2' ' A' ' 25' ' ' TYR . 3.1 p -105.61 140.94 22.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 120.945 0.402 . . . . 0.0 111.975 -172.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.7 m -84.29 120.98 26.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.327 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.527 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 59.2 m-85 -107.51 128.47 54.54 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.845 175.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.6 m -66.77 -25.66 66.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.315 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.587 ' OD1' ' HB3' ' A' ' 29' ' ' CYS . 7.4 p30 -171.54 170.36 2.7 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -177.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.53 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 79.3 Cg_exo -50.19 -42.13 47.77 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.46 2.107 . . . . 0.0 112.454 176.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.587 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 35.7 t -57.77 -40.75 80.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.883 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.4 ' ND2' ' HD1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -62.51 -45.03 94.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.049 177.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -64.32 -48.42 75.66 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.013 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.4 t -63.99 -52.21 60.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.39 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.43 -45.33 84.25 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 120.961 0.41 . . . . 0.0 111.508 -173.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.628 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 7.7 tp60 -64.12 -41.23 97.31 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.283 -177.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.664 ' NE2' HD11 ' A' ' 42' ' ' ILE . 59.7 mt-30 -77.76 -36.6 50.42 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -176.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -64.52 -26.13 68.29 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.276 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.587 HE22 ' HG2' ' A' ' 8' ' ' LYS . 8.2 mt-30 -86.84 -36.86 18.24 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.75 0.31 . . . . 0.0 111.661 173.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.6 m -112.26 -79.15 0.58 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -169.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.439 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 8.8 t70 -126.43 91.44 47.61 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.515 -172.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -68.96 -12.12 33.58 Favored 'Trans proline' 0 C--N 1.332 -0.301 0 C-N-CA 122.858 2.372 . . . . 0.0 112.142 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -88.67 -12.94 40.99 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -166.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.803 ' HB ' ' HB2' ' A' ' 20' ' ' SER . 10.5 pt -80.35 162.29 3.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.581 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.7 p -121.54 169.2 10.9 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.148 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.1 mt -69.98 117.83 13.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.7 -48.37 26.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.287 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -160.75 154.69 22.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.839 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -73.56 140.34 46.22 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.82 141.21 10.42 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.391 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -56.92 144.19 34.66 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 122.447 0.299 . . . . 0.0 111.143 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.915 -0.564 . . . . 0.0 111.203 -176.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? . . . . . 0 N--CA 1.449 -0.475 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.08 117.95 17.49 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.795 0.807 . . . . 0.0 112.706 -165.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 36.5 t -138.55 145.58 40.84 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 168.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.8 m -157.83 66.29 0.48 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.814 0.816 . . . . 0.0 110.602 -177.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -101.26 8.89 42.29 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 173.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 178.03 154.58 0.34 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 113.984 -1.462 . . . . 0.0 107.896 -171.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -128.32 92.52 3.45 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.494 174.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.681 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 30.9 m-85 -122.54 101.29 40.43 Favored Pre-proline 0 N--CA 1.441 -0.917 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 164.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -81.78 138.68 10.67 Favored 'Trans proline' 0 N--CA 1.439 -1.703 0 C-N-CA 120.92 1.08 . . . . 0.0 111.586 -172.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.7 m -140.32 169.69 15.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.131 0.491 . . . . 0.0 109.997 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.6 t -117.03 129.61 56.13 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.318 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.06 144.69 26.35 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 174.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.465 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 50.8 p -61.29 -11.42 9.63 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -171.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -73.88 -10.18 59.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.501 0.667 . . . . 0.0 109.662 171.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.85 25.64 14.53 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.744 -178.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.531 HG13 ' CE2' ' A' ' 25' ' ' TYR . 3.1 p -106.73 142.0 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.438 -175.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.554 HG23 ' HA ' ' A' ' 49' ' ' GLU . 85.8 m -84.21 119.47 25.06 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 120.959 0.409 . . . . 0.0 110.643 -178.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.531 ' CE2' HG13 ' A' ' 23' ' ' VAL . 37.0 m-85 -106.87 132.91 52.29 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.525 0.678 . . . . 0.0 111.08 177.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.3 t -64.88 -31.37 72.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.186 -172.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.681 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 26.8 p30 -175.5 170.7 1.3 Allowed Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.554 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 82.0 Cg_exo -50.2 -40.92 51.36 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.316 2.011 . . . . 0.0 112.508 176.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 35.2 t -54.46 -48.64 71.51 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.094 0.473 . . . . 0.0 110.569 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -66.62 -46.37 76.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.486 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.511 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 38.3 t80 -63.73 -48.09 78.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.521 0.201 . . . . 0.0 110.947 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.5 p -64.1 -50.65 67.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.013 -175.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.501 ' HA ' ' HG2' ' A' ' 36' ' ' GLU . . . -65.3 -44.44 87.92 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.071 0.462 . . . . 0.0 110.937 -176.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -63.52 -37.38 87.07 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.446 0.641 . . . . 0.0 110.395 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.588 ' HG3' ' O ' ' A' ' 39' ' ' ASP . 2.1 mp0 -77.61 -37.59 49.95 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.873 -177.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.501 ' HG2' ' HA ' ' A' ' 33' ' ' ALA . 12.8 pt-20 -73.62 -27.76 61.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.842 0.353 . . . . 0.0 110.762 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.482 HE21 ' HB2' ' A' ' 37' ' ' GLN . 11.0 mt-30 -91.36 -34.09 15.02 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.774 -178.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 64.2 m -119.96 -74.88 0.59 Allowed 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.068 -0.653 . . . . 0.0 112.761 -169.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.588 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 4.8 t0 -115.33 97.96 49.51 Favored Pre-proline 0 C--N 1.326 -0.444 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.113 -175.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 39' ' ' ASP . 41.8 Cg_endo -71.14 -13.23 31.06 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 123.2 2.6 . . . . 0.0 113.698 -177.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -85.57 -21.85 28.34 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -163.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.577 HD11 ' NE2' ' A' ' 35' ' ' GLN . 6.5 pt -87.99 154.1 3.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 119.294 -0.963 . . . . 0.0 111.126 -175.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.5 p -127.88 169.68 13.66 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.515 -1.221 . . . . 0.0 109.036 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.483 HD12 ' H ' ' A' ' 44' ' ' ILE . 4.5 mp -68.87 119.41 14.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.53 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.465 ' HB2' ' HA ' ' A' ' 20' ' ' SER . . . -81.18 -46.15 15.3 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.428 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -168.02 157.13 9.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.561 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 87.7 mtp -79.99 130.56 35.37 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.63 162.2 11.56 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 -173.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.554 ' HA ' HG23 ' A' ' 24' ' ' THR . 0.5 OUTLIER -73.35 147.93 43.92 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.067 0.46 . . . . 0.0 111.095 -178.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.832 -0.604 . . . . 0.0 111.033 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.537 ' HB2' ' OE1' ' A' ' 34' ' ' GLN . 6.6 tmtm? . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.44 117.63 16.48 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.896 0.855 . . . . 0.0 112.184 -166.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.542 ' SG ' ' HG3' ' A' ' 12' ' ' ARG . 44.5 t -138.51 146.38 41.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.103 -1.408 . . . . 0.0 107.494 172.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.2 m -152.54 64.22 0.81 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.79 0.805 . . . . 0.0 110.144 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.542 ' HG3' ' SG ' ' A' ' 10' ' ' CYS . 21.2 mtm180 -104.27 0.78 29.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.291 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 177.02 153.16 0.21 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 113.837 -1.529 . . . . 0.0 107.129 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 65.2 t-105 -117.45 92.21 3.78 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.847 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.666 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 37.3 m-85 -122.87 101.9 38.71 Favored Pre-proline 0 N--CA 1.434 -1.237 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 164.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.16 137.95 12.43 Favored 'Trans proline' 0 N--CA 1.441 -1.606 0 C-N-CA 120.546 0.83 . . . . 0.0 111.566 -172.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.0 m -138.01 173.86 11.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.044 0.45 . . . . 0.0 110.101 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.1 t -122.73 132.5 54.27 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.634 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.11 146.5 25.26 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 173.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.627 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 10.0 t -57.95 -13.92 5.4 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -172.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.466 ' HB2' HG21 ' A' ' 42' ' ' ILE . 31.4 t70 -74.94 -8.41 56.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.51 0.671 . . . . 0.0 109.924 174.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.47 25.38 21.24 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.287 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.5 p -105.73 140.88 22.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.921 0.391 . . . . 0.0 111.285 -173.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.431 HG23 ' HA ' ' A' ' 49' ' ' GLU . 36.8 m -85.15 123.77 31.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.19 0.519 . . . . 0.0 111.239 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -111.51 137.47 49.3 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.933 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 65.5 m -68.4 -26.09 65.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.229 -175.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.666 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 30.8 p30 -172.67 171.96 1.8 Allowed Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.551 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 75.5 Cg_exo -52.34 -39.87 71.92 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.379 2.053 . . . . 0.0 112.597 176.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.431 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 21.5 t -55.14 -44.91 75.52 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.959 0.409 . . . . 0.0 110.558 176.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.435 ' C ' HD22 ' A' ' 30' ' ' ASN . 0.2 OUTLIER -61.68 -46.45 89.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.367 179.207 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -65.96 -47.9 73.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.928 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.7 t -63.58 -49.26 74.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.571 -174.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.469 ' HA ' ' HG2' ' A' ' 36' ' ' GLU . . . -64.78 -44.92 88.44 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.706 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.537 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 7.5 tp60 -62.65 -40.79 98.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.543 0.687 . . . . 0.0 110.398 -177.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.565 ' HG3' ' O ' ' A' ' 39' ' ' ASP . 2.2 mp0 -76.08 -36.29 59.01 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.98 -177.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.469 ' HG2' ' HA ' ' A' ' 33' ' ' ALA . 11.1 pt-20 -67.08 -42.92 83.83 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.364 -178.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -111.74 5.85 19.42 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -175.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 34' ' ' GLN . 66.5 m -135.0 -63.25 0.7 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.158 0.89 . . . . 0.0 113.0 175.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.565 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 8.6 t0 -116.94 92.57 39.31 Favored Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 118.808 0.731 . . . . 0.0 110.7 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -72.08 -12.95 28.53 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.43 2.753 . . . . 0.0 113.374 -177.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -92.62 -21.86 19.8 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -163.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.627 ' HB ' ' HB3' ' A' ' 20' ' ' SER . 19.0 pt -90.72 160.04 2.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.835 0.826 . . . . 0.0 112.363 -174.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.5 p -123.22 169.37 11.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.323 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.5 mt -65.17 119.29 9.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 175.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.53 -50.69 10.35 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.523 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -164.76 161.43 20.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 44.7 tpp -75.92 139.25 41.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.025 173.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 107.33 159.73 21.17 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.53 -176.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.437 ' CD ' ' H ' ' A' ' 49' ' ' GLU . 0.8 OUTLIER -73.69 149.12 42.11 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.916 0.389 . . . . 0.0 111.04 -178.64 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.331 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.13 118.67 30.62 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.961 -174.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 30' ' ' ASN . 21.2 p -137.34 148.68 46.48 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 168.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.7 m -148.89 89.0 1.64 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.408 0.623 . . . . 0.0 111.381 -175.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -109.67 -19.8 13.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.527 173.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -177.61 163.92 1.97 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -169.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -118.28 92.99 3.97 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.156 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.669 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 15.3 m-85 -122.67 101.09 40.27 Favored Pre-proline 0 N--CA 1.441 -0.911 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 164.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.59 140.04 11.62 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 121.345 1.363 . . . . 0.0 112.487 -172.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 25' ' ' TYR . 27.2 m -143.29 170.91 9.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.98 0.419 . . . . 0.0 109.944 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 18.5 t -123.63 139.41 54.03 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.5 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -94.5 156.96 22.27 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.285 177.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.856 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 64.1 m -57.22 -12.67 2.45 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -174.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -76.71 -7.92 56.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.841 0.829 . . . . 0.0 109.712 173.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.04 28.68 36.55 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -173.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.516 HG13 ' CE2' ' A' ' 25' ' ' TYR . 2.7 p -101.48 140.8 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 121.066 0.46 . . . . 0.0 111.427 -172.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.526 HG23 ' N ' ' A' ' 50' ' ' CYS . 1.3 m -82.49 117.27 22.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.252 -177.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.516 ' CE2' HG13 ' A' ' 23' ' ' VAL . 52.3 m-85 -106.56 130.42 54.33 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-O 121.269 0.556 . . . . 0.0 110.744 176.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.4 t -70.29 -26.86 64.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.746 -174.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.672 ' HB2' ' HD2' ' A' ' 28' ' ' PRO . 26.1 p-10 178.25 173.9 0.38 Allowed Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -173.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.672 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 79.6 Cg_exo -47.8 -49.48 13.56 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 123.219 2.613 . . . . 0.0 114.901 -176.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.455 ' SG ' ' ND2' ' A' ' 27' ' ' ASN . 7.8 p -59.27 -35.77 74.34 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.044 0.45 . . . . 0.0 111.058 -177.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.403 ' OD1' ' HA ' ' A' ' 25' ' ' TYR . 2.1 t-20 -64.84 -46.02 83.66 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.946 -178.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.42 ' HD2' ' CD2' ' A' ' 25' ' ' TYR . 65.0 t80 -65.4 -47.92 74.62 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.129 0.49 . . . . 0.0 109.726 178.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.8 t -64.03 -51.71 62.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.905 -175.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.465 ' O ' ' HG2' ' A' ' 36' ' ' GLU . . . -69.01 -44.09 73.46 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.088 0.47 . . . . 0.0 111.452 -175.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -62.47 -41.66 98.93 Favored 'General case' 0 C--O 1.215 -0.715 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.949 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.632 ' NE2' HD11 ' A' ' 42' ' ' ILE . 61.9 mt-30 -78.69 -35.91 44.33 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 33' ' ' ALA . 12.8 pt-20 -61.94 -27.94 69.18 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.797 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.63 ' HG3' ' SG ' ' A' ' 38' ' ' CYS . 20.6 pt20 -100.85 -38.06 8.41 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 119.488 -0.885 . . . . 0.0 112.793 174.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.63 ' SG ' ' HG3' ' A' ' 37' ' ' GLN . 17.7 m -96.12 -77.98 0.47 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.897 -169.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.463 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 5.8 t0 -124.13 89.76 51.46 Favored Pre-proline 0 C--N 1.331 -0.207 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.06 -175.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.32 -11.8 32.27 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 123.315 2.677 . . . . 0.0 112.836 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -79.66 -21.81 44.28 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -167.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.856 ' HB ' ' HB2' ' A' ' 20' ' ' SER . 9.0 pt -85.62 161.91 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.406 -175.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.96 169.5 12.04 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.258 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.4 mt -65.4 117.89 6.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.242 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.84 -44.24 50.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.005 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -166.96 151.58 7.23 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.38 176.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -73.54 139.4 45.61 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 108.67 145.14 11.24 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -171.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.459 ' HB2' ' CG2' ' A' ' 24' ' ' THR . 0.9 OUTLIER -73.97 145.64 44.48 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.996 0.398 . . . . 0.0 110.692 -175.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.526 ' N ' HG23 ' A' ' 24' ' ' THR . 1.3 m . . . . . 0 C--O 1.242 0.697 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.32 173.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.8 mmtt . . . . . 0 CA--C 1.512 -0.481 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.55 115.42 16.29 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.49 -173.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 48.8 t -139.98 146.1 38.68 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 167.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -168.0 56.17 0.06 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.642 0.734 . . . . 0.0 110.641 -172.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -80.72 -23.81 39.23 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.265 175.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -163.31 157.66 20.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.612 -1.176 . . . . 0.0 107.923 -177.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 71.2 t-105 -112.42 94.43 4.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.403 0.62 . . . . 0.0 111.038 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.568 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 30.4 m-85 -120.33 100.02 47.78 Favored Pre-proline 0 N--CA 1.442 -0.852 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 165.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -81.36 138.37 10.99 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 120.996 1.131 . . . . 0.0 113.266 -168.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.23 174.15 6.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.504 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.0 t -126.7 138.61 53.42 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.447 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.83 153.14 21.79 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 175.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.547 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 16.2 m -56.81 -15.17 4.22 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -174.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -74.01 -7.82 53.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.691 0.758 . . . . 0.0 109.968 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.09 27.89 29.84 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -175.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.428 HG13 ' CE2' ' A' ' 25' ' ' TYR . 3.6 p -105.73 140.73 22.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.269 -0.466 . . . . 0.0 111.18 -172.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.422 HG23 ' HA ' ' A' ' 49' ' ' GLU . 42.0 m -85.05 122.19 28.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.98 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.428 ' CE2' HG13 ' A' ' 23' ' ' VAL . 29.7 m-85 -109.91 133.07 53.57 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.225 177.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.8 m -65.97 -34.6 78.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.586 -173.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.568 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 8.2 p30 -178.07 177.23 0.43 Allowed Pre-proline 0 C--O 1.237 0.403 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.528 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 95.7 Cg_exo -46.03 -43.21 20.48 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 122.821 2.347 . . . . 0.0 114.765 -177.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 29.1 p -60.96 -37.33 82.0 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.222 0.465 . . . . 0.0 110.695 -177.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -67.89 -46.27 72.09 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.541 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.51 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 62.7 t80 -65.95 -46.7 77.19 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 176.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 39.3 t -63.39 -50.88 68.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.515 -176.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.55 ' O ' ' HG2' ' A' ' 37' ' ' GLN . . . -68.07 -44.79 75.5 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 120.78 0.324 . . . . 0.0 111.018 -175.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.8 tp60 -65.85 -35.4 80.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.223 0.535 . . . . 0.0 110.246 -177.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.772 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -77.43 -36.7 52.85 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.365 -177.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.506 ' HG2' ' HA ' ' A' ' 33' ' ' ALA . 9.5 pt-20 -70.92 -28.05 64.23 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.105 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.629 ' HG3' ' SG ' ' A' ' 38' ' ' CYS . 9.7 pt20 -99.79 -35.16 9.88 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.069 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.629 ' SG ' ' HG3' ' A' ' 37' ' ' GLN . 25.0 m -104.49 -77.57 0.58 Allowed 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.805 -172.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 9.2 t70 -118.08 99.3 51.89 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.885 0.374 . . . . 0.0 111.136 -175.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.23 -13.95 25.68 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 123.111 2.541 . . . . 0.0 112.92 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -86.43 -21.75 26.93 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -164.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.772 HD11 ' NE2' ' A' ' 35' ' ' GLN . 23.5 pt -85.67 166.21 2.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.608 -177.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.8 p -132.12 170.56 14.8 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.317 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.3 mt -65.77 118.16 7.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 175.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.26 -43.55 27.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.52 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -164.38 157.69 17.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.545 177.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.77 138.48 36.28 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 175.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 110.69 151.89 12.77 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -173.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.422 ' HA ' HG23 ' A' ' 24' ' ' THR . 14.2 pt-20 -65.54 149.4 50.12 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.75 0.31 . . . . 0.0 111.269 -178.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.134 0 CA-C-O 119.225 -0.417 . . . . 0.0 110.464 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp . . . . . 0 N--CA 1.455 -0.208 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.08 121.96 27.23 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.358 0.599 . . . . 0.0 112.286 -171.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 46.8 t -136.32 147.44 47.43 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 170.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.0 m -153.42 67.21 0.77 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.406 0.622 . . . . 0.0 111.805 -174.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.3 ptt85 -110.87 -3.05 15.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.236 0.541 . . . . 0.0 109.82 172.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 174.63 151.33 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.592 -1.186 . . . . 0.0 108.396 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -110.02 94.62 5.11 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.143 0.497 . . . . 0.0 110.366 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.756 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 31.2 m-85 -120.52 100.44 47.06 Favored Pre-proline 0 N--CA 1.441 -0.901 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 167.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.93 138.52 10.4 Favored 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 121.02 1.146 . . . . 0.0 111.744 -172.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.2 m -143.75 176.98 2.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.125 0.488 . . . . 0.0 110.292 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.2 t -124.7 130.25 52.06 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.319 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.67 147.71 29.81 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 174.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.908 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 32.7 t -57.85 -12.58 3.24 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -172.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -77.59 -7.95 57.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.702 0.763 . . . . 0.0 110.214 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.14 24.96 20.94 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -176.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.41 HG13 ' CE2' ' A' ' 25' ' ' TYR . 3.2 p -106.01 140.96 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 120.934 0.397 . . . . 0.0 111.269 -174.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.9 m -83.73 124.52 30.96 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.383 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.494 ' HE1' ' HG2' ' A' ' 34' ' ' GLN . 29.9 m-85 -113.05 135.85 53.34 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.421 177.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.1 m -69.24 -29.07 66.92 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.422 -173.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.756 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 28.6 p30 -170.17 168.8 4.13 Favored Pre-proline 0 C--O 1.236 0.353 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.518 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 72.3 Cg_exo -50.6 -38.19 54.51 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.515 2.143 . . . . 0.0 112.515 177.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.432 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 7.6 t -55.21 -50.9 68.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.551 176.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -62.14 -45.26 94.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.735 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.513 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 58.7 t80 -61.17 -49.13 78.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.305 0.098 . . . . 0.0 111.028 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.484 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 16.2 t -65.86 -51.0 62.55 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.485 0.18 . . . . 0.0 111.485 -177.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.66 -43.51 93.37 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.487 0.661 . . . . 0.0 110.995 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.494 ' HG2' ' HE1' ' A' ' 25' ' ' TYR . 9.5 tp60 -64.68 -36.92 85.85 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.166 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.725 ' HG3' ' O ' ' A' ' 39' ' ' ASP . 2.2 mp0 -72.81 -44.39 61.53 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.383 -176.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.492 ' HG3' ' NE2' ' A' ' 37' ' ' GLN . 9.3 pt-20 -63.68 -31.01 72.05 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.092 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.492 ' NE2' ' HG3' ' A' ' 36' ' ' GLU . 2.9 mp0 -87.32 -35.09 18.61 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 177.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 18.7 m -108.59 -80.7 0.57 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -171.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.725 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 55.8 t0 -126.14 83.91 62.61 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 120.871 0.367 . . . . 0.0 110.662 -172.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -67.99 -12.64 35.89 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 123.446 2.764 . . . . 0.0 114.13 -170.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -99.54 11.71 38.43 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -169.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.908 ' HB ' ' HB3' ' A' ' 20' ' ' SER . 12.5 pt -97.31 151.36 4.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.371 174.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.428 ' H ' ' HB2' ' A' ' 20' ' ' SER . 0.3 OUTLIER -107.54 167.67 9.78 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.361 -179.526 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.2 mt -70.33 118.94 15.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 173.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.24 -51.07 16.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.473 -176.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -160.75 158.43 28.61 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.271 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.4 tpt -71.3 145.03 49.76 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.003 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.35 154.45 30.75 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.609 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -62.53 149.28 43.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.821 0.344 . . . . 0.0 110.699 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.86 -0.59 . . . . 0.0 110.842 -173.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.463 ' HD3' ' HA ' ' A' ' 8' ' ' LYS . 65.2 mmtt . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.69 120.44 21.08 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.872 0.844 . . . . 0.0 113.104 -162.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 43.4 t -128.55 147.2 50.68 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 168.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.9 m -150.21 61.98 0.97 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.554 0.693 . . . . 0.0 111.326 -175.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -91.52 -13.38 32.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.697 174.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -173.71 157.5 3.12 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -173.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 67.2 t-105 -119.07 92.99 3.93 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.038 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.732 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 14.6 m-85 -122.15 101.06 41.88 Favored Pre-proline 0 CA--C 1.501 -0.92 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 166.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -80.88 138.1 11.44 Favored 'Trans proline' 0 N--CA 1.443 -1.475 0 C-N-CA 120.697 0.931 . . . . 0.0 111.767 -172.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.4 m -142.77 -179.9 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.361 -177.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.4 t -127.98 134.57 49.28 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.583 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.48 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -82.69 147.58 25.36 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 174.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.655 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 10.6 t -57.88 -13.77 4.98 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -172.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.462 ' HB2' HG21 ' A' ' 42' ' ' ILE . 18.6 t70 -76.83 -8.53 57.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.531 0.681 . . . . 0.0 109.931 175.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.49 26.39 17.99 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.377 -177.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.613 HG13 ' CE2' ' A' ' 25' ' ' TYR . 2.5 p -106.57 141.93 20.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 120.698 0.285 . . . . 0.0 111.721 -174.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.7 m -83.63 126.86 33.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.23 -176.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.613 ' CE2' HG13 ' A' ' 23' ' ' VAL . 51.2 m-85 -117.07 137.99 51.9 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.408 0.623 . . . . 0.0 111.894 177.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.7 m -70.21 -28.37 65.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.121 -175.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.732 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 26.6 p30 -173.84 169.33 2.04 Favored Pre-proline 0 C--O 1.234 0.285 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.549 -177.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.545 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 78.3 Cg_exo -51.47 -42.13 56.76 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.473 2.115 . . . . 0.0 112.416 177.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 41.5 t -54.72 -45.36 74.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.093 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.466 ' C ' HD22 ' A' ' 30' ' ' ASN . 0.2 OUTLIER -62.43 -47.58 83.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.953 -179.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.561 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 55.3 t80 -66.57 -48.11 70.64 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.569 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.408 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 22.2 t -63.79 -50.63 68.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.052 -174.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.92 -45.43 74.37 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.169 0.509 . . . . 0.0 111.126 -175.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.417 ' OE1' ' HE1' ' A' ' 25' ' ' TYR . 22.0 tt0 -65.57 -31.9 73.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.172 0.511 . . . . 0.0 110.695 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.778 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -78.15 -46.97 19.18 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.367 -177.136 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.646 ' HG3' ' HG3' ' A' ' 37' ' ' GLN . 11.7 pt-20 -61.57 -30.59 70.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.875 0.369 . . . . 0.0 110.481 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.646 ' HG3' ' HG3' ' A' ' 36' ' ' GLU . 10.9 mt-30 -94.29 -34.81 12.7 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.593 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 59.8 m -120.13 -65.82 1.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -170.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.501 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 0.7 OUTLIER -116.19 74.66 5.7 Favored Pre-proline 0 N--CA 1.465 0.312 0 CA-C-O 120.729 0.299 . . . . 0.0 111.667 -173.005 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.593 ' HD3' ' O ' ' A' ' 38' ' ' CYS . 6.9 Cg_exo -72.62 -13.11 27.21 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 123.131 2.554 . . . . 0.0 112.698 -174.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -77.36 -20.99 53.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.346 -169.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.778 HD11 ' NE2' ' A' ' 35' ' ' GLN . 10.9 pt -95.32 153.13 3.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.597 -175.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.43 ' O ' ' HB2' ' A' ' 20' ' ' SER . 22.1 p -112.23 168.21 9.8 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.624 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.0 mt -65.93 118.71 9.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.97 -50.82 11.4 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.699 -176.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -166.0 163.27 18.35 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.2 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 86.5 mmm -74.89 146.59 41.74 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 173.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.52 146.37 18.41 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.658 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.41 149.19 50.78 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.718 0.294 . . . . 0.0 110.983 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.976 -0.535 . . . . 0.0 110.978 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.439 -1.025 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.24 128.86 35.77 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -162.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 36.7 t -119.01 147.72 43.78 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 170.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.7 m -153.35 79.59 1.17 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.19 0.519 . . . . 0.0 111.919 -175.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -115.33 -29.09 6.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.4 0.619 . . . . 0.0 109.783 170.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -148.11 158.88 44.32 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -118.17 93.79 4.26 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.15 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.746 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 67.3 m-85 -121.39 99.78 45.35 Favored Pre-proline 0 CA--C 1.504 -0.799 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 164.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -81.77 139.61 11.17 Favored 'Trans proline' 0 N--CA 1.442 -1.537 0 C-N-CA 121.132 1.221 . . . . 0.0 112.558 -171.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.5 m -138.71 172.28 13.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 176.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 29.6 t -116.38 130.61 56.86 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.859 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.656 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -83.65 142.09 20.75 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 172.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.566 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 4.5 t -60.04 -11.04 4.95 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -171.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.579 ' HB2' HG21 ' A' ' 42' ' ' ILE . 19.2 t70 -74.28 -8.21 55.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.487 0.66 . . . . 0.0 109.504 173.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.1 24.91 23.5 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.357 -177.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.572 HG13 ' CE2' ' A' ' 25' ' ' TYR . 2.3 p -105.35 138.52 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 121.061 0.458 . . . . 0.0 111.423 -175.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.52 HG23 ' N ' ' A' ' 50' ' ' CYS . 7.6 m -85.06 116.46 23.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.564 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.656 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 47.5 m-85 -101.37 133.0 46.65 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.337 0.589 . . . . 0.0 111.704 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.9 m -64.18 -30.25 71.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.299 -1.319 . . . . 0.0 112.384 -175.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.746 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 22.1 p30 -174.58 169.6 1.72 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.463 -175.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.657 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 9.2 Cg_endo -52.39 -38.76 74.14 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.599 2.2 . . . . 0.0 112.022 176.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 33.3 t -55.22 -45.01 75.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.451 176.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.49 ' O ' ' HB3' ' A' ' 34' ' ' GLN . 0.2 OUTLIER -66.31 -46.26 77.52 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.961 -178.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.434 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 61.3 t80 -65.87 -48.06 72.82 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.517 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.569 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 19.9 t -64.37 -52.09 60.06 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.415 -175.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.512 ' O ' ' HB2' ' A' ' 37' ' ' GLN . . . -68.02 -42.85 80.01 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.014 0.435 . . . . 0.0 111.27 -174.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.49 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 42.4 tp60 -63.92 -34.64 78.43 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.416 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.768 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -78.01 -50.22 12.54 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.316 -178.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 32' ' ' SER . 12.2 pt-20 -65.27 -26.51 68.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.732 0.301 . . . . 0.0 111.055 -177.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.512 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 2.4 mp0 -92.38 -33.84 14.4 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 82.4 m -133.49 -58.2 0.88 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -169.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.537 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 16.2 m-20 -114.54 68.98 1.98 Allowed Pre-proline 0 N--CA 1.467 0.386 0 CA-C-N 117.996 0.362 . . . . 0.0 111.764 -173.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.25 -14.25 28.44 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.42 2.08 . . . . 0.0 112.614 -174.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -89.06 -6.85 56.83 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -167.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.768 HD11 ' NE2' ' A' ' 35' ' ' GLN . 10.2 pt -91.7 170.79 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 119.964 -0.695 . . . . 0.0 110.941 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.3 p -126.61 168.64 14.03 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.733 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.497 HD12 ' H ' ' A' ' 44' ' ' ILE . 4.5 mp -72.27 119.47 18.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.566 ' HB2' ' HA ' ' A' ' 20' ' ' SER . . . -81.79 -46.72 13.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.751 -176.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 34.8 p80 -167.08 156.69 10.78 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.219 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 96.9 mmm -74.22 156.47 37.22 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 175.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.9 156.76 28.04 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.088 -1.053 . . . . 0.0 110.551 -173.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.453 ' HB2' ' CG2' ' A' ' 24' ' ' THR . 11.6 pt-20 -65.52 135.26 54.91 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.013 0.435 . . . . 0.0 110.292 -177.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.52 ' N ' HG23 ' A' ' 24' ' ' THR . 1.6 t . . . . . 0 C--O 1.251 1.171 0 CA-C-O 118.4 -0.809 . . . . 0.0 110.746 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.437 ' HD3' ' HA ' ' A' ' 8' ' ' LYS . 64.2 mmtt . . . . . 0 N--CA 1.455 -0.221 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.79 119.41 19.75 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -162.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 78.4 m -127.55 146.08 50.64 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 165.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.2 m -154.22 28.95 0.45 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.215 1.007 . . . . 0.0 110.29 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -82.82 -5.06 58.78 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.865 177.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -171.76 150.94 2.75 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -167.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -128.81 93.62 3.66 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.666 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.693 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 77.0 m-85 -121.73 100.48 43.72 Favored Pre-proline 0 CA--C 1.501 -0.915 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 164.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.47 138.11 10.72 Favored 'Trans proline' 0 N--CA 1.441 -1.605 0 C-N-CA 120.555 0.837 . . . . 0.0 111.59 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.4 m -141.42 176.12 4.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.7 t -123.09 128.99 50.87 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.617 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.448 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -81.09 146.46 26.56 Favored Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 174.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.658 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 8.6 t -58.91 -12.79 4.91 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -172.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -74.08 -8.63 56.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.641 0.734 . . . . 0.0 110.128 173.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.92 26.84 23.25 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.12 -176.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.455 HG13 ' CE2' ' A' ' 25' ' ' TYR . 3.3 p -106.54 141.08 22.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.808 0.337 . . . . 0.0 111.384 -174.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.477 HG23 ' HA ' ' A' ' 49' ' ' GLU . 90.1 m -84.43 123.23 30.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.057 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.455 ' CE2' HG13 ' A' ' 23' ' ' VAL . 35.8 m-85 -109.84 136.13 49.64 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.563 0.697 . . . . 0.0 111.525 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.3 m -70.17 -32.07 69.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.323 -1.308 . . . . 0.0 112.361 -173.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.718 ' HB2' ' HD2' ' A' ' 28' ' ' PRO . 27.5 p30 -175.61 171.92 1.12 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.216 -174.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.718 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 6.1 Cg_endo -49.47 -41.49 43.87 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.736 2.291 . . . . 0.0 112.616 176.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.42 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 48.2 t -54.8 -50.62 68.09 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.163 0.506 . . . . 0.0 110.296 177.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -63.32 -45.92 89.05 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.296 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -65.74 -47.26 75.86 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.61 0.243 . . . . 0.0 110.818 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.419 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 41.6 t -63.61 -51.43 65.31 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.291 -176.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.45 -43.71 84.82 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 120.814 0.34 . . . . 0.0 110.828 -174.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.557 ' OE1' ' HA ' ' A' ' 34' ' ' GLN . 6.6 tp60 -64.06 -37.78 88.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.317 0.58 . . . . 0.0 110.576 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.819 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -74.8 -50.32 17.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.967 -178.017 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 32' ' ' SER . 12.8 pt-20 -64.8 -26.15 68.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.559 0.218 . . . . 0.0 111.477 -176.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.404 ' HB2' HE21 ' A' ' 37' ' ' GLN . 18.7 mt-30 -93.33 -35.94 12.8 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 98.9 m -124.74 -54.67 1.64 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -167.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -133.58 85.68 41.98 Favored Pre-proline 0 N--CA 1.465 0.313 0 CA-C-N 119.094 0.861 . . . . 0.0 111.38 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.98 -12.97 23.93 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 123.314 2.676 . . . . 0.0 112.751 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -81.72 -14.22 56.8 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.354 -165.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.819 HD11 ' NE2' ' A' ' 35' ' ' GLN . 9.9 pt -86.53 157.05 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.605 0.717 . . . . 0.0 111.0 -178.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.4 p -110.99 167.39 10.29 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.783 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.444 HD12 ' H ' ' A' ' 44' ' ' ILE . 4.5 mp -70.1 119.27 15.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 173.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.31 -48.7 19.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.279 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -168.93 158.69 8.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.31 176.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 25.9 ttt -77.75 140.07 39.44 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 172.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 110.68 161.15 17.7 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -172.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.477 ' HA ' HG23 ' A' ' 24' ' ' THR . 9.6 pt-20 -75.4 149.24 38.65 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.041 0.448 . . . . 0.0 111.234 -176.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.749 -0.643 . . . . 0.0 111.051 -177.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.0 tptp . . . . . 0 N--CA 1.446 -0.643 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.71 122.63 24.29 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.687 0.756 . . . . 0.0 112.366 -168.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 34.8 t -134.37 147.85 50.58 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 172.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.73 44.75 0.68 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -172.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -84.45 -13.82 50.97 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.593 0.711 . . . . 0.0 109.51 173.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -170.7 151.84 3.62 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.526 ' CZ3' ' HB3' ' A' ' 26' ' ' SER . 57.7 t-105 -118.82 91.84 3.66 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.008 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.721 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 10.4 m-85 -123.73 100.77 37.2 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 164.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -80.59 143.36 15.06 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 121.236 1.291 . . . . 0.0 112.499 -170.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.0 m -137.04 -179.03 2.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.944 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 18.8 t -129.35 131.88 46.97 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.34 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.9 151.19 36.95 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 176.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.634 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 31.2 t -59.65 -12.69 7.33 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -171.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -80.24 -8.49 59.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.26 0.553 . . . . 0.0 110.101 174.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.22 28.77 10.28 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 -175.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.431 HG13 ' CE2' ' A' ' 25' ' ' TYR . 3.6 p -104.86 141.73 19.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.03 0.443 . . . . 0.0 111.592 -172.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.565 HG23 ' N ' ' A' ' 50' ' ' CYS . 0.9 OUTLIER -82.43 121.78 27.17 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.2 -175.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.431 ' CE2' HG13 ' A' ' 23' ' ' VAL . 23.9 m-85 -116.67 134.0 55.34 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.241 0.543 . . . . 0.0 111.137 176.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.526 ' HB3' ' CZ3' ' A' ' 14' ' ' TRP . 16.9 m -67.28 -26.27 66.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.005 -173.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.721 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 25.7 p30 -179.62 175.6 0.42 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.114 -172.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.654 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 71.6 Cg_exo -51.67 -49.23 17.89 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.487 2.125 . . . . 0.0 113.636 177.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.8 p -62.38 -32.04 72.79 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.662 0.267 . . . . 0.0 111.117 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.461 ' C ' HD22 ' A' ' 30' ' ' ASN . 0.2 OUTLIER -63.38 -46.32 87.01 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.865 175.152 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.476 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 42.5 t80 -66.19 -47.48 73.78 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.329 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.3 m -62.43 -49.8 74.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.768 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.42 ' HA ' ' HG2' ' A' ' 36' ' ' GLU . . . -67.39 -44.07 79.81 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.323 0.582 . . . . 0.0 111.114 -177.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.1 tp60 -67.71 -34.39 76.79 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.263 -177.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.788 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -77.41 -37.98 50.71 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.282 -178.217 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.599 ' HG3' ' HG3' ' A' ' 37' ' ' GLN . 10.2 pt-20 -70.09 -29.89 66.98 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.631 -0.427 . . . . 0.0 111.052 -177.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.599 ' HG3' ' HG3' ' A' ' 36' ' ' GLU . 9.7 mt-30 -103.05 -35.99 8.33 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -177.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 10.0 m -107.64 -66.96 0.99 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -169.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.401 ' OD1' HG23 ' A' ' 42' ' ' ILE . 4.2 t70 -126.29 85.59 59.67 Favored Pre-proline 0 C--N 1.328 -0.33 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.9 -175.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.56 -13.12 27.38 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 123.119 2.546 . . . . 0.0 112.696 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -97.95 19.53 13.74 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -168.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.788 HD11 ' NE2' ' A' ' 35' ' ' GLN . 10.9 pt -115.74 156.67 16.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.736 172.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.487 ' H ' ' CB ' ' A' ' 20' ' ' SER . 0.2 OUTLIER -109.05 168.49 9.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.147 178.775 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.55 HD12 ' H ' ' A' ' 44' ' ' ILE . 4.9 mp -66.25 119.24 10.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.526 ' HB2' ' HA ' ' A' ' 20' ' ' SER . . . -82.47 -47.42 12.24 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.094 0.473 . . . . 0.0 110.333 -177.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -168.47 158.55 9.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.198 176.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 82.5 mtp -81.55 154.2 26.36 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.08 135.56 8.82 Favored Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -170.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.457 ' HB2' ' CG2' ' A' ' 24' ' ' THR . 9.6 pt-20 -68.84 141.09 55.21 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.078 0.466 . . . . 0.0 111.266 -175.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.565 ' N ' HG23 ' A' ' 24' ' ' THR . 3.9 m . . . . . 0 C--O 1.245 0.825 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.179 172.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.629 ' HG2' HE22 ' A' ' 37' ' ' GLN . 24.4 tptp . . . . . 0 N--CA 1.446 -0.667 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.91 117.29 16.6 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 122.025 0.917 . . . . 0.0 112.852 -160.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.5 t -138.96 144.09 38.85 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 166.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.5 m -162.26 71.96 0.34 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.398 0.618 . . . . 0.0 110.621 -174.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.9 ppt_? -115.17 6.95 15.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.423 0.63 . . . . 0.0 109.953 176.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 178.99 148.22 0.21 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -174.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 64.2 t-105 -118.41 95.28 4.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.42 0.629 . . . . 0.0 111.814 -177.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.65 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 48.1 m-85 -120.31 99.78 47.99 Favored Pre-proline 0 CA--C 1.505 -0.778 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 165.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -82.55 137.54 9.16 Favored 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 120.981 1.121 . . . . 0.0 112.616 -171.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.0 m -141.85 175.92 4.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.589 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 52.6 t -127.45 123.86 37.03 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.705 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -78.08 150.37 35.53 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 177.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.805 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 26.9 t -58.04 -12.25 3.21 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -171.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -74.96 -10.12 59.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.706 0.765 . . . . 0.0 109.612 173.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.04 21.07 34.15 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.382 -176.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.7 p -106.94 140.36 25.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.787 -176.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.533 ' OG1' ' HA ' ' A' ' 49' ' ' GLU . 1.6 t -87.72 131.28 34.53 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.58 0.705 . . . . 0.0 111.003 -176.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.705 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 69.7 m-85 -106.09 132.38 52.23 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.729 177.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.1 t -63.2 -26.73 68.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.998 -176.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.65 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 26.0 p30 -176.23 171.15 1.1 Allowed Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.154 -175.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.577 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 74.4 Cg_exo -50.76 -43.77 44.59 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.359 2.039 . . . . 0.0 112.247 177.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.3 t -54.62 -43.38 72.18 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.203 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -66.18 -46.08 78.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.006 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -66.41 -47.19 74.06 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.431 0.159 . . . . 0.0 111.431 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.6 p -63.34 -50.0 71.72 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.016 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.15 -43.92 85.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.944 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.589 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 9.5 tp60 -64.17 -41.15 97.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.805 -177.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.659 ' NE2' HD11 ' A' ' 42' ' ' ILE . 2.6 mp0 -72.93 -37.42 67.18 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.888 -176.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.48 -26.88 62.88 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.706 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.629 HE22 ' HG2' ' A' ' 8' ' ' LYS . 18.5 mt-30 -87.55 -31.6 19.82 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.6 m -117.14 -75.93 0.58 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -168.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.526 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 2.7 t70 -130.53 87.64 49.46 Favored Pre-proline 0 N--CA 1.463 0.206 0 CA-C-O 120.781 0.324 . . . . 0.0 111.073 -173.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -62.95 -13.32 34.27 Favored 'Trans proline' 0 N--CA 1.473 0.289 0 C-N-CA 123.578 2.852 . . . . 0.0 113.499 -176.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -84.56 -21.33 30.48 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -167.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.805 ' HB ' ' HB3' ' A' ' 20' ' ' SER . 3.0 pt -77.53 151.18 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.924 -177.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.3 p -110.75 168.2 9.65 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.114 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.4 mt -70.53 118.47 15.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 173.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.457 ' HB2' ' HA ' ' A' ' 20' ' ' SER . . . -75.38 -43.91 47.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.502 -176.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 26.8 p80 -167.79 155.94 9.0 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.668 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 22.7 ttt -77.04 145.14 38.14 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 174.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.33 167.45 16.67 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.26 -0.972 . . . . 0.0 112.042 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.533 ' HA ' ' OG1' ' A' ' 24' ' ' THR . 24.6 mt-10 -82.9 124.36 30.27 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.135 0.493 . . . . 0.0 111.524 -175.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.47 ' H ' ' CB ' ' A' ' 24' ' ' THR . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.124 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.844 173.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.465 ' HD3' ' HA ' ' A' ' 8' ' ' LYS . 55.4 mmtt . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.86 119.22 20.33 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.388 0.613 . . . . 0.0 112.485 -165.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.51 ' SG ' ' HG3' ' A' ' 12' ' ' ARG . 43.6 t -138.32 146.78 42.81 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 171.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.47 62.49 0.75 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.685 0.755 . . . . 0.0 111.568 -177.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.51 ' HG3' ' SG ' ' A' ' 10' ' ' CYS . 6.2 mtm180 -95.42 -3.47 46.9 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 174.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 179.05 156.26 0.49 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.599 -163.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -128.86 91.93 3.31 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.034 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.739 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 60.3 m-85 -122.73 101.2 39.95 Favored Pre-proline 0 CA--C 1.503 -0.864 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 165.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -80.37 140.0 13.36 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 120.933 1.089 . . . . 0.0 111.695 -172.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.1 m -143.82 -175.49 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.373 0.606 . . . . 0.0 110.596 -177.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.3 t -128.59 134.48 48.6 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.694 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.538 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -82.26 148.23 26.55 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 175.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.757 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 32.3 t -59.16 -13.74 8.26 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -170.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -91.06 6.56 44.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.102 0.477 . . . . 0.0 110.599 175.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.22 28.74 16.56 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.507 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.536 HG13 ' CE2' ' A' ' 25' ' ' TYR . 7.1 p -105.37 144.08 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.088 0.47 . . . . 0.0 111.972 -173.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.505 ' CG2' ' HB2' ' A' ' 49' ' ' GLU . 1.3 m -82.39 122.39 27.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.012 -176.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.538 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 31.0 m-85 -114.59 132.81 56.22 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 121.497 0.665 . . . . 0.0 111.633 176.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.0 m -70.81 -28.73 64.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.862 -176.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.739 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 28.4 p30 -172.5 166.83 3.32 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.464 -175.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.494 ' HD3' ' HB2' ' A' ' 15' ' ' TYR . 75.0 Cg_exo -50.77 -44.11 42.82 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.336 2.024 . . . . 0.0 112.619 178.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 14.4 t -54.91 -45.91 74.79 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.159 0.504 . . . . 0.0 111.493 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.411 ' OD1' ' HD1' ' A' ' 25' ' ' TYR . 1.5 t-20 -59.26 -45.34 91.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.536 177.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -66.33 -48.92 68.72 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.802 178.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.2 p -64.65 -49.18 72.02 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -174.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.453 ' HA ' ' HG2' ' A' ' 36' ' ' GLU . . . -66.42 -44.74 82.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.728 0.299 . . . . 0.0 111.151 -177.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.455 ' OE1' ' HE1' ' A' ' 25' ' ' TYR . 36.0 tt0 -67.64 -33.36 74.81 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.54 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.768 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -72.96 -43.33 62.42 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.114 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.453 ' HG2' ' HA ' ' A' ' 33' ' ' ALA . 14.1 pt-20 -67.41 -29.46 68.96 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.394 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.423 HE21 ' HB2' ' A' ' 37' ' ' GLN . 16.5 mt-30 -84.31 -34.66 23.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.84 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 91.7 m -127.5 -66.46 0.88 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -164.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -120.56 90.17 45.42 Favored Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.271 -176.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -72.6 -11.77 26.43 Favored 'Trans proline' 0 CA--C 1.529 0.251 0 C-N-CA 123.287 2.658 . . . . 0.0 112.407 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -90.23 -22.53 21.6 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -167.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.768 HD11 ' NE2' ' A' ' 35' ' ' GLN . 17.5 pt -80.68 162.76 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.27 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.6 ' H ' ' HB2' ' A' ' 20' ' ' SER . 15.4 p -123.8 167.73 13.67 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.692 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.3 mt -67.93 118.77 12.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 173.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.42 -49.9 11.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.659 -176.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -160.36 161.94 33.28 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 79.0 mtp -84.57 150.24 25.35 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.76 150.32 26.7 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -170.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.505 ' HB2' ' CG2' ' A' ' 24' ' ' THR . 0.3 OUTLIER -61.93 138.52 58.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.211 0.529 . . . . 0.0 110.581 -176.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.43 ' N ' HG23 ' A' ' 24' ' ' THR . 0.7 OUTLIER . . . . . 0 C--O 1.244 0.803 0 CA-C-O 118.661 -0.685 . . . . 0.0 110.481 -178.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.678 ' HB2' ' OE1' ' A' ' 34' ' ' GLN . 2.3 tmtp? . . . . . 0 CA--C 1.515 -0.388 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.84 115.68 16.83 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.458 -172.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 44.2 t -139.02 147.12 41.69 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 171.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.9 m -157.91 63.48 0.46 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.348 0.594 . . . . 0.0 110.396 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -93.85 -18.9 21.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.249 174.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -173.03 156.9 3.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.034 -0.984 . . . . 0.0 108.357 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 28.2 t-105 -111.58 93.07 4.28 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.964 178.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.731 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 14.5 m-85 -121.56 100.08 44.58 Favored Pre-proline 0 CA--C 1.504 -0.802 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 163.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -82.61 143.27 11.98 Favored 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 121.125 1.216 . . . . 0.0 112.749 -169.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.6 m -133.47 169.06 22.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 33.6 t -121.52 122.61 40.09 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.134 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.89 144.19 28.53 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 176.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.498 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 59.1 m -57.26 -12.07 2.14 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -172.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -78.85 -2.42 39.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.615 0.721 . . . . 0.0 109.773 174.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.68 28.73 45.96 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -175.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.453 HG13 ' CE2' ' A' ' 25' ' ' TYR . 2.7 p -104.59 129.19 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 121.088 0.47 . . . . 0.0 110.922 -175.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.595 ' OG1' ' HB2' ' A' ' 50' ' ' CYS . 26.8 m -82.24 116.52 21.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.051 -169.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.543 ' HE1' ' HG2' ' A' ' 34' ' ' GLN . 33.9 m-85 -104.52 131.21 52.18 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.476 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.1 t -68.28 -27.08 66.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.975 -173.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.731 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 21.2 p30 -174.98 172.87 1.09 Allowed Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.211 -174.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.574 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 72.6 Cg_exo -52.24 -46.55 32.06 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.369 2.046 . . . . 0.0 113.465 178.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.2 p -61.95 -31.37 71.69 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.017 0.437 . . . . 0.0 111.327 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.402 ' C ' HD22 ' A' ' 30' ' ' ASN . 0.3 OUTLIER -65.82 -47.56 74.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.852 175.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -66.62 -47.51 72.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.816 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.0 m -63.18 -50.19 71.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.851 -175.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.471 ' HA ' ' HG2' ' A' ' 36' ' ' GLU . . . -68.32 -43.06 78.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.164 0.506 . . . . 0.0 111.239 -177.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.678 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 44.0 tp60 -64.24 -35.49 81.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.022 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.815 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -77.98 -43.96 28.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.638 -178.311 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.477 ' HG3' ' HG3' ' A' ' 37' ' ' GLN . 11.4 pt-20 -66.11 -30.85 71.43 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.281 -177.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.477 ' HG3' ' HG3' ' A' ' 36' ' ' GLU . 16.4 mt-30 -93.74 -35.47 12.77 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.997 -178.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.3 m -109.35 -75.34 0.63 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.825 -169.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.414 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 12.4 t0 -124.39 91.23 49.81 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.843 0.354 . . . . 0.0 110.654 -176.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.45 -13.25 27.68 Favored 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 123.123 2.549 . . . . 0.0 112.868 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -82.62 -21.74 34.99 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -166.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.815 HD11 ' NE2' ' A' ' 35' ' ' GLN . 10.9 pt -78.34 164.41 3.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.04 -177.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.09 169.45 9.09 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.985 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.5 mt -72.19 117.47 15.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 167.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.447 ' HB2' ' HA ' ' A' ' 20' ' ' SER . . . -77.05 -42.48 38.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 -175.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -168.5 158.71 9.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.422 176.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.0 tpt -72.66 139.77 47.52 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 175.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.26 153.67 26.19 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.458 -175.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.563 ' HB2' HG23 ' A' ' 24' ' ' THR . 6.9 pt-20 -67.44 149.34 50.36 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.665 0.269 . . . . 0.0 111.421 -177.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.595 ' HB2' ' OG1' ' A' ' 24' ' ' THR . 60.3 m . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.873 -0.584 . . . . 0.0 111.243 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.7 tptp . . . . . 0 N--CA 1.449 -0.503 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.75 120.22 21.61 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.439 0.638 . . . . 0.0 112.362 -167.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.47 ' SG ' ' N ' ' A' ' 30' ' ' ASN . 16.9 p -136.14 148.45 48.22 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 166.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.1 m -148.81 83.89 1.46 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.344 0.592 . . . . 0.0 111.385 -172.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.654 HH21 ' HB2' ' A' ' 28' ' ' PRO . 27.5 ptt180 -115.57 -10.25 11.9 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.262 176.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 177.51 159.04 0.41 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -174.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -114.0 93.69 4.48 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.802 176.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.662 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 50.2 m-85 -119.53 99.93 49.66 Favored Pre-proline 0 CA--C 1.502 -0.887 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 165.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.74 138.58 10.66 Favored 'Trans proline' 0 N--CA 1.438 -1.792 0 C-N-CA 120.69 0.927 . . . . 0.0 112.146 -171.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.3 m -140.99 168.87 15.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 45.1 t -119.68 126.95 52.35 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.696 -178.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.619 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -77.16 145.97 31.43 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 175.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.44 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 28.2 t -57.84 -11.8 2.6 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -172.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -78.75 -8.93 59.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.357 0.598 . . . . 0.0 110.31 174.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.73 28.26 11.48 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.666 -177.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.559 HG13 ' CE2' ' A' ' 25' ' ' TYR . 2.1 p -106.21 141.79 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -174.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.1 m -83.45 122.53 28.64 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.482 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.619 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 49.6 m-85 -111.27 136.82 49.82 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.429 0.633 . . . . 0.0 112.195 177.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.7 m -70.62 -38.68 73.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.31 -1.314 . . . . 0.0 112.401 -174.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.662 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 6.3 p30 -173.35 175.45 0.97 Allowed Pre-proline 0 C--N 1.329 -0.326 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.654 ' HB2' HH21 ' A' ' 12' ' ' ARG . 92.6 Cg_exo -46.01 -42.01 20.79 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 122.911 2.407 . . . . 0.0 114.944 -176.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.5 p -63.79 -33.39 75.57 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.626 0.648 . . . . 0.0 111.083 -177.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.47 ' N ' ' SG ' ' A' ' 10' ' ' CYS . 1.8 t-20 -67.56 -47.1 70.78 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.421 -176.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.512 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 62.4 t80 -66.49 -46.94 74.63 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.698 175.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.5 t -60.86 -50.89 71.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.424 -175.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.437 ' HA ' ' HG2' ' A' ' 36' ' ' GLU . . . -68.8 -47.39 66.22 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.484 -175.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.548 ' O ' ' HB2' ' A' ' 38' ' ' CYS . 31.9 tt0 -65.63 -31.35 72.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.367 0.603 . . . . 0.0 110.203 -176.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.827 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -78.15 -44.62 25.47 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.595 -178.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.437 ' HG2' ' HA ' ' A' ' 33' ' ' ALA . 10.7 pt-20 -65.25 -36.67 84.86 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.293 -176.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.637 ' HG3' ' SG ' ' A' ' 38' ' ' CYS . 12.8 pt20 -98.21 -34.14 10.84 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.994 -176.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.637 ' SG ' ' HG3' ' A' ' 37' ' ' GLN . 62.2 m -108.43 -67.58 0.96 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -170.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -123.66 86.59 52.76 Favored Pre-proline 0 N--CA 1.465 0.31 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.043 -176.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -73.61 -11.95 24.42 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 123.076 2.518 . . . . 0.0 113.115 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -86.02 -12.39 50.4 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -167.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.827 HD11 ' NE2' ' A' ' 35' ' ' GLN . 11.6 pt -93.97 159.17 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.05 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.5 p -121.35 168.0 12.14 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.381 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.9 mt -69.1 119.98 15.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.09 -50.94 7.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.859 -177.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 27.6 p80 -162.08 159.12 25.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.157 177.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 80.7 mtp -76.94 148.79 36.15 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 175.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.1 150.96 22.64 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -175.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.451 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 1.2 pm0 -71.06 148.99 46.97 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.961 0.41 . . . . 0.0 111.023 -178.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.73 -178.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 8' ' ' LYS . 23.5 mmtt . . . . . 0 N--CA 1.451 -0.415 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.33 119.6 17.79 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.581 0.705 . . . . 0.0 112.009 -169.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 44.8 t -137.56 146.2 43.78 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 174.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 m -156.38 53.71 0.55 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.284 0.564 . . . . 0.0 111.414 -174.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 23.7 ptt85 -100.84 -0.04 37.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.461 0.648 . . . . 0.0 110.037 173.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -172.56 155.15 3.29 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -175.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -129.3 93.32 3.54 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.447 177.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.65 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 50.7 m-85 -122.72 102.35 38.65 Favored Pre-proline 0 CA--C 1.5 -0.973 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 165.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -81.26 137.84 10.83 Favored 'Trans proline' 0 N--CA 1.439 -1.719 0 C-N-CA 120.732 0.955 . . . . 0.0 112.283 -172.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.0 m -140.8 172.28 11.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.329 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 47.7 t -121.25 132.7 54.97 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.59 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.591 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -84.48 149.74 25.04 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 174.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.492 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 8.2 t -59.28 -12.46 5.59 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -171.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.481 ' HB2' HG21 ' A' ' 42' ' ' ILE . 23.3 t70 -77.08 -7.26 55.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.58 0.705 . . . . 0.0 109.599 174.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.39 25.13 24.53 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.279 -177.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.565 HG13 ' CE2' ' A' ' 25' ' ' TYR . 3.5 p -105.51 140.99 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 121.13 0.491 . . . . 0.0 111.557 -172.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.0 m -82.78 121.66 27.19 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.183 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.591 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 51.6 m-85 -105.65 132.93 51.19 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.995 177.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.4 m -70.46 -26.42 63.63 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.765 -1.107 . . . . 0.0 112.181 -174.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.687 ' HB2' ' HD2' ' A' ' 28' ' ' PRO . 30.3 p30 -173.93 170.4 1.78 Allowed Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.687 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 9.3 Cg_endo -52.63 -37.28 74.4 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.569 2.179 . . . . 0.0 111.866 175.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.483 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 12.8 t -54.42 -51.55 64.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.375 175.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.424 ' CG ' ' HD1' ' A' ' 25' ' ' TYR . 1.8 t-20 -63.93 -44.8 91.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.13 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.501 ' HD1' ' CD2' ' A' ' 25' ' ' TYR . 64.8 t80 -63.21 -50.06 71.77 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 120.895 0.378 . . . . 0.0 110.466 -178.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.453 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 34.8 t -64.88 -52.2 57.86 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.141 -176.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.54 -40.88 89.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.881 0.372 . . . . 0.0 111.502 -173.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.401 ' OE1' ' HG2' ' A' ' 8' ' ' LYS . 49.4 tp60 -62.69 -42.04 99.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.393 0.616 . . . . 0.0 110.485 -178.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.588 ' NE2' HD11 ' A' ' 42' ' ' ILE . 43.5 mt-30 -78.96 -41.3 29.58 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -176.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 32' ' ' SER . 12.6 pt-20 -69.14 -25.6 64.46 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.827 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -95.58 -27.76 15.18 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 78.8 m -137.77 -50.8 0.61 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -172.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.528 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 57.9 m-20 -119.92 68.81 12.8 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 118.229 0.468 . . . . 0.0 111.492 -170.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.55 -13.78 35.74 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.526 2.151 . . . . 0.0 113.73 -170.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -94.38 10.04 35.89 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -166.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.588 HD11 ' NE2' ' A' ' 35' ' ' GLN . 7.7 pt -109.59 156.6 10.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 118.981 -1.088 . . . . 0.0 111.47 175.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.0 p -118.53 168.58 10.54 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.562 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.7 mt -64.8 119.45 9.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.492 ' HB2' ' HA ' ' A' ' 20' ' ' SER . . . -84.31 -44.98 13.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.953 -177.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -168.37 156.89 8.67 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.736 175.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 95.8 mmm -74.62 144.72 43.77 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.18 148.44 24.07 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 110.614 -0.995 . . . . 0.0 110.614 -174.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.434 ' H ' ' HG3' ' A' ' 49' ' ' GLU . 0.4 OUTLIER -71.85 149.27 45.38 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.003 0.43 . . . . 0.0 111.037 -176.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.011 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.584 -171.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 120.379 0.133 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 70.57 -66.85 0.27 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.705 0.802 . . . . 0.0 111.7 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -119.48 113.19 20.37 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.448 0.642 . . . . 0.0 110.298 -177.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -153.64 145.04 23.12 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.636 -1.166 . . . . 0.0 108.765 174.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.4 t -128.24 132.04 68.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 120.984 0.421 . . . . 0.0 111.55 -173.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.14 -136.48 9.61 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 173.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.0 ptt180 -126.2 140.45 52.54 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 173.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.628 ' HB2' ' OE1' ' A' ' 34' ' ' GLN . 19.5 tptm -97.86 123.76 41.97 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 175.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.59 120.59 20.36 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.732 0.777 . . . . 0.0 112.218 -166.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 51.0 t -136.57 145.68 45.24 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 169.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.9 m -147.77 63.13 1.13 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.499 0.666 . . . . 0.0 110.769 -172.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.444 ' HG3' ' HB3' ' A' ' 13' ' ' GLU . 7.6 ptt180 -88.73 -18.72 27.24 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.147 176.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.444 ' HB3' ' HG3' ' A' ' 12' ' ' ARG . 37.8 tt0 -179.76 161.45 0.99 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.739 -1.119 . . . . 0.0 107.994 -163.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -121.11 92.03 3.66 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.896 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.578 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 16.5 m-85 -121.06 99.22 46.76 Favored Pre-proline 0 CA--C 1.501 -0.925 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 164.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -83.23 138.71 8.98 Favored 'Trans proline' 0 N--CA 1.437 -1.83 0 C-N-CA 121.17 1.247 . . . . 0.0 112.614 -171.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -140.23 164.52 22.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.126 177.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.5 t -116.35 131.3 56.98 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.527 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -85.74 156.04 29.76 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.416 -0.897 . . . . 0.0 111.113 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.803 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 68.5 m -57.71 -11.68 2.36 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -175.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -77.23 -6.8 54.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.664 0.745 . . . . 0.0 109.914 173.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.03 28.29 37.95 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 -174.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.473 HG13 ' CE2' ' A' ' 25' ' ' TYR . 3.1 p -105.61 140.94 22.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 120.945 0.402 . . . . 0.0 111.975 -172.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.7 m -84.29 120.98 26.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.327 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.527 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 59.2 m-85 -107.51 128.47 54.54 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.845 175.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.6 m -66.77 -25.66 66.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.315 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.587 ' OD1' ' HB3' ' A' ' 29' ' ' CYS . 7.4 p30 -171.54 170.36 2.7 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -177.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.53 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 79.3 Cg_exo -50.19 -42.13 47.77 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.46 2.107 . . . . 0.0 112.454 176.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.587 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 35.7 t -57.77 -40.75 80.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.883 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.4 ' ND2' ' HD1' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -62.51 -45.03 94.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.049 177.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -64.32 -48.42 75.66 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.013 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.4 t -63.99 -52.21 60.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.39 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.43 -45.33 84.25 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 120.961 0.41 . . . . 0.0 111.508 -173.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.628 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 7.7 tp60 -64.12 -41.23 97.31 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.283 -177.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.664 ' NE2' HD11 ' A' ' 42' ' ' ILE . 59.7 mt-30 -77.76 -36.6 50.42 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -176.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -64.52 -26.13 68.29 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.276 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.587 HE22 ' HG2' ' A' ' 8' ' ' LYS . 8.2 mt-30 -86.84 -36.86 18.24 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.75 0.31 . . . . 0.0 111.661 173.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.6 m -112.26 -79.15 0.58 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -169.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.439 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 8.8 t70 -126.43 91.44 47.61 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.515 -172.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -68.96 -12.12 33.58 Favored 'Trans proline' 0 C--N 1.332 -0.301 0 C-N-CA 122.858 2.372 . . . . 0.0 112.142 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -88.67 -12.94 40.99 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -166.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.803 ' HB ' ' HB2' ' A' ' 20' ' ' SER . 10.5 pt -80.35 162.29 3.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.581 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.7 p -121.54 169.2 10.9 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.148 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.1 mt -69.98 117.83 13.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.7 -48.37 26.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.287 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -160.75 154.69 22.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.839 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -73.56 140.34 46.22 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.82 141.21 10.42 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.391 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -56.92 144.19 34.66 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 122.447 0.299 . . . . 0.0 111.143 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.915 -0.564 . . . . 0.0 111.203 -176.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 111.386 0.143 . . . . 0.0 111.386 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 38' ' ' CYS . 2.2 mp0 66.63 -72.98 0.08 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.274 0.63 . . . . 0.0 111.211 -177.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -125.68 119.45 28.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.828 -178.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.418 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . 31.7 p -150.97 116.01 5.29 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.164 0.507 . . . . 0.0 109.918 173.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -112.13 132.28 61.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.997 177.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 122.03 -123.0 5.3 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.068 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -130.51 130.9 44.76 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.359 0.599 . . . . 0.0 111.399 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.418 ' HD3' ' HB2' ' A' ' 4' ' ' CYS . 2.0 mmmp? -100.48 123.48 44.75 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 168.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.08 117.95 17.49 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.795 0.807 . . . . 0.0 112.706 -165.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 36.5 t -138.55 145.58 40.84 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 168.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.8 m -157.83 66.29 0.48 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.814 0.816 . . . . 0.0 110.602 -177.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -101.26 8.89 42.29 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 173.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 178.03 154.58 0.34 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 113.984 -1.462 . . . . 0.0 107.896 -171.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -128.32 92.52 3.45 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.494 174.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.681 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 30.9 m-85 -122.54 101.29 40.43 Favored Pre-proline 0 N--CA 1.441 -0.917 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 164.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -81.78 138.68 10.67 Favored 'Trans proline' 0 N--CA 1.439 -1.703 0 C-N-CA 120.92 1.08 . . . . 0.0 111.586 -172.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.7 m -140.32 169.69 15.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.131 0.491 . . . . 0.0 109.997 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.6 t -117.03 129.61 56.13 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.318 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.06 144.69 26.35 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 174.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.465 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 50.8 p -61.29 -11.42 9.63 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -171.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -73.88 -10.18 59.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.501 0.667 . . . . 0.0 109.662 171.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.85 25.64 14.53 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.744 -178.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.531 HG13 ' CE2' ' A' ' 25' ' ' TYR . 3.1 p -106.73 142.0 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.438 -175.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.554 HG23 ' HA ' ' A' ' 49' ' ' GLU . 85.8 m -84.21 119.47 25.06 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 120.959 0.409 . . . . 0.0 110.643 -178.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.531 ' CE2' HG13 ' A' ' 23' ' ' VAL . 37.0 m-85 -106.87 132.91 52.29 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.525 0.678 . . . . 0.0 111.08 177.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.3 t -64.88 -31.37 72.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.186 -172.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.681 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 26.8 p30 -175.5 170.7 1.3 Allowed Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.554 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 82.0 Cg_exo -50.2 -40.92 51.36 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.316 2.011 . . . . 0.0 112.508 176.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 35.2 t -54.46 -48.64 71.51 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.094 0.473 . . . . 0.0 110.569 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -66.62 -46.37 76.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.486 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.511 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 38.3 t80 -63.73 -48.09 78.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.521 0.201 . . . . 0.0 110.947 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.5 p -64.1 -50.65 67.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.013 -175.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.501 ' HA ' ' HG2' ' A' ' 36' ' ' GLU . . . -65.3 -44.44 87.92 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.071 0.462 . . . . 0.0 110.937 -176.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -63.52 -37.38 87.07 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.446 0.641 . . . . 0.0 110.395 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.588 ' HG3' ' O ' ' A' ' 39' ' ' ASP . 2.1 mp0 -77.61 -37.59 49.95 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.873 -177.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.501 ' HG2' ' HA ' ' A' ' 33' ' ' ALA . 12.8 pt-20 -73.62 -27.76 61.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.842 0.353 . . . . 0.0 110.762 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.482 HE21 ' HB2' ' A' ' 37' ' ' GLN . 11.0 mt-30 -91.36 -34.09 15.02 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.774 -178.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 2' ' ' GLU . 64.2 m -119.96 -74.88 0.59 Allowed 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.068 -0.653 . . . . 0.0 112.761 -169.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.588 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 4.8 t0 -115.33 97.96 49.51 Favored Pre-proline 0 C--N 1.326 -0.444 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.113 -175.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 39' ' ' ASP . 41.8 Cg_endo -71.14 -13.23 31.06 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 123.2 2.6 . . . . 0.0 113.698 -177.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -85.57 -21.85 28.34 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -163.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.577 HD11 ' NE2' ' A' ' 35' ' ' GLN . 6.5 pt -87.99 154.1 3.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 119.294 -0.963 . . . . 0.0 111.126 -175.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.5 p -127.88 169.68 13.66 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.515 -1.221 . . . . 0.0 109.036 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.483 HD12 ' H ' ' A' ' 44' ' ' ILE . 4.5 mp -68.87 119.41 14.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.53 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.465 ' HB2' ' HA ' ' A' ' 20' ' ' SER . . . -81.18 -46.15 15.3 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.428 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -168.02 157.13 9.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.561 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 87.7 mtp -79.99 130.56 35.37 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.63 162.2 11.56 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 -173.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.554 ' HA ' HG23 ' A' ' 24' ' ' THR . 0.5 OUTLIER -73.35 147.93 43.92 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.067 0.46 . . . . 0.0 111.095 -178.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.832 -0.604 . . . . 0.0 111.033 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 120.941 0.4 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -117.14 -49.61 2.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.427 178.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -125.87 115.57 20.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.695 174.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.1 p -149.67 117.96 6.43 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.158 0.504 . . . . 0.0 110.512 177.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.8 p -103.85 119.82 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 121.34 0.591 . . . . 0.0 110.161 176.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 140.58 -125.31 2.83 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -131.1 139.64 49.89 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.128 0.49 . . . . 0.0 110.318 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.537 ' HB2' ' OE1' ' A' ' 34' ' ' GLN . 6.6 tmtm? -98.86 122.4 42.05 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 174.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.44 117.63 16.48 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.896 0.855 . . . . 0.0 112.184 -166.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.542 ' SG ' ' HG3' ' A' ' 12' ' ' ARG . 44.5 t -138.51 146.38 41.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.103 -1.408 . . . . 0.0 107.494 172.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.2 m -152.54 64.22 0.81 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.79 0.805 . . . . 0.0 110.144 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.542 ' HG3' ' SG ' ' A' ' 10' ' ' CYS . 21.2 mtm180 -104.27 0.78 29.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.291 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 177.02 153.16 0.21 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 113.837 -1.529 . . . . 0.0 107.129 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 65.2 t-105 -117.45 92.21 3.78 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.847 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.666 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 37.3 m-85 -122.87 101.9 38.71 Favored Pre-proline 0 N--CA 1.434 -1.237 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 164.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.16 137.95 12.43 Favored 'Trans proline' 0 N--CA 1.441 -1.606 0 C-N-CA 120.546 0.83 . . . . 0.0 111.566 -172.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.0 m -138.01 173.86 11.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.044 0.45 . . . . 0.0 110.101 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.1 t -122.73 132.5 54.27 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.634 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.11 146.5 25.26 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 173.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.627 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 10.0 t -57.95 -13.92 5.4 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -172.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.466 ' HB2' HG21 ' A' ' 42' ' ' ILE . 31.4 t70 -74.94 -8.41 56.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.51 0.671 . . . . 0.0 109.924 174.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.47 25.38 21.24 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.287 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.5 p -105.73 140.88 22.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.921 0.391 . . . . 0.0 111.285 -173.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.431 HG23 ' HA ' ' A' ' 49' ' ' GLU . 36.8 m -85.15 123.77 31.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.19 0.519 . . . . 0.0 111.239 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -111.51 137.47 49.3 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.933 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 65.5 m -68.4 -26.09 65.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.229 -175.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.666 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 30.8 p30 -172.67 171.96 1.8 Allowed Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.551 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 75.5 Cg_exo -52.34 -39.87 71.92 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.379 2.053 . . . . 0.0 112.597 176.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.431 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 21.5 t -55.14 -44.91 75.52 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.959 0.409 . . . . 0.0 110.558 176.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.435 ' C ' HD22 ' A' ' 30' ' ' ASN . 0.2 OUTLIER -61.68 -46.45 89.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.367 179.207 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -65.96 -47.9 73.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.928 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.7 t -63.58 -49.26 74.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.571 -174.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.469 ' HA ' ' HG2' ' A' ' 36' ' ' GLU . . . -64.78 -44.92 88.44 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.706 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.537 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 7.5 tp60 -62.65 -40.79 98.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.543 0.687 . . . . 0.0 110.398 -177.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.565 ' HG3' ' O ' ' A' ' 39' ' ' ASP . 2.2 mp0 -76.08 -36.29 59.01 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.98 -177.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.469 ' HG2' ' HA ' ' A' ' 33' ' ' ALA . 11.1 pt-20 -67.08 -42.92 83.83 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.364 -178.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -111.74 5.85 19.42 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -175.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 34' ' ' GLN . 66.5 m -135.0 -63.25 0.7 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.158 0.89 . . . . 0.0 113.0 175.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.565 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 8.6 t0 -116.94 92.57 39.31 Favored Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 118.808 0.731 . . . . 0.0 110.7 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -72.08 -12.95 28.53 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.43 2.753 . . . . 0.0 113.374 -177.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -92.62 -21.86 19.8 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -163.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.627 ' HB ' ' HB3' ' A' ' 20' ' ' SER . 19.0 pt -90.72 160.04 2.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.835 0.826 . . . . 0.0 112.363 -174.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.5 p -123.22 169.37 11.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.323 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.5 mt -65.17 119.29 9.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 175.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.53 -50.69 10.35 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.523 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -164.76 161.43 20.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 44.7 tpp -75.92 139.25 41.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.025 173.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 107.33 159.73 21.17 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.53 -176.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.437 ' CD ' ' H ' ' A' ' 49' ' ' GLU . 0.8 OUTLIER -73.69 149.12 42.11 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.916 0.389 . . . . 0.0 111.04 -178.64 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.331 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -55.29 -27.29 45.74 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.779 -176.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -125.86 111.39 14.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.345 0.593 . . . . 0.0 111.15 174.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -153.5 115.52 4.32 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.906 166.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.7 p -121.04 127.76 75.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 121.259 0.552 . . . . 0.0 110.926 -176.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 138.18 -140.21 10.97 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -123.95 132.9 53.79 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.051 0.453 . . . . 0.0 110.542 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -100.6 137.9 38.39 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 171.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.13 118.67 30.62 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.961 -174.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 30' ' ' ASN . 21.2 p -137.34 148.68 46.48 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 168.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.7 m -148.89 89.0 1.64 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.408 0.623 . . . . 0.0 111.381 -175.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -109.67 -19.8 13.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.527 173.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -177.61 163.92 1.97 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -169.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -118.28 92.99 3.97 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.156 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.669 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 15.3 m-85 -122.67 101.09 40.27 Favored Pre-proline 0 N--CA 1.441 -0.911 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 164.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.59 140.04 11.62 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 121.345 1.363 . . . . 0.0 112.487 -172.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 25' ' ' TYR . 27.2 m -143.29 170.91 9.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.98 0.419 . . . . 0.0 109.944 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 18.5 t -123.63 139.41 54.03 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.5 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -94.5 156.96 22.27 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.285 177.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.856 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 64.1 m -57.22 -12.67 2.45 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -174.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -76.71 -7.92 56.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.841 0.829 . . . . 0.0 109.712 173.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.04 28.68 36.55 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -173.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.516 HG13 ' CE2' ' A' ' 25' ' ' TYR . 2.7 p -101.48 140.8 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 121.066 0.46 . . . . 0.0 111.427 -172.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.526 HG23 ' N ' ' A' ' 50' ' ' CYS . 1.3 m -82.49 117.27 22.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.252 -177.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.516 ' CE2' HG13 ' A' ' 23' ' ' VAL . 52.3 m-85 -106.56 130.42 54.33 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-O 121.269 0.556 . . . . 0.0 110.744 176.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.4 t -70.29 -26.86 64.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.746 -174.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.672 ' HB2' ' HD2' ' A' ' 28' ' ' PRO . 26.1 p-10 178.25 173.9 0.38 Allowed Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -173.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.672 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 79.6 Cg_exo -47.8 -49.48 13.56 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 123.219 2.613 . . . . 0.0 114.901 -176.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.455 ' SG ' ' ND2' ' A' ' 27' ' ' ASN . 7.8 p -59.27 -35.77 74.34 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.044 0.45 . . . . 0.0 111.058 -177.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.403 ' OD1' ' HA ' ' A' ' 25' ' ' TYR . 2.1 t-20 -64.84 -46.02 83.66 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.946 -178.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.42 ' HD2' ' CD2' ' A' ' 25' ' ' TYR . 65.0 t80 -65.4 -47.92 74.62 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.129 0.49 . . . . 0.0 109.726 178.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.8 t -64.03 -51.71 62.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.905 -175.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.465 ' O ' ' HG2' ' A' ' 36' ' ' GLU . . . -69.01 -44.09 73.46 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.088 0.47 . . . . 0.0 111.452 -175.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -62.47 -41.66 98.93 Favored 'General case' 0 C--O 1.215 -0.715 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.949 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.632 ' NE2' HD11 ' A' ' 42' ' ' ILE . 61.9 mt-30 -78.69 -35.91 44.33 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 33' ' ' ALA . 12.8 pt-20 -61.94 -27.94 69.18 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.797 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.63 ' HG3' ' SG ' ' A' ' 38' ' ' CYS . 20.6 pt20 -100.85 -38.06 8.41 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 119.488 -0.885 . . . . 0.0 112.793 174.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.63 ' SG ' ' HG3' ' A' ' 37' ' ' GLN . 17.7 m -96.12 -77.98 0.47 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.897 -169.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.463 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 5.8 t0 -124.13 89.76 51.46 Favored Pre-proline 0 C--N 1.331 -0.207 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.06 -175.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.32 -11.8 32.27 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 123.315 2.677 . . . . 0.0 112.836 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -79.66 -21.81 44.28 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -167.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.856 ' HB ' ' HB2' ' A' ' 20' ' ' SER . 9.0 pt -85.62 161.91 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.406 -175.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.96 169.5 12.04 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.258 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.4 mt -65.4 117.89 6.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.242 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.84 -44.24 50.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.005 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -166.96 151.58 7.23 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.38 176.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -73.54 139.4 45.61 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 108.67 145.14 11.24 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -171.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.459 ' HB2' ' CG2' ' A' ' 24' ' ' THR . 0.9 OUTLIER -73.97 145.64 44.48 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.996 0.398 . . . . 0.0 110.692 -175.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.526 ' N ' HG23 ' A' ' 24' ' ' THR . 1.3 m . . . . . 0 C--O 1.242 0.697 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.32 173.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -103.64 -36.89 7.74 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.149 0.499 . . . . 0.0 110.098 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -124.59 113.78 18.5 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.39 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 38' ' ' CYS . 0.5 OUTLIER -152.43 116.39 4.87 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.719 -179.653 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.9 t -107.35 124.02 62.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.04 0.447 . . . . 0.0 110.425 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 147.26 -138.7 7.4 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.5 ttp180 -129.11 133.66 47.74 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.037 0.446 . . . . 0.0 110.911 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.8 mmtt -98.88 130.49 45.28 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 172.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.55 115.42 16.29 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.49 -173.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 48.8 t -139.98 146.1 38.68 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 167.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -168.0 56.17 0.06 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.642 0.734 . . . . 0.0 110.641 -172.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -80.72 -23.81 39.23 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.265 175.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -163.31 157.66 20.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.612 -1.176 . . . . 0.0 107.923 -177.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 71.2 t-105 -112.42 94.43 4.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.403 0.62 . . . . 0.0 111.038 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.568 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 30.4 m-85 -120.33 100.02 47.78 Favored Pre-proline 0 N--CA 1.442 -0.852 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 165.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -81.36 138.37 10.99 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 120.996 1.131 . . . . 0.0 113.266 -168.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.23 174.15 6.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.504 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.0 t -126.7 138.61 53.42 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.447 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.83 153.14 21.79 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 175.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.547 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 16.2 m -56.81 -15.17 4.22 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -174.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -74.01 -7.82 53.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.691 0.758 . . . . 0.0 109.968 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.09 27.89 29.84 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -175.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.428 HG13 ' CE2' ' A' ' 25' ' ' TYR . 3.6 p -105.73 140.73 22.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.269 -0.466 . . . . 0.0 111.18 -172.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.422 HG23 ' HA ' ' A' ' 49' ' ' GLU . 42.0 m -85.05 122.19 28.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.98 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.428 ' CE2' HG13 ' A' ' 23' ' ' VAL . 29.7 m-85 -109.91 133.07 53.57 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.225 177.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.8 m -65.97 -34.6 78.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.586 -173.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.568 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 8.2 p30 -178.07 177.23 0.43 Allowed Pre-proline 0 C--O 1.237 0.403 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.528 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 95.7 Cg_exo -46.03 -43.21 20.48 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 122.821 2.347 . . . . 0.0 114.765 -177.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 29.1 p -60.96 -37.33 82.0 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.222 0.465 . . . . 0.0 110.695 -177.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -67.89 -46.27 72.09 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.541 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.51 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 62.7 t80 -65.95 -46.7 77.19 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 176.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 39.3 t -63.39 -50.88 68.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.515 -176.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.55 ' O ' ' HG2' ' A' ' 37' ' ' GLN . . . -68.07 -44.79 75.5 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 120.78 0.324 . . . . 0.0 111.018 -175.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.8 tp60 -65.85 -35.4 80.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.223 0.535 . . . . 0.0 110.246 -177.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.772 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -77.43 -36.7 52.85 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.365 -177.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.506 ' HG2' ' HA ' ' A' ' 33' ' ' ALA . 9.5 pt-20 -70.92 -28.05 64.23 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.105 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.629 ' HG3' ' SG ' ' A' ' 38' ' ' CYS . 9.7 pt20 -99.79 -35.16 9.88 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.069 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.629 ' SG ' ' HG3' ' A' ' 37' ' ' GLN . 25.0 m -104.49 -77.57 0.58 Allowed 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.805 -172.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 9.2 t70 -118.08 99.3 51.89 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.885 0.374 . . . . 0.0 111.136 -175.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.23 -13.95 25.68 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 123.111 2.541 . . . . 0.0 112.92 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -86.43 -21.75 26.93 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -164.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.772 HD11 ' NE2' ' A' ' 35' ' ' GLN . 23.5 pt -85.67 166.21 2.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.608 -177.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.8 p -132.12 170.56 14.8 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.317 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.3 mt -65.77 118.16 7.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 175.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.26 -43.55 27.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.52 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -164.38 157.69 17.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.545 177.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.77 138.48 36.28 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 175.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 110.69 151.89 12.77 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -173.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.422 ' HA ' HG23 ' A' ' 24' ' ' THR . 14.2 pt-20 -65.54 149.4 50.12 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.75 0.31 . . . . 0.0 111.269 -178.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.134 0 CA-C-O 119.225 -0.417 . . . . 0.0 110.464 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 120.77 0.319 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -127.67 -34.44 2.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.626 171.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -115.64 112.12 21.65 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 38' ' ' CYS . 0.8 OUTLIER -154.32 134.73 13.38 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.719 175.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.2 p -129.19 132.98 66.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.781 -177.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 132.0 -131.42 6.28 Favored Glycine 0 N--CA 1.439 -1.14 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.853 175.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -130.11 128.5 41.96 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.337 0.589 . . . . 0.0 110.973 -176.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -100.36 133.46 44.74 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.448 172.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.08 121.96 27.23 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.358 0.599 . . . . 0.0 112.286 -171.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 46.8 t -136.32 147.44 47.43 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 170.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.0 m -153.42 67.21 0.77 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.406 0.622 . . . . 0.0 111.805 -174.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.3 ptt85 -110.87 -3.05 15.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.236 0.541 . . . . 0.0 109.82 172.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 174.63 151.33 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.592 -1.186 . . . . 0.0 108.396 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -110.02 94.62 5.11 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.143 0.497 . . . . 0.0 110.366 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.756 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 31.2 m-85 -120.52 100.44 47.06 Favored Pre-proline 0 N--CA 1.441 -0.901 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 167.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.93 138.52 10.4 Favored 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 121.02 1.146 . . . . 0.0 111.744 -172.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.2 m -143.75 176.98 2.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.125 0.488 . . . . 0.0 110.292 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.2 t -124.7 130.25 52.06 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.319 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.67 147.71 29.81 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 174.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.908 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 32.7 t -57.85 -12.58 3.24 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -172.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -77.59 -7.95 57.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.702 0.763 . . . . 0.0 110.214 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.14 24.96 20.94 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -176.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.41 HG13 ' CE2' ' A' ' 25' ' ' TYR . 3.2 p -106.01 140.96 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 120.934 0.397 . . . . 0.0 111.269 -174.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.9 m -83.73 124.52 30.96 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.383 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.494 ' HE1' ' HG2' ' A' ' 34' ' ' GLN . 29.9 m-85 -113.05 135.85 53.34 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.421 177.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.1 m -69.24 -29.07 66.92 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.422 -173.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.756 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 28.6 p30 -170.17 168.8 4.13 Favored Pre-proline 0 C--O 1.236 0.353 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.518 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 72.3 Cg_exo -50.6 -38.19 54.51 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.515 2.143 . . . . 0.0 112.515 177.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.432 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 7.6 t -55.21 -50.9 68.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.551 176.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -62.14 -45.26 94.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.735 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.513 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 58.7 t80 -61.17 -49.13 78.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.305 0.098 . . . . 0.0 111.028 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.484 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 16.2 t -65.86 -51.0 62.55 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.485 0.18 . . . . 0.0 111.485 -177.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.66 -43.51 93.37 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.487 0.661 . . . . 0.0 110.995 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.494 ' HG2' ' HE1' ' A' ' 25' ' ' TYR . 9.5 tp60 -64.68 -36.92 85.85 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.166 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.725 ' HG3' ' O ' ' A' ' 39' ' ' ASP . 2.2 mp0 -72.81 -44.39 61.53 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.383 -176.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.492 ' HG3' ' NE2' ' A' ' 37' ' ' GLN . 9.3 pt-20 -63.68 -31.01 72.05 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.092 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.492 ' NE2' ' HG3' ' A' ' 36' ' ' GLU . 2.9 mp0 -87.32 -35.09 18.61 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 177.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 4' ' ' CYS . 18.7 m -108.59 -80.7 0.57 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -171.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.725 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 55.8 t0 -126.14 83.91 62.61 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 120.871 0.367 . . . . 0.0 110.662 -172.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -67.99 -12.64 35.89 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 123.446 2.764 . . . . 0.0 114.13 -170.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -99.54 11.71 38.43 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -169.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.908 ' HB ' ' HB3' ' A' ' 20' ' ' SER . 12.5 pt -97.31 151.36 4.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.371 174.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.428 ' H ' ' HB2' ' A' ' 20' ' ' SER . 0.3 OUTLIER -107.54 167.67 9.78 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.361 -179.526 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.2 mt -70.33 118.94 15.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 173.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.24 -51.07 16.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.473 -176.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -160.75 158.43 28.61 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.271 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.4 tpt -71.3 145.03 49.76 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.003 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.35 154.45 30.75 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.609 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -62.53 149.28 43.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.821 0.344 . . . . 0.0 110.699 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.86 -0.59 . . . . 0.0 110.842 -173.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -132.39 -35.75 1.15 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.979 176.279 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -116.78 114.23 23.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.057 0.456 . . . . 0.0 110.341 174.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.637 ' HB2' ' HE2' ' A' ' 8' ' ' LYS . 19.3 p -151.76 139.74 20.06 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 172.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.0 p -128.93 132.37 67.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.433 0.635 . . . . 0.0 111.325 -171.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 109.49 -117.99 5.03 Favored Glycine 0 N--CA 1.44 -1.079 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.589 ' HA ' ' OE1' ' A' ' 34' ' ' GLN . 24.7 ptt180 -131.39 134.16 45.99 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.032 0.444 . . . . 0.0 110.435 171.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.637 ' HE2' ' HB2' ' A' ' 4' ' ' CYS . 65.2 mmtt -99.52 123.2 43.57 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 171.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.69 120.44 21.08 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.872 0.844 . . . . 0.0 113.104 -162.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 43.4 t -128.55 147.2 50.68 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 168.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.9 m -150.21 61.98 0.97 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.554 0.693 . . . . 0.0 111.326 -175.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -91.52 -13.38 32.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.697 174.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -173.71 157.5 3.12 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -173.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 67.2 t-105 -119.07 92.99 3.93 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.038 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.732 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 14.6 m-85 -122.15 101.06 41.88 Favored Pre-proline 0 CA--C 1.501 -0.92 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 166.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -80.88 138.1 11.44 Favored 'Trans proline' 0 N--CA 1.443 -1.475 0 C-N-CA 120.697 0.931 . . . . 0.0 111.767 -172.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.4 m -142.77 -179.9 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.361 -177.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.4 t -127.98 134.57 49.28 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.583 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.48 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -82.69 147.58 25.36 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 174.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.655 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 10.6 t -57.88 -13.77 4.98 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -172.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.462 ' HB2' HG21 ' A' ' 42' ' ' ILE . 18.6 t70 -76.83 -8.53 57.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.531 0.681 . . . . 0.0 109.931 175.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.49 26.39 17.99 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.377 -177.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.613 HG13 ' CE2' ' A' ' 25' ' ' TYR . 2.5 p -106.57 141.93 20.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 120.698 0.285 . . . . 0.0 111.721 -174.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.7 m -83.63 126.86 33.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.23 -176.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.613 ' CE2' HG13 ' A' ' 23' ' ' VAL . 51.2 m-85 -117.07 137.99 51.9 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.408 0.623 . . . . 0.0 111.894 177.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.7 m -70.21 -28.37 65.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.121 -175.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.732 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 26.6 p30 -173.84 169.33 2.04 Favored Pre-proline 0 C--O 1.234 0.285 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.549 -177.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.545 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 78.3 Cg_exo -51.47 -42.13 56.76 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.473 2.115 . . . . 0.0 112.416 177.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 41.5 t -54.72 -45.36 74.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.093 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.466 ' C ' HD22 ' A' ' 30' ' ' ASN . 0.2 OUTLIER -62.43 -47.58 83.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.953 -179.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.561 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 55.3 t80 -66.57 -48.11 70.64 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.569 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.408 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 22.2 t -63.79 -50.63 68.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.052 -174.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.92 -45.43 74.37 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.169 0.509 . . . . 0.0 111.126 -175.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.589 ' OE1' ' HA ' ' A' ' 7' ' ' ARG . 22.0 tt0 -65.57 -31.9 73.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.172 0.511 . . . . 0.0 110.695 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.778 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -78.15 -46.97 19.18 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.367 -177.136 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.646 ' HG3' ' HG3' ' A' ' 37' ' ' GLN . 11.7 pt-20 -61.57 -30.59 70.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.875 0.369 . . . . 0.0 110.481 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.646 ' HG3' ' HG3' ' A' ' 36' ' ' GLU . 10.9 mt-30 -94.29 -34.81 12.7 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.593 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 59.8 m -120.13 -65.82 1.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -170.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.501 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 0.7 OUTLIER -116.19 74.66 5.7 Favored Pre-proline 0 N--CA 1.465 0.312 0 CA-C-O 120.729 0.299 . . . . 0.0 111.667 -173.005 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.593 ' HD3' ' O ' ' A' ' 38' ' ' CYS . 6.9 Cg_exo -72.62 -13.11 27.21 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 123.131 2.554 . . . . 0.0 112.698 -174.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -77.36 -20.99 53.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.346 -169.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.778 HD11 ' NE2' ' A' ' 35' ' ' GLN . 10.9 pt -95.32 153.13 3.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.597 -175.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.43 ' O ' ' HB2' ' A' ' 20' ' ' SER . 22.1 p -112.23 168.21 9.8 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.624 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.0 mt -65.93 118.71 9.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.97 -50.82 11.4 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.699 -176.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -166.0 163.27 18.35 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.2 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 86.5 mmm -74.89 146.59 41.74 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 173.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.52 146.37 18.41 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.658 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.41 149.19 50.78 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.718 0.294 . . . . 0.0 110.983 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.976 -0.535 . . . . 0.0 110.978 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.507 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 120.23 0.062 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 70.36 -68.37 0.21 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.388 0.675 . . . . 0.0 111.373 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -119.8 112.03 18.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.079 0.466 . . . . 0.0 111.007 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.9 p -153.85 124.72 7.25 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 169.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.8 t -101.6 126.15 55.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.239 -172.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 116.66 -118.12 4.07 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.17 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.488 ' HA ' ' HG2' ' A' ' 34' ' ' GLN . 22.5 ptt180 -131.87 134.26 45.53 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 174.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -100.72 122.6 43.63 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 168.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.24 128.86 35.77 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -162.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 36.7 t -119.01 147.72 43.78 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 170.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.7 m -153.35 79.59 1.17 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.19 0.519 . . . . 0.0 111.919 -175.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -115.33 -29.09 6.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.4 0.619 . . . . 0.0 109.783 170.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -148.11 158.88 44.32 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -118.17 93.79 4.26 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.15 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.746 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 67.3 m-85 -121.39 99.78 45.35 Favored Pre-proline 0 CA--C 1.504 -0.799 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 164.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -81.77 139.61 11.17 Favored 'Trans proline' 0 N--CA 1.442 -1.537 0 C-N-CA 121.132 1.221 . . . . 0.0 112.558 -171.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.5 m -138.71 172.28 13.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 176.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 29.6 t -116.38 130.61 56.86 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.859 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.656 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -83.65 142.09 20.75 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 172.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.566 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 4.5 t -60.04 -11.04 4.95 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -171.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.579 ' HB2' HG21 ' A' ' 42' ' ' ILE . 19.2 t70 -74.28 -8.21 55.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.487 0.66 . . . . 0.0 109.504 173.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.1 24.91 23.5 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.357 -177.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.572 HG13 ' CE2' ' A' ' 25' ' ' TYR . 2.3 p -105.35 138.52 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 121.061 0.458 . . . . 0.0 111.423 -175.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.52 HG23 ' N ' ' A' ' 50' ' ' CYS . 7.6 m -85.06 116.46 23.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.564 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.656 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 47.5 m-85 -101.37 133.0 46.65 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.337 0.589 . . . . 0.0 111.704 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.9 m -64.18 -30.25 71.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.299 -1.319 . . . . 0.0 112.384 -175.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.746 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 22.1 p30 -174.58 169.6 1.72 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.463 -175.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.657 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 9.2 Cg_endo -52.39 -38.76 74.14 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.599 2.2 . . . . 0.0 112.022 176.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 33.3 t -55.22 -45.01 75.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.451 176.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.49 ' O ' ' HB3' ' A' ' 34' ' ' GLN . 0.2 OUTLIER -66.31 -46.26 77.52 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.961 -178.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.434 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 61.3 t80 -65.87 -48.06 72.82 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.517 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.569 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 19.9 t -64.37 -52.09 60.06 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.415 -175.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.512 ' O ' ' HB2' ' A' ' 37' ' ' GLN . . . -68.02 -42.85 80.01 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.014 0.435 . . . . 0.0 111.27 -174.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.49 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 42.4 tp60 -63.92 -34.64 78.43 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.416 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.768 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -78.01 -50.22 12.54 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.316 -178.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 32' ' ' SER . 12.2 pt-20 -65.27 -26.51 68.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.732 0.301 . . . . 0.0 111.055 -177.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.512 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 2.4 mp0 -92.38 -33.84 14.4 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 82.4 m -133.49 -58.2 0.88 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -169.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.537 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 16.2 m-20 -114.54 68.98 1.98 Allowed Pre-proline 0 N--CA 1.467 0.386 0 CA-C-N 117.996 0.362 . . . . 0.0 111.764 -173.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.25 -14.25 28.44 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.42 2.08 . . . . 0.0 112.614 -174.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -89.06 -6.85 56.83 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -167.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.768 HD11 ' NE2' ' A' ' 35' ' ' GLN . 10.2 pt -91.7 170.79 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 119.964 -0.695 . . . . 0.0 110.941 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.3 p -126.61 168.64 14.03 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.733 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.497 ' H ' HD12 ' A' ' 44' ' ' ILE . 4.5 mp -72.27 119.47 18.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.566 ' HB2' ' HA ' ' A' ' 20' ' ' SER . . . -81.79 -46.72 13.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.751 -176.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 34.8 p80 -167.08 156.69 10.78 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.219 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 96.9 mmm -74.22 156.47 37.22 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 175.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.9 156.76 28.04 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.088 -1.053 . . . . 0.0 110.551 -173.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.453 ' HB2' ' CG2' ' A' ' 24' ' ' THR . 11.6 pt-20 -65.52 135.26 54.91 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.013 0.435 . . . . 0.0 110.292 -177.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.52 ' N ' HG23 ' A' ' 24' ' ' THR . 1.6 t . . . . . 0 C--O 1.251 1.171 0 CA-C-O 118.4 -0.809 . . . . 0.0 110.746 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -114.53 -34.3 5.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.97 0.414 . . . . 0.0 110.199 176.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -120.88 111.78 17.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.305 0.574 . . . . 0.0 110.223 175.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.0 p -153.91 142.76 21.06 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 172.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.04 130.99 66.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 121.115 0.483 . . . . 0.0 111.063 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 124.69 -117.92 3.19 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -130.34 140.14 50.65 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.105 0.479 . . . . 0.0 110.932 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.437 ' HD3' ' HA ' ' A' ' 8' ' ' LYS . 64.2 mmtt -99.6 123.22 43.67 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 166.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.79 119.41 19.75 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -162.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 78.4 m -127.55 146.08 50.64 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 165.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.2 m -154.22 28.95 0.45 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.215 1.007 . . . . 0.0 110.29 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -82.82 -5.06 58.78 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.865 177.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -171.76 150.94 2.75 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -167.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -128.81 93.62 3.66 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.666 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.693 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 77.0 m-85 -121.73 100.48 43.72 Favored Pre-proline 0 CA--C 1.501 -0.915 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 164.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.47 138.11 10.72 Favored 'Trans proline' 0 N--CA 1.441 -1.605 0 C-N-CA 120.555 0.837 . . . . 0.0 111.59 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.4 m -141.42 176.12 4.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.7 t -123.09 128.99 50.87 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.617 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.448 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -81.09 146.46 26.56 Favored Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 174.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.658 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 8.6 t -58.91 -12.79 4.91 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -172.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -74.08 -8.63 56.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.641 0.734 . . . . 0.0 110.128 173.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.92 26.84 23.25 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.12 -176.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.455 HG13 ' CE2' ' A' ' 25' ' ' TYR . 3.3 p -106.54 141.08 22.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.808 0.337 . . . . 0.0 111.384 -174.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.477 HG23 ' HA ' ' A' ' 49' ' ' GLU . 90.1 m -84.43 123.23 30.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.057 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.455 ' CE2' HG13 ' A' ' 23' ' ' VAL . 35.8 m-85 -109.84 136.13 49.64 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.563 0.697 . . . . 0.0 111.525 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.3 m -70.17 -32.07 69.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.323 -1.308 . . . . 0.0 112.361 -173.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.718 ' HB2' ' HD2' ' A' ' 28' ' ' PRO . 27.5 p30 -175.61 171.92 1.12 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.216 -174.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.718 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 6.1 Cg_endo -49.47 -41.49 43.87 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.736 2.291 . . . . 0.0 112.616 176.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.42 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 48.2 t -54.8 -50.62 68.09 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.163 0.506 . . . . 0.0 110.296 177.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -63.32 -45.92 89.05 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.296 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -65.74 -47.26 75.86 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.61 0.243 . . . . 0.0 110.818 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.419 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 41.6 t -63.61 -51.43 65.31 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.291 -176.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.45 -43.71 84.82 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 120.814 0.34 . . . . 0.0 110.828 -174.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.557 ' OE1' ' HA ' ' A' ' 34' ' ' GLN . 6.6 tp60 -64.06 -37.78 88.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.317 0.58 . . . . 0.0 110.576 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.819 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -74.8 -50.32 17.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.967 -178.017 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 32' ' ' SER . 12.8 pt-20 -64.8 -26.15 68.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.559 0.218 . . . . 0.0 111.477 -176.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.404 ' HB2' HE21 ' A' ' 37' ' ' GLN . 18.7 mt-30 -93.33 -35.94 12.8 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 98.9 m -124.74 -54.67 1.64 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -167.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -133.58 85.68 41.98 Favored Pre-proline 0 N--CA 1.465 0.313 0 CA-C-N 119.094 0.861 . . . . 0.0 111.38 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.98 -12.97 23.93 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 123.314 2.676 . . . . 0.0 112.751 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -81.72 -14.22 56.8 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.354 -165.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.819 HD11 ' NE2' ' A' ' 35' ' ' GLN . 9.9 pt -86.53 157.05 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.605 0.717 . . . . 0.0 111.0 -178.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.4 p -110.99 167.39 10.29 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.783 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.444 HD12 ' H ' ' A' ' 44' ' ' ILE . 4.5 mp -70.1 119.27 15.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 173.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.31 -48.7 19.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.279 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -168.93 158.69 8.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.31 176.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 25.9 ttt -77.75 140.07 39.44 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 172.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 110.68 161.15 17.7 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -172.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.477 ' HA ' HG23 ' A' ' 24' ' ' THR . 9.6 pt-20 -75.4 149.24 38.65 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.041 0.448 . . . . 0.0 111.234 -176.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.749 -0.643 . . . . 0.0 111.051 -177.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -109.64 -21.07 12.6 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 174.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -120.78 112.3 18.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.414 0.626 . . . . 0.0 110.648 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 38' ' ' CYS . 0.5 OUTLIER -153.1 128.86 10.15 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.933 -1.031 . . . . 0.0 108.975 176.094 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.3 t -123.76 127.02 73.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.023 0.439 . . . . 0.0 111.25 -174.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 130.18 -135.6 8.43 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 176.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.56 137.25 54.41 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.09 0.472 . . . . 0.0 109.778 175.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -98.36 121.97 40.95 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 174.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.71 122.63 24.29 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.687 0.756 . . . . 0.0 112.366 -168.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 34.8 t -134.37 147.85 50.58 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 172.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.73 44.75 0.68 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -172.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -84.45 -13.82 50.97 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.593 0.711 . . . . 0.0 109.51 173.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -170.7 151.84 3.62 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.526 ' CZ3' ' HB3' ' A' ' 26' ' ' SER . 57.7 t-105 -118.82 91.84 3.66 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.008 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.721 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 10.4 m-85 -123.73 100.77 37.2 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 164.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -80.59 143.36 15.06 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 121.236 1.291 . . . . 0.0 112.499 -170.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.0 m -137.04 -179.03 2.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.944 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 18.8 t -129.35 131.88 46.97 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.34 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.9 151.19 36.95 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 176.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.634 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 31.2 t -59.65 -12.69 7.33 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -171.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -80.24 -8.49 59.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.26 0.553 . . . . 0.0 110.101 174.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.22 28.77 10.28 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 -175.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.431 HG13 ' CE2' ' A' ' 25' ' ' TYR . 3.6 p -104.86 141.73 19.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.03 0.443 . . . . 0.0 111.592 -172.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.565 HG23 ' N ' ' A' ' 50' ' ' CYS . 0.9 OUTLIER -82.43 121.78 27.17 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.2 -175.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.431 ' CE2' HG13 ' A' ' 23' ' ' VAL . 23.9 m-85 -116.67 134.0 55.34 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.241 0.543 . . . . 0.0 111.137 176.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.526 ' HB3' ' CZ3' ' A' ' 14' ' ' TRP . 16.9 m -67.28 -26.27 66.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.005 -173.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.721 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 25.7 p30 -179.62 175.6 0.42 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.114 -172.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.654 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 71.6 Cg_exo -51.67 -49.23 17.89 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.487 2.125 . . . . 0.0 113.636 177.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.8 p -62.38 -32.04 72.79 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.662 0.267 . . . . 0.0 111.117 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.461 ' C ' HD22 ' A' ' 30' ' ' ASN . 0.2 OUTLIER -63.38 -46.32 87.01 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.865 175.152 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.476 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 42.5 t80 -66.19 -47.48 73.78 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.329 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.3 m -62.43 -49.8 74.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.768 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.42 ' HA ' ' HG2' ' A' ' 36' ' ' GLU . . . -67.39 -44.07 79.81 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.323 0.582 . . . . 0.0 111.114 -177.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.1 tp60 -67.71 -34.39 76.79 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.263 -177.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.788 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -77.41 -37.98 50.71 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.282 -178.217 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.599 ' HG3' ' HG3' ' A' ' 37' ' ' GLN . 10.2 pt-20 -70.09 -29.89 66.98 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.631 -0.427 . . . . 0.0 111.052 -177.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.599 ' HG3' ' HG3' ' A' ' 36' ' ' GLU . 9.7 mt-30 -103.05 -35.99 8.33 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -177.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 4' ' ' CYS . 10.0 m -107.64 -66.96 0.99 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -169.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.401 ' OD1' HG23 ' A' ' 42' ' ' ILE . 4.2 t70 -126.29 85.59 59.67 Favored Pre-proline 0 C--N 1.328 -0.33 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.9 -175.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.56 -13.12 27.38 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 123.119 2.546 . . . . 0.0 112.696 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -97.95 19.53 13.74 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -168.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.788 HD11 ' NE2' ' A' ' 35' ' ' GLN . 10.9 pt -115.74 156.67 16.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.736 172.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.487 ' H ' ' CB ' ' A' ' 20' ' ' SER . 0.2 OUTLIER -109.05 168.49 9.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.147 178.775 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.55 HD12 ' H ' ' A' ' 44' ' ' ILE . 4.9 mp -66.25 119.24 10.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.526 ' HB2' ' HA ' ' A' ' 20' ' ' SER . . . -82.47 -47.42 12.24 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.094 0.473 . . . . 0.0 110.333 -177.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -168.47 158.55 9.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.198 176.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 82.5 mtp -81.55 154.2 26.36 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.08 135.56 8.82 Favored Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -170.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.457 ' HB2' ' CG2' ' A' ' 24' ' ' THR . 9.6 pt-20 -68.84 141.09 55.21 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.078 0.466 . . . . 0.0 111.266 -175.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.565 ' N ' HG23 ' A' ' 24' ' ' THR . 3.9 m . . . . . 0 C--O 1.245 0.825 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.179 172.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.425 ' HB3' ' SG ' ' A' ' 4' ' ' CYS . . . . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 111.215 0.08 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 72.55 -52.8 0.7 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.56 0.744 . . . . 0.0 111.178 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -116.94 109.42 17.01 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.264 0.554 . . . . 0.0 110.606 173.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.425 ' SG ' ' HB3' ' A' ' 1' ' ' ALA . 0.8 OUTLIER -157.08 130.89 8.18 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.349 171.262 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.5 p -128.52 130.01 68.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 C-N-CA 119.813 -0.755 . . . . 0.0 112.205 -174.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 111.99 -112.45 3.08 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.037 173.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 25.4 ttp180 -130.43 122.29 27.48 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.951 0.405 . . . . 0.0 110.166 -174.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.629 ' HG2' HE22 ' A' ' 37' ' ' GLN . 24.4 tptp -97.38 123.51 41.24 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 176.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.91 117.29 16.6 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 122.025 0.917 . . . . 0.0 112.852 -160.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.5 t -138.96 144.09 38.85 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 166.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.5 m -162.26 71.96 0.34 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.398 0.618 . . . . 0.0 110.621 -174.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.9 ppt_? -115.17 6.95 15.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.423 0.63 . . . . 0.0 109.953 176.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 178.99 148.22 0.21 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -174.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 64.2 t-105 -118.41 95.28 4.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.42 0.629 . . . . 0.0 111.814 -177.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.65 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 48.1 m-85 -120.31 99.78 47.99 Favored Pre-proline 0 CA--C 1.505 -0.778 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 165.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -82.55 137.54 9.16 Favored 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 120.981 1.121 . . . . 0.0 112.616 -171.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.0 m -141.85 175.92 4.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.589 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 52.6 t -127.45 123.86 37.03 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.705 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -78.08 150.37 35.53 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 177.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.805 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 26.9 t -58.04 -12.25 3.21 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -171.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -74.96 -10.12 59.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.706 0.765 . . . . 0.0 109.612 173.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.04 21.07 34.15 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.382 -176.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.7 p -106.94 140.36 25.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.787 -176.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.533 ' OG1' ' HA ' ' A' ' 49' ' ' GLU . 1.6 t -87.72 131.28 34.53 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.58 0.705 . . . . 0.0 111.003 -176.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.705 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 69.7 m-85 -106.09 132.38 52.23 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.729 177.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.1 t -63.2 -26.73 68.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.998 -176.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.65 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 26.0 p30 -176.23 171.15 1.1 Allowed Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.154 -175.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.577 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 74.4 Cg_exo -50.76 -43.77 44.59 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.359 2.039 . . . . 0.0 112.247 177.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.3 t -54.62 -43.38 72.18 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.203 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -66.18 -46.08 78.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.006 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -66.41 -47.19 74.06 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.431 0.159 . . . . 0.0 111.431 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.6 p -63.34 -50.0 71.72 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.016 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.15 -43.92 85.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.944 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.589 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 9.5 tp60 -64.17 -41.15 97.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.805 -177.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.659 ' NE2' HD11 ' A' ' 42' ' ' ILE . 2.6 mp0 -72.93 -37.42 67.18 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.888 -176.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.48 -26.88 62.88 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.706 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.629 HE22 ' HG2' ' A' ' 8' ' ' LYS . 18.5 mt-30 -87.55 -31.6 19.82 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.6 m -117.14 -75.93 0.58 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -168.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.526 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 2.7 t70 -130.53 87.64 49.46 Favored Pre-proline 0 N--CA 1.463 0.206 0 CA-C-O 120.781 0.324 . . . . 0.0 111.073 -173.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -62.95 -13.32 34.27 Favored 'Trans proline' 0 N--CA 1.473 0.289 0 C-N-CA 123.578 2.852 . . . . 0.0 113.499 -176.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -84.56 -21.33 30.48 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -167.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.805 ' HB ' ' HB3' ' A' ' 20' ' ' SER . 3.0 pt -77.53 151.18 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.924 -177.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.3 p -110.75 168.2 9.65 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.114 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.4 mt -70.53 118.47 15.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 173.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.457 ' HB2' ' HA ' ' A' ' 20' ' ' SER . . . -75.38 -43.91 47.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.502 -176.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 26.8 p80 -167.79 155.94 9.0 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.668 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 22.7 ttt -77.04 145.14 38.14 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 174.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.33 167.45 16.67 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.26 -0.972 . . . . 0.0 112.042 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.533 ' HA ' ' OG1' ' A' ' 24' ' ' THR . 24.6 mt-10 -82.9 124.36 30.27 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.135 0.493 . . . . 0.0 111.524 -175.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.47 ' H ' ' CB ' ' A' ' 24' ' ' THR . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.124 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.844 173.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.76 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 120.663 0.268 . . . . 0.0 110.713 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 72.0 -58.46 0.59 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.255 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -113.68 112.17 23.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.051 0.453 . . . . 0.0 110.409 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.484 ' SG ' ' HG3' ' A' ' 34' ' ' GLN . 30.5 p -153.46 116.13 4.47 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 170.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.2 p -113.33 126.38 70.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.518 0.675 . . . . 0.0 111.027 -173.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 109.02 -102.6 1.68 Allowed Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.546 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -134.48 129.01 34.55 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -175.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.465 ' HD3' ' HA ' ' A' ' 8' ' ' LYS . 55.4 mmtt -100.56 127.22 47.0 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 166.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.86 119.22 20.33 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.388 0.613 . . . . 0.0 112.485 -165.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.51 ' SG ' ' HG3' ' A' ' 12' ' ' ARG . 43.6 t -138.32 146.78 42.81 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 171.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.47 62.49 0.75 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.685 0.755 . . . . 0.0 111.568 -177.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.51 ' HG3' ' SG ' ' A' ' 10' ' ' CYS . 6.2 mtm180 -95.42 -3.47 46.9 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 174.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 179.05 156.26 0.49 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.599 -163.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -128.86 91.93 3.31 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.034 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.739 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 60.3 m-85 -122.73 101.2 39.95 Favored Pre-proline 0 CA--C 1.503 -0.864 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 165.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -80.37 140.0 13.36 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 120.933 1.089 . . . . 0.0 111.695 -172.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.1 m -143.82 -175.49 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.373 0.606 . . . . 0.0 110.596 -177.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.3 t -128.59 134.48 48.6 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.694 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.538 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -82.26 148.23 26.55 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 175.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.757 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 32.3 t -59.16 -13.74 8.26 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -170.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -91.06 6.56 44.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.102 0.477 . . . . 0.0 110.599 175.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.22 28.74 16.56 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.507 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.536 HG13 ' CE2' ' A' ' 25' ' ' TYR . 7.1 p -105.37 144.08 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.088 0.47 . . . . 0.0 111.972 -173.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.505 ' CG2' ' HB2' ' A' ' 49' ' ' GLU . 1.3 m -82.39 122.39 27.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.012 -176.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.538 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 31.0 m-85 -114.59 132.81 56.22 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 121.497 0.665 . . . . 0.0 111.633 176.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.0 m -70.81 -28.73 64.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.862 -176.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.739 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 28.4 p30 -172.5 166.83 3.32 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.464 -175.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.494 ' HD3' ' HB2' ' A' ' 15' ' ' TYR . 75.0 Cg_exo -50.77 -44.11 42.82 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.336 2.024 . . . . 0.0 112.619 178.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 14.4 t -54.91 -45.91 74.79 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.159 0.504 . . . . 0.0 111.493 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.411 ' OD1' ' HD1' ' A' ' 25' ' ' TYR . 1.5 t-20 -59.26 -45.34 91.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.536 177.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -66.33 -48.92 68.72 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.802 178.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.2 p -64.65 -49.18 72.02 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -174.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.453 ' HA ' ' HG2' ' A' ' 36' ' ' GLU . . . -66.42 -44.74 82.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.728 0.299 . . . . 0.0 111.151 -177.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.484 ' HG3' ' SG ' ' A' ' 4' ' ' CYS . 36.0 tt0 -67.64 -33.36 74.81 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.54 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.768 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -72.96 -43.33 62.42 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.114 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.453 ' HG2' ' HA ' ' A' ' 33' ' ' ALA . 14.1 pt-20 -67.41 -29.46 68.96 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.394 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.76 ' HB3' ' HB3' ' A' ' 1' ' ' ALA . 16.5 mt-30 -84.31 -34.66 23.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.84 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 91.7 m -127.5 -66.46 0.88 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -164.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -120.56 90.17 45.42 Favored Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.271 -176.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -72.6 -11.77 26.43 Favored 'Trans proline' 0 CA--C 1.529 0.251 0 C-N-CA 123.287 2.658 . . . . 0.0 112.407 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -90.23 -22.53 21.6 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -167.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.768 HD11 ' NE2' ' A' ' 35' ' ' GLN . 17.5 pt -80.68 162.76 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.27 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.6 ' H ' ' HB2' ' A' ' 20' ' ' SER . 15.4 p -123.8 167.73 13.67 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.692 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.3 mt -67.93 118.77 12.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 173.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.42 -49.9 11.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.659 -176.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -160.36 161.94 33.28 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 79.0 mtp -84.57 150.24 25.35 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.76 150.32 26.7 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -170.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.505 ' HB2' ' CG2' ' A' ' 24' ' ' THR . 0.3 OUTLIER -61.93 138.52 58.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.211 0.529 . . . . 0.0 110.581 -176.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.43 ' N ' HG23 ' A' ' 24' ' ' THR . 0.7 OUTLIER . . . . . 0 C--O 1.244 0.803 0 CA-C-O 118.661 -0.685 . . . . 0.0 110.481 -178.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.636 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.477 0.908 0 CA-C-O 121.013 0.435 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -131.69 -37.39 1.19 Allowed 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 171.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -112.11 113.12 25.21 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.321 172.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -153.75 116.52 4.46 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.452 174.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.7 p -117.65 127.86 74.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.425 0.631 . . . . 0.0 110.855 -176.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 124.04 -108.96 1.21 Allowed Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.383 176.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -131.74 140.92 49.38 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.222 0.534 . . . . 0.0 111.766 -176.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.678 ' HB2' ' OE1' ' A' ' 34' ' ' GLN . 2.3 tmtp? -97.87 122.3 40.82 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 168.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.84 115.68 16.83 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.458 -172.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 44.2 t -139.02 147.12 41.69 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 171.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.9 m -157.91 63.48 0.46 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.348 0.594 . . . . 0.0 110.396 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -93.85 -18.9 21.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.249 174.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -173.03 156.9 3.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.034 -0.984 . . . . 0.0 108.357 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 28.2 t-105 -111.58 93.07 4.28 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.964 178.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.731 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 14.5 m-85 -121.56 100.08 44.58 Favored Pre-proline 0 CA--C 1.504 -0.802 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 163.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -82.61 143.27 11.98 Favored 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 121.125 1.216 . . . . 0.0 112.749 -169.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.6 m -133.47 169.06 22.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 33.6 t -121.52 122.61 40.09 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.134 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.89 144.19 28.53 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 176.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.498 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 59.1 m -57.26 -12.07 2.14 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -172.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -78.85 -2.42 39.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.615 0.721 . . . . 0.0 109.773 174.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.68 28.73 45.96 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -175.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.453 HG13 ' CE2' ' A' ' 25' ' ' TYR . 2.7 p -104.59 129.19 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 121.088 0.47 . . . . 0.0 110.922 -175.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.595 ' OG1' ' HB2' ' A' ' 50' ' ' CYS . 26.8 m -82.24 116.52 21.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.051 -169.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.543 ' HE1' ' HG2' ' A' ' 34' ' ' GLN . 33.9 m-85 -104.52 131.21 52.18 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.476 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.1 t -68.28 -27.08 66.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.975 -173.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.731 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 21.2 p30 -174.98 172.87 1.09 Allowed Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.211 -174.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.574 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 72.6 Cg_exo -52.24 -46.55 32.06 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.369 2.046 . . . . 0.0 113.465 178.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.2 p -61.95 -31.37 71.69 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.017 0.437 . . . . 0.0 111.327 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.402 ' C ' HD22 ' A' ' 30' ' ' ASN . 0.3 OUTLIER -65.82 -47.56 74.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.852 175.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -66.62 -47.51 72.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.816 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.0 m -63.18 -50.19 71.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.851 -175.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.471 ' HA ' ' HG2' ' A' ' 36' ' ' GLU . . . -68.32 -43.06 78.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.164 0.506 . . . . 0.0 111.239 -177.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.678 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 44.0 tp60 -64.24 -35.49 81.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.022 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.815 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -77.98 -43.96 28.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.638 -178.311 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.477 ' HG3' ' HG3' ' A' ' 37' ' ' GLN . 11.4 pt-20 -66.11 -30.85 71.43 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.281 -177.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.636 ' HB3' ' HB3' ' A' ' 1' ' ' ALA . 16.4 mt-30 -93.74 -35.47 12.77 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.997 -178.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.3 m -109.35 -75.34 0.63 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.825 -169.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.414 ' O ' ' HG3' ' A' ' 35' ' ' GLN . 12.4 t0 -124.39 91.23 49.81 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.843 0.354 . . . . 0.0 110.654 -176.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.45 -13.25 27.68 Favored 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 123.123 2.549 . . . . 0.0 112.868 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -82.62 -21.74 34.99 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -166.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.815 HD11 ' NE2' ' A' ' 35' ' ' GLN . 10.9 pt -78.34 164.41 3.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.04 -177.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.09 169.45 9.09 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.985 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.5 mt -72.19 117.47 15.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 167.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.447 ' HB2' ' HA ' ' A' ' 20' ' ' SER . . . -77.05 -42.48 38.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 -175.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -168.5 158.71 9.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.422 176.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.0 tpt -72.66 139.77 47.52 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 175.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.26 153.67 26.19 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.458 -175.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.563 ' HB2' HG23 ' A' ' 24' ' ' THR . 6.9 pt-20 -67.44 149.34 50.36 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.665 0.269 . . . . 0.0 111.421 -177.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.595 ' HB2' ' OG1' ' A' ' 24' ' ' THR . 60.3 m . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.873 -0.584 . . . . 0.0 111.243 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.963 0 CA-C-O 120.758 0.313 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -123.27 -36.04 2.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.139 0.495 . . . . 0.0 109.938 173.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -114.6 129.34 56.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.949 174.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.541 ' SG ' ' HG3' ' A' ' 34' ' ' GLN . 28.5 p -151.17 116.13 5.25 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.61 129.59 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 121.687 0.756 . . . . 0.0 111.528 -172.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.01 -96.1 1.82 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 173.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -131.77 136.34 47.49 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 174.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -99.67 120.27 39.44 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 171.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.75 120.22 21.61 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.439 0.638 . . . . 0.0 112.362 -167.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.47 ' SG ' ' N ' ' A' ' 30' ' ' ASN . 16.9 p -136.14 148.45 48.22 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 166.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.1 m -148.81 83.89 1.46 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.344 0.592 . . . . 0.0 111.385 -172.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.654 HH21 ' HB2' ' A' ' 28' ' ' PRO . 27.5 ptt180 -115.57 -10.25 11.9 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.262 176.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 177.51 159.04 0.41 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -174.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -114.0 93.69 4.48 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.802 176.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.662 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 50.2 m-85 -119.53 99.93 49.66 Favored Pre-proline 0 CA--C 1.502 -0.887 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 165.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.74 138.58 10.66 Favored 'Trans proline' 0 N--CA 1.438 -1.792 0 C-N-CA 120.69 0.927 . . . . 0.0 112.146 -171.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.3 m -140.99 168.87 15.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 45.1 t -119.68 126.95 52.35 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.696 -178.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.619 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -77.16 145.97 31.43 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 175.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.44 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 28.2 t -57.84 -11.8 2.6 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -172.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -78.75 -8.93 59.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.357 0.598 . . . . 0.0 110.31 174.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.73 28.26 11.48 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.666 -177.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.559 HG13 ' CE2' ' A' ' 25' ' ' TYR . 2.1 p -106.21 141.79 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -174.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.1 m -83.45 122.53 28.64 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.482 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.619 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 49.6 m-85 -111.27 136.82 49.82 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.429 0.633 . . . . 0.0 112.195 177.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.7 m -70.62 -38.68 73.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.31 -1.314 . . . . 0.0 112.401 -174.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.662 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 6.3 p30 -173.35 175.45 0.97 Allowed Pre-proline 0 C--N 1.329 -0.326 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.654 ' HB2' HH21 ' A' ' 12' ' ' ARG . 92.6 Cg_exo -46.01 -42.01 20.79 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 122.911 2.407 . . . . 0.0 114.944 -176.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.5 p -63.79 -33.39 75.57 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.626 0.648 . . . . 0.0 111.083 -177.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.47 ' N ' ' SG ' ' A' ' 10' ' ' CYS . 1.8 t-20 -67.56 -47.1 70.78 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.421 -176.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.512 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 62.4 t80 -66.49 -46.94 74.63 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.698 175.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.5 t -60.86 -50.89 71.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.424 -175.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.437 ' HA ' ' HG2' ' A' ' 36' ' ' GLU . . . -68.8 -47.39 66.22 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.484 -175.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.548 ' O ' ' HB2' ' A' ' 38' ' ' CYS . 31.9 tt0 -65.63 -31.35 72.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.367 0.603 . . . . 0.0 110.203 -176.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.827 ' NE2' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -78.15 -44.62 25.47 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.595 -178.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.437 ' HG2' ' HA ' ' A' ' 33' ' ' ALA . 10.7 pt-20 -65.25 -36.67 84.86 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.293 -176.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.637 ' HG3' ' SG ' ' A' ' 38' ' ' CYS . 12.8 pt20 -98.21 -34.14 10.84 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.994 -176.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.637 ' SG ' ' HG3' ' A' ' 37' ' ' GLN . 62.2 m -108.43 -67.58 0.96 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -170.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -123.66 86.59 52.76 Favored Pre-proline 0 N--CA 1.465 0.31 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.043 -176.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -73.61 -11.95 24.42 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 123.076 2.518 . . . . 0.0 113.115 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -86.02 -12.39 50.4 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -167.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.827 HD11 ' NE2' ' A' ' 35' ' ' GLN . 11.6 pt -93.97 159.17 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.05 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.5 p -121.35 168.0 12.14 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.381 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.9 mt -69.1 119.98 15.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.09 -50.94 7.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.859 -177.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 27.6 p80 -162.08 159.12 25.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.157 177.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 80.7 mtp -76.94 148.79 36.15 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 175.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.1 150.96 22.64 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -175.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.451 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 1.2 pm0 -71.06 148.99 46.97 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.961 0.41 . . . . 0.0 111.023 -178.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.73 -178.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.688 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 120.402 0.144 . . . . 0.0 110.803 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 69.84 -78.36 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.322 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -121.01 113.84 20.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.336 0.589 . . . . 0.0 110.591 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.7 p -153.02 140.04 19.24 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 171.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.0 p -114.02 123.93 70.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.153 -173.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.511 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . 103.47 -90.32 0.75 Allowed Glycine 0 N--CA 1.439 -1.114 0 CA-C-N 114.997 -1.002 . . . . 0.0 112.077 169.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.531 ' H ' ' HD3' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -132.99 140.18 47.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.919 0.39 . . . . 0.0 110.903 179.78 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 8' ' ' LYS . 23.5 mmtt -98.73 131.61 44.75 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 168.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.33 119.6 17.79 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.581 0.705 . . . . 0.0 112.009 -169.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 44.8 t -137.56 146.2 43.78 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 174.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 m -156.38 53.71 0.55 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.284 0.564 . . . . 0.0 111.414 -174.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 23.7 ptt85 -100.84 -0.04 37.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.461 0.648 . . . . 0.0 110.037 173.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -172.56 155.15 3.29 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -175.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -129.3 93.32 3.54 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.447 177.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.65 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 50.7 m-85 -122.72 102.35 38.65 Favored Pre-proline 0 CA--C 1.5 -0.973 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 165.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -81.26 137.84 10.83 Favored 'Trans proline' 0 N--CA 1.439 -1.719 0 C-N-CA 120.732 0.955 . . . . 0.0 112.283 -172.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.0 m -140.8 172.28 11.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.329 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 47.7 t -121.25 132.7 54.97 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.59 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.591 ' HA3' ' HE2' ' A' ' 25' ' ' TYR . . . -84.48 149.74 25.04 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 174.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.492 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 8.2 t -59.28 -12.46 5.59 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -171.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.481 ' HB2' HG21 ' A' ' 42' ' ' ILE . 23.3 t70 -77.08 -7.26 55.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.58 0.705 . . . . 0.0 109.599 174.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.39 25.13 24.53 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.279 -177.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.565 HG13 ' CE2' ' A' ' 25' ' ' TYR . 3.5 p -105.51 140.99 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 121.13 0.491 . . . . 0.0 111.557 -172.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.0 m -82.78 121.66 27.19 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.183 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.591 ' HE2' ' HA3' ' A' ' 19' ' ' GLY . 51.6 m-85 -105.65 132.93 51.19 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.995 177.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.4 m -70.46 -26.42 63.63 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.765 -1.107 . . . . 0.0 112.181 -174.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.687 ' HB2' ' HD2' ' A' ' 28' ' ' PRO . 30.3 p30 -173.93 170.4 1.78 Allowed Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.687 ' HD2' ' HB2' ' A' ' 27' ' ' ASN . 9.3 Cg_endo -52.63 -37.28 74.4 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.569 2.179 . . . . 0.0 111.866 175.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.483 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 12.8 t -54.42 -51.55 64.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.375 175.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.424 ' CG ' ' HD1' ' A' ' 25' ' ' TYR . 1.8 t-20 -63.93 -44.8 91.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.13 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.501 ' HD1' ' CD2' ' A' ' 25' ' ' TYR . 64.8 t80 -63.21 -50.06 71.77 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 120.895 0.378 . . . . 0.0 110.466 -178.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.453 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 34.8 t -64.88 -52.2 57.86 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.141 -176.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.54 -40.88 89.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.881 0.372 . . . . 0.0 111.502 -173.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.511 ' HG2' ' O ' ' A' ' 6' ' ' GLY . 49.4 tp60 -62.69 -42.04 99.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.393 0.616 . . . . 0.0 110.485 -178.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.588 ' NE2' HD11 ' A' ' 42' ' ' ILE . 43.5 mt-30 -78.96 -41.3 29.58 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -176.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 32' ' ' SER . 12.6 pt-20 -69.14 -25.6 64.46 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.827 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.688 ' HB3' ' HB3' ' A' ' 1' ' ' ALA . 20.2 mt-30 -95.58 -27.76 15.18 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 78.8 m -137.77 -50.8 0.61 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -172.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.528 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 57.9 m-20 -119.92 68.81 12.8 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 118.229 0.468 . . . . 0.0 111.492 -170.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.55 -13.78 35.74 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.526 2.151 . . . . 0.0 113.73 -170.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -94.38 10.04 35.89 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -166.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.588 HD11 ' NE2' ' A' ' 35' ' ' GLN . 7.7 pt -109.59 156.6 10.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 118.981 -1.088 . . . . 0.0 111.47 175.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.0 p -118.53 168.58 10.54 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.562 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.7 mt -64.8 119.45 9.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.492 ' HB2' ' HA ' ' A' ' 20' ' ' SER . . . -84.31 -44.98 13.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.953 -177.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -168.37 156.89 8.67 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.736 175.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 95.8 mmm -74.62 144.72 43.77 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.18 148.44 24.07 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 110.614 -0.995 . . . . 0.0 110.614 -174.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.434 ' HG3' ' H ' ' A' ' 49' ' ' GLU . 0.4 OUTLIER -71.85 149.27 45.38 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.003 0.43 . . . . 0.0 111.037 -176.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.011 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.584 -171.365 . . . . . . . . 1 1 . 1 stop_ save_